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ABSTRACT 
Self-Assembling, Coiled Coil Interfaces for Nanoscale Amperometric Biosensors 
Mark Ryan Contarino 
Irwin M. Chaiken & Kambiz Pourrezaei 
 
 
 
 
Both gold nanostructures and carbon nanotubes are rapidly emerging platforms 
for amperometric biosensor detection. Homogeneous display of biomolecular ligands is a 
key process in forming nanoscale array biosensors, improving the chances for sufficient 
signal strength and reproducibility at the limits of sensor geometries. The use of self-
assembling interfaces on gold electrodes and CNT arrays enables homogeneous display, 
solvent access, target capture, sensor surface regeneration and potential for molecular 
wiring.  Our approach uses an anchor peptide, covalently linked to the sensor surface, 
that is able to non-covalently capture probe labeled targets in solution with a high affinity 
and minimal surface leaching.  The use of non-disrupting, metal-chelating scaffolds 
within the coiled coil sequence was tested for molecular wiring capabilities using model 
redox targets. Recombinant cassette production of probe sequences was investigated as a 
means to enable control over spatial and stoichiometric placement of redox active 
mediators and/or biomolecules. This thesis defines potential challenges that face protein 
interfacing in amperometric biosensors as well as opportunities for future developments. 
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CHAPTER 1: INTRODUCTION 
 
Nanotechnology 
 Richard Feynman gave a speech on December 29th, 1959 to the American 
Physical Society at California Institute of Technology decreeing that “there is plenty of 
room at the bottom,” in effect challenging the scientific community to focus on 
instrumentation and experimentation dealing with extreme miniaturization, as viewed in 
Figure 1.  Thus nanotechnology’s roots lie in chemistry and physics, but today 
encompass a diverse scholastic range including biology and engineering.  
Nanotechnology is broadly defined as those techniques that control and manipulate on the 
scale of  1-9 to 1-7 meters and often include bottom-up assembly (think masonry bricks), 
as opposed to top-down approaches (carving a statue from a block of marble), 
encompassing systems that can self-assemble and perform tasks.  
 
 
 
Figure 1.  A micrograph of the winner of Feynman’s first challenge, a motor smaller than 
1/64 of an inch in all dimensions.  The head of a pin is included at the top of the image to 
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provide a sense of scale.  Figure used with permission, courtesy of the Archives, 
California Institute of Technology (175).  
 
 
 Nature has provided examples of nanotechnology in action.  The minute workings 
of living organisms are built from a select number of molecules that self-assemble into 
larger units, forming complex structures that function autonomously in the macro-scale 
realm.  At the nanoscale, molecules utilize non-covalent electrostatic and hydrophobic 
interactions to form the smallest working machinery to date.  The study of nature at the 
nanoscale can help to gain insights into molecular structure and designs that perform 
specific tasks with high fidelity in extremely heterogeneous environments.  Harnessing 
these insights to engineer molecular machines with application driven tasks are quickly 
becoming a reality (229, 304, 305).   
 
Biosensors 
 One particular engineering application of nanotechnology focuses on the 
detection of biomolecules, known as biosensing.  A biosensor is a device for the detection 
of an analyte via the combination of a biological component and a physiochemical 
detection component.  The biological component is sensitive to the analyte and is often a 
living organism or a constituent thereof.  The detection component transduces the 
presence of the analyte into a physical event that can be monitored.  There are many 
kinds of detection schemes, the most popular of which can be grouped into 
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electrochemical, optical, piezoelectric, thermometric and magnetic transducers.  Figure 2 
depicts the basic framework of a typical biosensor. 
 
 
 
Figure 2.  Schematic diagram of the common elements that compose a biosensor.  A 
target is captured by a biological recognition element and then transduced into a 
measurable signal. 
  
 
Impact  
 Detection and monitoring analytes are big business.  Biosensors have tethered 
their roots into many fields, providing information-rich tools for diverse scientific 
investigations.  In basic scientific research, biosensors are routinely used to understand 
antagonist/agonist interactions at the molecular level and define the emerging bio-
complexity found within living organisms.  In the biotechnology and pharmaceutical 
industries, biosensors are discovering biological markers for indication of disease states.  
These are biosensors hoped to provide early-warning detection schemes before 
symptomatic onset of disease, the most decisive factor for the successful treatment of 
many types of cancer.  They also assist multiple other facets including drug screening, 
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drug design and testing of therapeutic leads.  The military is interested in biosensor 
development for the rapid detection of bioterrorism agents, as well as novel applications 
that harness energy from reusable sources.  Furthermore, these devices are invaluable for 
the assessment of environmental impact for pre/post remediation levels of toxic entities 
and pathogens.  
  
Challenges 
 The desired features of the quintessential biosensor would be 100% selective for 
the analyte of interest to ensure accurate detection.  False alarms may cause undue panic, 
say in the case of an anthrax biosensor in a public setting.  Similarly, this biosensor 
should be sensitive enough to enable real time detection of a few molecules.  The 
working detection range would also encompass a tunable limit for application specific 
tasks.  An alert should only be raised when the detection level of the target analyte 
crosses a defined threshold.  The operation of this biosensor should be robust to work in 
complex environments and possess a sufficient shelf-life for long term storage.  Finally, 
this biosensor should remain cost-effective and of minimal size.  This wish list may 
exceed the amassed capabilities of current biosensors, but provides unique research and 
development opportunities for new advancements in both the biological and 
physiochemical components of future biosensors. 
 We believe that the next generation of biosensors will be guided by a better 
understanding and utilization of biological molecules and their interactions with the 
sensor surface.  Several design principles of next-generation biosensors, outlined in 
Figure 3, should enable controlled and multi-functional interfacing of the biological 
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capture component with the physiochemical detection platform.  Oriented immobilization 
schemes ensure the isotropic display of biomolecules in a functional state; maintenance 
of solvent accessibility allows immobilized biomolecules to interact with solution-based 
targets without steric hindrance or detrimental adsorption artifacts caused by contact with 
the sensor surface.  Self-assembly and regeneration enable experimental repeats and 
automation on the same sensor surface, and multiplexing facilitates the detection of 
scalable target species on the same platform.  
 
 
 
Figure 3.  Several design principles for the development of next generation biosensors.  
 
 
Orientation 
 At the nanoscale, every molecule counts.  In order to achieve accurate nanoscale 
biosensing, individual biological elements should remain in an active functional state.  
An overarching goal of biosensor design is the orientation of biological elements by 
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immobilization through a single location, not the stochastic ensemble that will occur 
upon random immobilization.  The simplest immobilization technique, heterogeneous 
adsorption to biosensor surfaces, has been shown to diminish innate activity or even to 
render the peptide/protein recognition elements ineffective (291).  The most direct path to 
achieving uniform orientation of biological elements is through a covalent bond 
formation between the transducer and the biological component.  This linkage is stable 
under most operating conditions and easily obtained.  However, many covalent 
immobilization pathways target multiple loci on biological targets leading to a decrease 
or even total loss of target recognition.  In turn, this manifests itself in high signal 
variability between individual nanoscale biosensors.  
 Many biosensor surfaces only have one or two chemically distinguishable regions 
for attachment, but biomolecules are not that simplistic.  When interfacing biomolecules 
with inorganic biosensor elements, knowledge of potential attachment sites on those 
biomolecules is a must.  Nucleic acids, synthetic analogues, peptides, and proteins 
represent a diverse library of biosensor recognition elements, and the tools to 
functionalize biosensors with these molecules are of crucial importance.  Current 
biosensors that utilize nucleic acids are a mature technology that can ascertain massively 
paralleled information at the genomic level.  However, peptides and proteins are created 
downstream from genomic expression and may provide a more accurate reporter for 
biological systems.  Unfortunately, peptides and proteins also represent the most 
challenging recognition elements, although these biomolecules have a higher diversity of 
cognate target recognition. 
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 Peptides and proteins are created from a linear combination of the 20 amino acids, 
and have a defined molecular recognition area determined by the complex folding and 
display of their amino acid sequence.  In a suitable environment, this increased sequence 
complexity can provide more functionality than that of their nucleic acid counterparts.  
Peptides and proteins also have some control over their moieties for oriented covalent 
immobilization, albeit less than that of DNA/RNA.  There is a single amine and a single 
carboxyl at the N-terminus and C-terminus respectively of the sequence.  These 
potentially reactive moieties also exist in the side chains of several amino acids (amino 
acid-reactive moiety): lysine-amine, aspartic acid-carboxyl and glutamic acid-carboxyl.  
The zero length heterobifunctional crosslinker EDC/NHS is by far the most commonly 
employed means for covalent attachment of peptides/proteins to biosensor surfaces, 
forming a peptide bond between amines and carboxyls.  Since these reactive groups are 
present in charged residues, they are often present in abundant quantities on the solvent 
exposed surface of proteins.  Thus, immobilization via amine or carboxyl moieties will 
most often result in a heterogeneous display at the nanoscale.  As an example, the many 
lysine residues of a typical antibody are highlighted in Figure 4.  EDC/NHS 
immobilization pathways will only link this molecule in a manner that results in a 
stochastic ensemble of biosensor capture elements.  
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Figure 4.  Potential lysine residues (red), on an IgG1 antibody, that provide reactive 
amines for EDC/NHS functionalization in many biosensors.  Schematically, biosensor 
surfaces that have been functionalized with antibodies using EDC/NHS are typically 
drawn with the antigen binding sites oriented away from the surface, but in reality they 
are heterogeneously immobilized.  Antibody molecule was modeled with Pymol (62) 
using the 1IGY.pdb file (103). 
 
   
 Another opportunity to form a site-specific linkage is found within individual 
cysteine residues.  These amino acids present a single reactive thiol (also called 
sulfhydryl) group, and perhaps more attractive, their frequency of occurrence in peptides 
and proteins is very low.  Unfortunately, these residues are often critical for peptide and 
protein function and are rarely exposed to the solvent.  Their innate ability to form 
disulfides helps to stabilize both the three dimensional structure of proteins and peptides 
and potential complexes with other thiol containing molecules.  Formation of disulfides 
from two free thiols between proteins often serves to activate cellular machinery (110), 
implying that the disulfide is found along the recognition surface between the interacting 
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components.  In this way, covalent attachment through native thiols may limit target 
recognition, or even block downstream function in more complex biosensors.  
 Regardless of these limitations, free thiols still provide an attractive 
immobilization site for isotropic display of biologics.  Many proteins can have their 
native disulfides reduced into active thiols with the addition of a reduction agent, such as 
DTT, BME or TCEP, and still remain functional (195).  These reduced biomolecules are 
then covalently attached to a thiol reactive group for specific covalent linkage, as seen in 
Figure 5.  Haloalkyl groups, and largely iodoacetyl groups, primarily react with free 
thiols on cysteines to form a stable thioether bond, but can also react with methionine 
residues to a lesser degree.  Maleimides are more cysteine specific than their iodoacetyl 
counterparts and have optimum reactivity near pH = 7.0.  An added benefit is that the 
reduction agent TCEP can be used in conjunction with maleimide reactions, as where in 
other methodologies the reduction agent must be removed from the reaction mixture prior 
to covalent bond formation.  An additional thiol reactive chemistry utilizes a disulfide 
exchange reaction between pyridyldithiol groups and free thiols.  Because this 
pyridyldithiol chemistry results in a disulfide formation, it may be broken with the 
aforementioned reduction agents or an externally applied redox potential.  In the 
specialized case of noble metal surfaces, the thiol group on a cysteine residue can also 
covalently direct assembly without any additional chemistries (49, 68).   
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Figure 5.  Thiol directed chemistries and covalent bond formation. A)  Iodoacetyl groups 
react with free thiols to form a thioether bond. B) Maleimide groups also form a stable 
thioether bond with free thiols. C) Pyridyldithiol groups undergo a disulfide exchange 
with free thiols and release pyrine-2-thione as a byproduct. 
 
 
 If a protein or peptide does not have a free thiol or cannot function in a reduced 
state, engineering a single cysteine within the sequence of peptides and proteins affords 
an opportunity to limit the biomolecule attachment site to a single location for covalent 
crosslinking.  Recent progress in single molecule atomic force microscopy has led to the 
increased use of mutants with multiple cysteines expressed at the N- or C-termini, 
facilitating an oriented thiol linkage of the molecular-engineered proteins (68).  For 
example, a de novo designed protein has been recombinantly engineered to contain a 
terminal sequence of multiple cysteines that can be used to covalently link them to gold 
sensor surfaces (24).  Redox enzymes can also employ this multi-thiol linkage strategy to 
orient themselves onto conductive sensor surfaces (99).  Engineering cysteines into 
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recombinant peptides and proteins is also not without limitations; the additional potential 
disulfide formations can interfere with native protein folding, stabilizing inactive 
structures.   
Aside from the inclusion of additional cysteines, one alternative is to incorporate 
a non-natural amino acid that displays a single chemically reactive species, such as an 
azide or an alkyne via auxotrophic expression.  This technique utilizes a genetically 
modified cell that cannot produce a particular DNA-encoded amino acid, e.g. methionine, 
and the cellular machinery replaces it with an alternative, non-canonical amino acid in the 
peptide chain.  Upon auxotrophic protein expression, methionines coded in the sequences 
are replaced by homo-azido alanine or an amino acid featuring an alkyne on its side 
chain, as seen in Figure 6.  With the addition of a catalytic amount of copper, azide and 
alkyne moieties react virtually to completion at room temperature (~ 92 % yields) to form 
specific and stable triazole linkages without byproduct formation (232, 267).  Using 
auxotroph bacteria, Kiick et. al. pioneered such azide incorporation into engineered sites 
within recombinant proteins that were capable of the triazole formation (134).  Link et. 
al. improved this process using extremely pure copper bromide as the catalyst for copper-
catalyzed triazole formation on bacterial cell surface glycoproteins (159).  
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Figure 6.  Left: Auxotrophic expression of the non-native amino acid homo-azido 
alanine.  The tRNA that would typically insert a methionine now inserts a homo-azido 
alanine in order to display azide functionality within the sequence of the recombinantly 
produced protein or peptide.  Right: The gold standard of click chemistry, a 1,3 dipolar 
cycloaddition between an azide and an alkyne to form a 1,2,3 substituted triazole. 
 
 
Solvent access 
Oriented covalent immobilization may not be the only design principle required 
for functional display of biological components within nanoscale biosensors.  As an 
example, many redox enzymes require substrates to bind to a definitive site on the 
enzyme for substrate conversion and electronic signal acquisition.  If the attachment site 
on the biomolecule is near or within this crucial catalytic site, the substrate may not be 
converted because it cannot freely access this region.  The result of this blockage at the 
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protein’s active site is a reduction or complete loss of bioelectrocatalytic signal.  In turn, 
this would lead to decreased performance and greater variability between nanoscale 
biosensors.  Tethering the biomolecule away from the surface ensures uniform access to 
the solvent, previously shown to enhance sensor performance (239).  It is also known that 
biomolecule adsorption to the surface of many biosensor substrates may alter the native 
conformation of the protein, which can be avoided via tethering (290, 291). 
For instance, when the redox protein glucose oxidase was attached covalently to 
the CNT tips using EDC/NHS chemistry or adsorbed sidewalls on a CNT array 
biosensor, dramatically different redox events were observed with cyclic voltammetry 
experimentation, as seen in Figure 7.  The tip-directed scheme has a much narrower 
redox peak, whereas the sidewall scheme has significant broadening in its corresponding 
peak.  This result may be partially explained by the fact that the tip immobilization 
scheme allows for a more uniform substrate access to the enzyme’s binding site; the 
sidewall immobilization did not allow for such uniform substrate access and may have 
denatured the enzyme through strong hydrophobic interactions (291).  
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Figure 7.  Cyclic voltammetry of two redox protein-CNT electrode conjugates in the 
presence of 50 mM glucose.  The redox protein linked to the tips (a) produces a defined 
peak around the expected redox potential (0.42 V vs. Ag/AgCl), while the sidewall 
adsorbed protein (b) produces a broader peak at a slightly higher potential (0.58 V vs. 
Ag/AgCl).  A control electrode (c) was capped and coated with surfactant to block 
protein attachment and has no distinguishable peak.  On a second control electrode (d), 
no redox protein is added.  Figure and caption used with permission from (291). 
 
 
Self-assembly and regeneration 
 Beyond the design principles of isotropic display and uniform solvent access for 
biological recognition elements, lies the desire to reuse the sensor in an automated 
fashion.  Complete sensor regeneration allows for repeat experiments on the same sensor 
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surface as well as computer automation for varied experimental conditions.  Furthermore, 
the inherent instability of many proteins, especially enzymes, necessitates the renewed 
deposition of fresh and active biological recognition components after differing time 
periods.  In cells, these components are dynamically re-synthesized as they are required, 
while a biosensor would benefit greatly from a solution based assembly and disassembly.  
A disposable sensor most likely will not require such self-assembly and regeneration 
characteristics; most nanoscale biosensors have not yet reached this level of cost-
efficiency. 
 Regeneration of the sensor surface is also not without limitations.  The 
immobilized capture interface may not completely withstand the regeneration conditions.  
That is, there may be a decrease in activity for the capture interface over time.  
Incomplete regeneration on the other hand leads to “memory effects,” where a small 
amount of material remains captured on the biosensor, incorporating error in the acquired 
signal to a given amount of target substrate.  Furthermore, non-specific accumulation of 
material on the biosensor capture interface may reduce the response to a given target over 
multiple cycles.  Finding regeneration conditions that avoid these pitfalls is often very 
challenging, but when such conditions are found they can be successfully implemented 
for use in automated cycles. 
 One approach to incorporating self-assembling interfaces on biosensors can be 
described as an anchor/probe scheme.  In this scheme, the anchor is covalently linked via 
isotropic display of the biosensor platform substrate.  The probe component is then able 
to non-covalently recognize the anchor component, binding with a high interaction 
strength and selectivity.  At the desired time, an applied regeneration solution refreshes 
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the sensor surface ready for new probe deposition.  Through this means, sensor surfaces 
can be constructed, deconstructed and reconstructed, providing a fresh biological 
component for multiple experimental cycles as envisioned in Figure 8 for a model CNT 
array biosensor platform. 
 
 
 
Figure 8.  Self-assembly and regeneration of a CNT sensor surface using an 
anchor/probe strategy.  (Inset) The blue anchor is able to non-covalently recognize the 
red probe that can be fused to a cyan biological component. (a) Oriented covalent 
attachment of the anchor to the CNT tips enables a recognition surface for the probe.  (b) 
Upon addition of the probe in solution, self-assembly is able to isotropically display (c) 
the cyan target molecule through the capture component (red).  The biological component 
is free to access the solvent and its native target. (d) Upon addition of a regeneration 
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solution that disrupts biological assembly between the anchor/probe, the probe is washed 
from the surface and can be reapplied when desired for further experimentation. 
 
 
 Biological recognition is a reversible, non-covalent process that can be 
mathematically defined in terms of affinity for one molecule to interact with another.  
Driven by intermolecular forces (electrostatic, van der Waals, hydrogen bonding) in 
solvent, affinity is a function of the rate at which molecules associate with, and 
subsequently dissociate from their complementary molecule.  The affinity is often 
expressed in terms of the equilibrium dissociation constant (KD = koff / kon), a molar 
quantity that represents the concentration at which 50% of the species is interacting.  The 
implementation of protein and peptide anchor/probe interfaces in biosensors would 
ideally feature a fast association rate (kon) and a slow dissociation rate (koff), ensuring 
rapid and efficient capture with minimal target leaching.  This assures that the biological 
recognition element would remain in place until its desired time of release. 
 Researchers have borrowed from the immune system and its capability to produce 
antibodies that be directed to bind to virtually every biological target (antigens). 
Biosensors commonly employ the high affinity of antibodies towards their antigen as a 
biological recognition element.  The bivalent IgG form is the most commonly used 
antibody and is grouped into two types, polyclonal and monoclonal.  A polyclonal 
antibody is produced by the injection of antigen into live animals and purification from 
blood/serum. Polyclonal antibodies can bind to the entire surface of the specific antigen 
in multiple locations and result in randomly-oriented capture.  Monoclonal antibodies, 
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produced in cellular factories, are directed to interact with a single distinct location, 
called epitope, of a target antigen.  Thus, monoclonal antibodies are useful for oriented 
anchor/probe display of proteins in biosensors, attributing the same affinity for a single 
site on a target in solution.  On immobilized biosensor substrates, care must be taken to 
ensure that the antibody is not immobilized in a pathway that may hinder or block antigen 
recognition (128).  The regeneration of antibody/antigen interactions is readily achieved 
with a combination of high salts and low pH solutions.  However, these biomolecules are 
rather large ~150 kDa and have variable affinity between antibody/antigen pairings, 
resulting in regeneration conditions that are difficult to determine for a multiplexed array 
biosensor. They also have two binding sites resulting in lowered control of stoichiometry 
(number of binding sites), and can be quite expensive to obtain.  These drawbacks have 
not stopped the use of antibody arrays within multiplexed biosensors (61, 144); their 
specificity towards any desired epitope on virtually any target is unmatched. 
 What if there was a way to have a strong interaction without the use of antibodies, 
a kind of generic capture moiety?  Again, nature has already provided us with these tools.  
Perhaps the most commonly employed biological recognition pairing is that of the small 
protein streptavidin and the small molecule biotin (also known as Vitamin B).  This 
interaction is virtually irreversible, possessing an extraordinarily high affinity KD ~ 10-15 
M (97).  Unfortunately, this strong interaction makes biotin/streptavidin separation 
difficult and hinders the ability to regenerate the biosensor surface.  Mutations to the 
streptavidin protein have brought about marked advances, decreasing the stoichiometry  
to biotin from four to one and lowering the affinity to its biotin target, enabling greater 
stoichiometric control and complete regeneration capabilities (220). 
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 Similarly, there have been many advances in protein chemistry for the production 
and purification of proteins in sufficient quantity/purity for bioanalysis.  Tailoring the 
purification method to isolate a single protein species by its individual biophysical 
characteristics is extremely time consuming; thus simplified conditions were created for 
ease of purification via affinity tags.  These genetically-expressed affinity tags employ 
specialized amino acid sequences in either peptide (short) or protein (long) form that can 
capture or release expressed targets under standardized buffer conditions. This 
technology was driven largely by the requirements of structural biology, as milligrams of 
purified protein are often required to determine its native structure by crystallographic 
analysis.  Biosensors now borrow this recombinant anchor/probe technology to undergo 
multiple experimental cycles through sensor surface regeneration, bringing automation 
capabilities to these reversible, self-assembling interfaces. 
 Table 1 depicts the most commonly used recombinant expressed affinity tags in 
an anchor/probe format.  They vary in size, sequence, non-covalent recognition elements, 
stoichiometry and affinities.  Since the affinity tag is genetically encoded within the 
protein, the protein is always captured via the same location, usually at the beginning (N-
terminus) or end of the sequence (C-terminus), although some tags can be expressed 
internally.  This eliminates the inherent variability of covalent immobilization of 
recognition elements through surface residues.  The smaller tags are generally preferred 
for protein purification as they do not interfere with native protein function.  However, 
larger affinity tags may offer unique capabilities beyond simply purification and 
increased solubility.  Larger tags afford a spacer between the non-covalent recognition 
site of the recognition element and the biosensor surface, resulting in enhanced solvent 
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access.  The downside of the larger tags (such as antibodies) is that for amperometric 
biosensor applications, the gap between the electron source and the electrode may hinder 
efficient electronic communication.  This limitation has partially been overcome via 
labeling the large molecule with redox mediators (58, 145, 297).  Nevertheless, the 
proper selection of recombinant anchor/probe pairing is largely application driven.  As a 
general rule biosensors desire a pairing with a high-affinity interaction (KD of ~10-8 to 10-
12 M) with slow dissociation to prevent surface leaching.  Stronger affinity interactions 
between anchor/probe components (KD > 10-12 M) may interfere with complete surface 
regeneration. 
 
Multiplexing 
 The ability to detect multiple biospecies on a single biosensor platform is an 
important focus to many researchers.  These so-called lab-on-chip (LOC) devices would 
potentially monitor several molecular signatures simultaneously, providing information-
rich data for automated analysis.  For example, biomolecular signatures that mark a 
disease state such as cancer may not accurately be predicted by tracking a single 
biomolecule.  The ability to monitor global changes in multiple DNA, RNA and protein 
targets at the same time drives the field of multiplexed biosensors (240) and provides 
unique challenges to those specific biosensors built with protein and peptide recognition 
elements. 
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Table 1.  Commonly employed affinity tags and relevant characteristics that can be used 
to self-assemble biological elements, including recombinantly-produced peptides and 
proteins as recognition elements for advanced biosensors.  The anchor component is 
covalently linked to the surface of the sensor and can reversibly assemble the probe 
component. 
Recombinant Probe Anchor References 
Name Molecular Mass (Da) Recognition element # of sites Affinity Regeneration  
Biotin 244 Streptavidin 4 10-15 Excess Biotin (97) 
Poly-histidine (His)x 841 Ni/Co-NTA 1 10-6 Excess Imidazole (217) 
  Antibody 2 10-8 low pH (242) 
FLAG (DYKDDDDK) 1013 Antibody 2 10-7 EDTA (25, 112, 113, 136, 218) 
HA (YPYDVPDYA) 1102 Antibody 2  low pH (194) 
c-myc (EQKLISEEDL) 1203 Antibody 2 10-8 low pH (77) 
V5 (GKPIPNPLLGLDST) 1422 Antibody 2 10-9 low pH (131) 
S-tag (KETAAAKFERQHMDS) 1749 S-protein - - - (263) 
StrepTagII (WSHPQFEK) 1058 Streptavidin 4 10-5 - (237) 
  StrepTactin - 10-6 - (237) 
Nanotag9 (DVEAWELGAR) 1145 Streptavidin - 10-9 - (147) 
Nanotag15 (VEAWELGARVPLVET) 1784 Streptavidin - 10-8 - (147) 
T7-tag (MASMTGGQQMG) 1098 Antibody 2 - -  
CBP (Calmodulin binding peptide) - Ca2+-Calmodulin 1 10-9 EDTA (255) 
SBPtag (Streptavidin binding protein 
tag) 4,300 Streptavidin 4 10
-9 50 mM NaOH (130) 
Coiled coil (E rich peptide) 2,300-5,400 R/K rich peptide 1 10
-5 to 10-
11 
5M GndHCl, 
0.05%SDS (272) 
BCCP (Biotin Carboxy Carrier 
peptide) - Streptavidin 4 10
-15 Excess Biotin (37, 57, 130) 
Ubitquitin 8,600 lacoperator - - - (266) 
Thioredoxin 11,700 phenylarsine oxide 1 - - (263) 
GST (Glutathione-S-Transferase) 26,000 Reduced Glutathione 1 - - (250) 
MBP (Maltose Binding Protein) 42,000 Amylose 1 - Excess Maltose (132) 
Protein A (Antibody binding protein) 45,000 Antibody 5 - low pH (193) 
Protein G (Antibody binding protein) 22,000 Albumin 2 - low pH (21) 
 
 
 The first step to multiplexing is controlling the “where” of the biomolecule 
detection reaction proceeds.  That is, the distinct location to which each detected signal 
can be attributed.  Ultimately, this has to be achieved by the controlled deposition of a 
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single species at the micrometer and potentially nanometer scale.  Two processes that 
may provide pathways forward in this respect are briefly presented here: 
micro/nanofluidics and dip pen nanolithography. 
 Perhaps the most straightforward approach to immobilizing biomolecules onto 
distinct sites of a multiplexed array would be to deliver the biomolecule in solution 
exclusively to a precise location through fluidic channels.  Traditional top-down 
lithography techniques are now able to produce 1-D and 2-D features in the nanometer 
realm (119).  Thus, fluidic channels can deliver reagents to distinct locales and 
functionalize specific regions on biosensor arrays.  Additionally, regeneration of the 
captured biomolecules at specific regions on the array or the entire surface would enable 
the reuse of a multiplexed biosensor.  However, this route for multiplexing would require 
a different fluidic channel for each biological target and may prove cost-inefficient for 
multiplexing a set of biological detection elements of any considerable number.  
 Spotting delivers the target species for immobilization in a solution to a distinct 
location using a nanopipette.  This is the current methodology utilized in massively 
multiplexed DNA and peptide LOC biosensors (81, 224).  While conventional 
microarrays are spotted to micron-sized locations, the precision nanoscale deposition of 
selective species is an important challenge in further reducing the size of multiplexed 
biosensors.  Dip pen nanolithography (DPN) affords the ability to do just this, tailoring 
chemical composition and surface structure with a sub-100 nm precision (91, 214).  It 
works exactly like a stylus dipped into ink, with the exception that the stylus is an AFM 
tip of nanometer dimensions.  DPN readily deposits self-assembled monolayers (SAMs) 
of different alkanethiols onto gold sensor surfaces for further covalent attachment, as 
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illustrated in Figure 9.  This technique has been used to control the template assembly of 
nanomaterials onto gold surfaces into higher-ordered structures (283).  Beyond patterning 
nanomaterials, DPN is also extremely useful for patterning biological and soft, organic 
structures onto surfaces; these molecules can be deposited in either ambient or inert 
environments without ionization or radiation exposure.  Biomolecules can be deposited in 
buffered solutions, with complete retention of activity upon immobilization.  When 
spotting biomolecule solutions, the DPN method can produce nanoscale spotted features 
which are much smaller than conventional spotted bio-arrays (91, 214). 
 
 
 
Figure 9.  Dip pen nanolithography (DPN) in the deposition of alkanethiols onto a gold 
surface.  The spatial resolution of molecular deposition is determined by tip geometry, 
contact time, humidity and initial species concentration. 
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Coiled Coils 
 One particular anchor/probe system that satisfies all four of the design principles 
for the development of next generation of protein-based biosensors outlined in Figure 3 
is the coiled coil motif.  Similar to strands in a rope, a coiled coil is formed when two or 
more amphipathic alpha helices are supercoiled together in a left-handed arrangement.  
The coiled coil is often referred to as “peptide Velcro” because multiple interactions 
combine to stabilize the tightly formed, but reversible structure (199).  Coiled coils are 
known to exist in dimeric, trimeric, tetrameric and even octomeric forms (27, 138).  In 
vivo, the ubiquitous coiled coil motif is found in DNA transcription factors (74, 198), 
cytoskeletal elements (55, 114), cell membrane receptors (228) and viral fusion elements, 
including the trimeric coiled coil insertion spikes of both the human immunodeficiency 
virus (HIV), gp41 (260) and the influenza virus (32).  By algorithmic analysis, it is 
estimated that one-tenth of all prokaryotic proteins contain some form of a coiled coil 
motif and mammalians, almost one-fifth (164, 230).  This suggests that small changes in 
the sequence of coiled coils impart a high degree of specificity for interaction in complex 
environments, similar to that of complementary DNA strands. 
 The individual helices of a coiled coil may be aligned in a parallel formation, in 
which the N-termini are located at the same end, or antiparallel, when the N-terminus of 
one strand is located at the C-terminus of the other.  The alpha helices that form coiled 
coils are characterized by a heptad repeat design of seven amino acid residues, denoted 
abcdefg, shown in Figure 10.  Typically, positions a and d are filled with hydrophobic 
residues that pack as a “knobs into holes” formation first postulated by Crick in 1953 
(56).  This packing was later confirmed by X-ray crystallography and nuclear magnetic 
  
25
 
resonance (NMR) structures of the coiled coil region in the yeast transcriptional activator 
GCN4 (198, 200, 202, 222).  Positions e and g are charged and can dictate the assembly 
of the individual alpha helices.  Homodimer and higher order homo-oligomer formations 
are favored if individual strands have oppositely charged residues in the e and g 
positions.  Hetero formations are energetically favored if these positions are occupied by 
similar charges (95, 201).  For example, a heterodimer formation commonly has one 
strand with positive charges and the other strand with all negative charges, acting to 
repulse homodimer formation.  The remaining positions b, c and f are exposed to solvent 
and tolerate a variety of polar residues (27, 170, 199). 
 
 
 
Figure 10.  Heptad repeat, helical wheel schematic and formation of coiled coil along a 
hydrophobic axis. 
 
 
 Significant progress has been made in the field of de novo coiled coil design, and 
research into coiled coil assembly has had marked progress.  The ability of individual 
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coiled coil peptides to form higher oligomerization states has largely been investigated by 
the DeGrado, Alber and Kim labs.  The native sequence of the GCN4 coiled coil peptide 
has a homodimer formation (198, 200), but substitution of the hydrophobic core residues 
in the a and d positions can switch oligomerization states between homo-dimer, homo-
trimer, and homo-tetramer forms (94, 101, 102).  These forms are energetically favored 
due to the specific side chain packing of various buried hydrophobic residues along the 
interface of the individual coiled coil peptides (293).  Table 2 summarizes the residues 
that can drive homo-oligomerization states in mutated sequences of the GCN4 coiled 
coil.  As seen in this table, increased oligomerization states led to increased stability, 
determined by temperature melting profiles.  This increased stability can be explained by 
the summation of additional hydrophobic interactions that occurs with increasing 
stoichiometry of assembled components. 
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Table 2.  Mutants of the individual GCN4-p1 peptide form stable dimer, trimer and 
tetramer structures.  Table and caption reproduced with permission from (102). 
 
 
 
 
 Similarly, the rational design and optimization of the sequences that form 
heterodimeric coiled coils have largely been carried out within the laboratories of 
Chaiken, Hodges, Kim and Vinson.  There are preferred residues that increase packing 
and strengthen the hydrophobic interactions between heterodimers, namely valine and 
leucine in the a and d positions respectively (271).  The electrostatic interactions have 
also been thermodynamically optimized favoring glutamic acid/arginine (E/R) and or 
glutamic acid/lysine (E/K) electrostatic pairings between strands in the e and g positions 
(143).  Additionally, these residues can contribute to individual helix stabilization 
through intra-chain hydrogen bonding (273).  The solvent exposed residues have also 
been shown to increase helical propensity, as in the case of serine and alanine.  Perhaps 
most useful, simply changing the number of heptad repeats can tailor the assembly 
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characteristics to form a range of interaction strengths.  For example, DeCrescenzo et. al. 
found that a three hetpad repeat coiled coil has moderate affinity (KD ~ 10-5 M) where as 
a five heptad repeat had a six order of magnitude increase (KD ~10-11 M).  It was also 
found that the central heptads have a larger stabilization effect than those near the ends 
(59).  Furthermore, there have been trigger sequences identified that are often required 
for the initiation of higher-order oligomer formation (82, 125, 253) as well as capping 
sequences that serve to stabilize the end termini of coiled coils (111, 270). Also possible 
are coiled coil stem loop structures in which a single chain polypeptide folds onto itself to 
form an intramolecular antiparallel coiled coil from a linear heterodimeric sequence 
(188).      
 Novel pharmaceutical applications of coiled coils have been realized as well. 
Because they are found in viral fusion elements like gp41 of HIV, coiled coils have 
become a therapeutic target for curtailing the growing pandemic of HIV infection.  The 
only FDA approved HIV fusion inhibitor is a 36 amino acid peptide named Enfuvirtide 
(also known as T-20), which blocks the formation of a collapsed (119) coiled coil in gp41 
through competitive inhibition (173).  Enfuvirtide was a great success in clinical trials, 
but HIV has shown that it can quickly adapt and acquire drug resistance.  The application 
of the knowledge garnered within synthetic coiled coil formation has led to the rational 
redesign of this peptide with promising results.  Optimizing the hydrophobic, electrostatic 
and helical propensity of the inhibitor peptide has shown an astounding 3,600 fold 
activity improvement in live viral assays that are resistant to Enfuvirtide.  The 
pharmacokinetics of the redesigned therapeutic also benefited with increased half-life and 
decreased clearance in cynomolgus monkeys (71).   
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 In biotechnology, coiled coils are useful tools as affinity tags for recombinant 
protein production and purification in bacterial, insect and mammalian expression 
systems.  Proteins can be expressed with one half of a coiled coil dimer fused to a 
biological target and subsequently isolated by chromatographic means through assembly 
to its corresponding coil (272).  The number of heptad repeats incorporated into the 
design again defines the strength of the self-assembly interaction and thus the 
regeneration of the bound target can be controlled.  The small size of the coiled coil 
recombinant tag is unlikely to compromise the function of the fusion protein, but still 
provides a spacer region to facilitate sufficient solvent access. 
 Furthermore, this labeling strategy can be used as a capture and display motif on 
biosensor surfaces, providing an on-chip purification and display methodology that 
retains the biological activity of the fused peptide (242) or protein (60, 269).  This 
enables direct capture of coiled labeled targets in crude cell lysates for further proteomic 
investigation without time-consuming and costly purification steps.  One group has 
furthered coiled coils as an artificial scaffold for protein immobilization, incorporating 
the technology into spotting techniques that are currently employed in massively 
paralleled DNA arrays (303).  Using an immobilized coiled coil array, another group was 
able to identify 492 different members of the bZIP (basic leucine zipper, a coiled coil 
motif) family of transcription factors (189), demonstrating high throughput applications.  
There exists at least one commercial company, Helix Biopharma Corporation, which has 
patents on the use of heterodimeric E/K paired coiled coils as a capture and display motif 
in biosensors for DNA detection and as novel oligomerization motifs for membrane 
spanning receptors.  
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 Nanotechnology has also borrowed this ubiquitous biological assembly motif.  
We have focused on chemical means to attach these versatile coiled coils to carbon and 
gold-based nanostructures that provide unique opportunities in current nanosensor design.  
We also have designed the solvent exposed residues to self-assemble metal ions and 
metal nanoparticles for the reversible wiring of redox enzymes and other surrogates for 
novel  amperometric biosensor applications (49).  However, coiled coils are not limited to 
just advanced nanosensor applications.  Coiled coils constitute a means for nanoscale 
drug delivery (300) as well as potential for fluorophore targeting vehicles (See Appendix 
1).  They also serve as scaffolds for self-assembly in well-defined nanoscale multimeric 
geometries (305), even performing as molecular machines (229).  For example, Wagner 
et. al. has used this assembly motif to form supramolecular nanorope templates in a 
bottom up approach by inserting a bi-glycine spacer between coiled coil heptad 
recognition domains (277).  Diehl et. al. has recently employed coiled coils to provide 
nanoscale spatial coupling between microtubule motors investigate cooperativity in 
multiunit bio-motor assemblies (67). 
 Taken together, coiled coils have made a substantial cross-disciplinary impact and 
provide an attractive path towards future research.  This thesis project focuses on the 
development of coiled coils to form modular anchor/probe self-assembling linkers to 
interface redox-active probes with nanoscale biosensor platforms.  This configuration 
provides a means for self-assembling and self-disassembling, isotropically oriented 
biological elements for use in biosensors.  The coiled peptide components of this type of 
linker system are produced by both peptide synthesis and recombinant protein 
engineering.  These production paths offer the means to incorporate stoichiometrically-
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defined redox centers on the probes and spatially- and stoichiometrically-controlled metal 
conducting sites in the linker, potentially transforming an otherwise insulative linkage 
into a conductive one.  In an effort to achieve these demanding goals, the following three 
specific aims were created and accomplished. 
 
 Specific Aim 1: Synthetic design, production and characterization of 
multifunctional coiled coil components.  We utilized rational design, solid phase peptide 
synthesis and reverse phase high performance liquid chromatography for the creation of 
milligram quantities of heterodimeric coiled coil anchor/probe peptides for 
experimentation.  Peptide assembly was then characterized by circular dichroism, Förster 
resonance energy transfer and surface plasmon resonance biosensing. 
  
 Specific Aim 2: Anchor/probe coiled coil assembly on biosensor substrates.  We 
demonstrated two distinct pathways for the covalent attachment of anchor peptides and 
the subsequent self-assembly and isotropic display of complementary probe peptides on 
nanoscale biosensor substrates.  This versatile system was constructed on highly ordered 
carbon nanotube arrays, macroscale electrodes as well as nanoscale electrode ensembles 
of gold composition and carboxymethyldextran sensor surfaces of surface plasmon 
resonance biosensors. 
 
 Specific Aim 3: Signal acquisition using coiled coil directed assembly of redox 
targets.  We utilized several combinations of coiled coil directed assemblies in an attempt 
to acquire redox signals on gold electrodes.  Using a bi-histidine scaffold, metallization 
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sites were incorporated into the coiled coil peptide design to facilitate electron 
transduction through the linker via chelation of metal ions.  Electroactive targets 
including ferrocene and the redox enzyme Npx, were chemically fused to the probe 
peptides, assembled into coiled coils and tested by cyclic voltammetry on macro- and 
nanoscale gold electrodes in two orientations with and without metallization.  
Recombinant expression was also utilized to broaden the scope of our anchor/probe 
system towards a variety of redox targets and mediators using a cassette vector 
expression system. 
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CHAPTER 2: MATERIALS AND METHODS 
 
Materials 
 Ammonium persulfate (APS) was acquired from Acros Organics, Morris Plains, 
NJ, USA.  Fmoc-PAL-PEG-PS resin, 0.9” filter papers, 13 mm cartridge caps and in-line 
filters were purchased from Applied Biosystems, Foster City, CA, USA.  Fmoc-
Arg(Pbf)-OH, Fmoc-Cys(Trt)-OH, Fmoc-Glu(OtBu)-OH, Fmoc-His(Trt)-OH, Fmoc-
Leu-OH, Fmoc-Lys(Boc)-OH, Fmoc-L-propargylglycine, Fmoc-Trp(Boc)-OH and 
Fmoc-Val-OH were obtained from Anaspec, San Jose, CA, USA.  CM5 sensor chips, P-
20 surfactant, HBS-P buffer, thiol coupling kit containing N-ethyl-N’-(3-
diethylaminopropyl)-carbodiimide (EDC), N-hydroxy-succinimide (NHS), L-cysteine, 
ethanolamine hydrochloride and 2-(2-pyridinyldithio)-ethaneamine hydrochloride 
(PDEA) were obtained from Biacore Inc., Piscataway, NJ, USA.  30% Acrylamide/Bis 
solution 29:1, 10X TRIS/Tricine/SDS (TTS) buffer, Lammeli sample buffer, Precision 
PlusTM protein dual color standards, Polypeptide SDS Page standards, N,N,N',N'-
tetramethylethylenediamine (TEMED) and Tricine gels were received from Biorad, 
Hercules, CA, USA.  1-Hydroxybenzotriazole monohydrate (HOBt · H2O) and 2-(1H-
Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) were 
obtained from Chem Impex International, Wood Dale, IL, USA.  5” disposable 
chromatography columns were purchased from Evergreen Scientific, Los Angeles CA, 
USA.  5 ml HiTrapTM Chelating HP chromatography columns were purchased from GE 
Healthcare Bio-Sciences Corp., Piscataway NJ, USA.  Acetonitrile was purchased 
through Honeywell Burdick & Jackson, Muskegon, MI, USA.  All forward and reverse 
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primer oligonucleotides, Alexa Fluor® 488 C5 maleimide, QSY® 7 C5 maleimide, 
SimplyBlueTM SafeStain and SilverQuestTM Silver Staining Kit were obtained from 
Invitrogen, Carlsbad CA, USA.  The restriction enzymes NotI and SalI were acquired 
from New England Biolabs, Ipswich, MA, USA.  pET-28c+ vector, 10 mM dNTP mix 
and B834(DE3) competent cells were procured from Novagen, San Diego, CA, USA.  
Tris(2-carboxyethyl)phosphine hydrochloric acid (TCEP · HCl) was obtained from Pierce 
Biotechnology, Rockford IL, USA.  Wizard® Plus Miniprep DNA purification system 
was purchased from Promega, Madison, WI, USA.  Ni-NTA agarose resin was obtained 
from Qiagen, Valencia, CA, USA.  PfuUltraTM High Fidelity DNA polymerase, XL-10 
GoldTM and BL21(DE3)RIL competent cells were procured from Strategene, La Jolla, 
CA, USA. Glacial acetic acid, dichloromethane (DCM), diethyl ether, 
diisopropylethylamine (DIEA), dimethyl formamide (DMF), dimethyl sulfoxide 
(DMSO), ethanedithiol, ethyl acetate, hydrochloric acid (HCl), piperidine, thianosole, 
trifluoroacetic acid (TFA) and tryflic anhydride were acquired from Sigma Aldrich, St. 
Louis, MO, USA.  Bis(p-sulfonatophenyl) phenylphosphine dihydrate dipotassium salt 
(BSP) procured from Strem Chemicals, Newburyport, MA, USA.  Au colloidal 
nanoparticles were purchased from Ted Pella Inc., Redding, CA, USA.  All other 
reagents were of analytical grade or better, including peptide synthesis-grade N-methyl-
2-pyrrolidinone (NMP), and were from Fisher Biosciences, Fairlawn, NJ, USA.  
Distilled, 0.22 μm filtered water with a conductivity of 18.2 MΩ*cm was used for all 
buffers and washing steps.   
 
Buffers 
 
HBS-P 
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0.01 M HEPES 
0.15 M NaCl 
0.005% (v/v) P-20 
pH 7.4 
 
PDEA 
0.1 M Sodium Borate 
pH 8.5 
 
L-Cys 
0.1 M Sodium Formate  
pH 4.3 
 
Preconcentration buffer 
0.01 M Sodium Acetate 
pH 5.0 
 
SPR Regen I 
0.01% (v/v) SDS 
 
SPR Regen II 
5 M Guanidine HCl 
 
25/25 buffer 
0.025 M Sodium Phosphate  
0.025 M NaCl  
pH 7.0 
 
IMAC buffer A 
0.02 M TRIS 
0.2 M NaCl 
pH 7.0 
 
IMAC buffer B 
0.02 M TRIS 
0.2 M NaCl 
0.2 M Imidazole 
pH 7.0 
 
NTA column running buffer 
0.05 M TRIS 
0.2 M NaCl 
0.02 M Imidazole 
pH 8.0 
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NTA column elution buffer 
0.05 M TRIS 
0.2 M NaCl 
0.2 M Imidazole 
pH 8.0 
 
SDS Page running buffer 
1.5 M TRIS 
pH 8.8 
 
SDS Page stacking buffer 
0.5 M TRIS 
pH 6.8 
 
TGS 
0.025 M TRIS 
0.192 M Glycine 
0.1% (v/v) SDS  
pH 8.6 
 
TTS 
0.1 M TRIS 
0.1 M Tricine 
0.1% (v/v) SDS 
pH 8.3 
 
Cell Resuspension Solution 
0.05 M TRIS 
0.01 M EDTA 
100 µg/ml RNase A 
pH 7.5 
 
Cell Lysis Solution 
0.2 M NaOH 
1% (v/v) SDS 
 
Neutralization Solution 
4.09 M Guanidine HCl 
0.759 M Potassium Acetate 
2.12 M Glacial Acetic Acid 
 
Column Wash Solution 
60% (v/v) Ethanol 
0.06 M Potassium Acetate 
0.0083 M TRIS 
0.04 M EDTA 
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10X Pfu reaction buffer 
0.3 M TRIS 
0.02 M MgSO4 
0.1 M KCl 
0.1 M (NH4)2SO4 
1% (v/v) Triton X-100 
1 mg/ml nuclease-free bovine serum albumin 
 
M9 minimal salts 
0.042 M Na2HPO4  
0.024 M KH2PO4  
0.009 M NaCl  
0.019 M NH4Cl 
0.002 M MgSO4  
0.0001 M CaCl2  
0.001 M Thiamine 
1.0 % (w/v) Glucose 
pH 7.0 
 
M9AA 
M9 minimal salts with  
40 mg/ml of the 20 amino acids 
 
Luria-Bertani (LB) broth 
1 % (w/v) Tryptone 
0.5 % (w/v) Yeast Extract 
1% (w/v) NaCl 
pH 7.0 
 
LB Agar 
1 % (w/v) Tryptone 
0.5 % (w/v) Yeast Extract 
1% (w/v) NaCl 
2 % (w/v) Agar 
pH 7.0 
 
S.O.C. Media 
2 % (w/v) Tryptone 
0.5 % (w/v) Yeast Extract 
0.010 M NaCl 
0.0025 M KCl 
0.01 M M MgCl2 
0.01 M MgSO4 
0.02 M Glucose 
pH 7.0 
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For the above buffers, % (v/v) is the percentage of liquid in total volume, i.e. 10% (v/v) is 
10 ml into 100 ml, and % (w/v) is grams per 100 ml, i.e. 10% (w/v) is 10 grams into 100 
ml.  The molarity (M) is the number of moles per liter with 1 M = MW / 1 L, where MW 
is the molecular weight of the compound in grams. 
 
Synthetic peptide production 
 Anchor peptides R39C, R39Pra and R39H10 and the probe peptides E42C and 
E37Ferro were prepared by solid-phase synthesis methodology using conventional Fmoc 
chemistry on an Applied Biosystems model 433A peptide synthesizer, 0.1 mmoles scale, 
using Fmoc-PAL-PEG-PS resin with a 0.18 mmol/g substitution.  The protocol for the 
usage of the peptide synthesizer is included as Appendix 2.  Peptides were cleaved from 
the resin by reaction with 95% trifluoroacetic acid (TFA) containing 2% (v/v) thioanisole 
and 4% (v/v) 1,2-ethanedithiol for 3 hours at room temperature.  Crude peptides were 
then precipitated with cold diethyl ether and dried.  Purification of each peptide was 
performed with a Beckman Coultier System Gold RP-HPLC running 32 Karat software 
on a Vydac semi-preparative C18 column (250 mm x 10 mm inner diameter, 10 mm 
particle size, 300 Å pore size) with a linear AB gradient (ranging from 5% to 95% B in 
50 min) at a flow-rate of 5 ml/min, where solvent A was aqueous 0.1% (v/v) TFA in 
water and solvent B was 0.1% (v/v) TFA in acetonitrile.  Peaks were collected, flash 
frozen in liquid nitrogen, lyophilized on a Freezone 4.5 vacuum desiccator instrument 
(LabConco, Kansas City, MO, USA) and stored until further use.  Homogeneity of the 
purified peptides was verified by analytical RP-HPLC and MALDI-TOF MS, the latter of 
which was performed at the Wistar Proteomics Institute, Philadelphia, PA, USA.  The 
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control peptide 12p1 NH2-(RINNIPWSEAMM)-COOH was prepared in house 
previously by this methodology (20, 80).  Concentration of peptides was determined 
using UV/Vis absorption on a DU640B UV/Vis spectrometer (Beckman Instruments, 
Fullerton, CA, USA), discussed in further detail in Appendix 3. 
 
Circular dichroism spectroscopy 
 All circular dichroism measurements were obtained using an AVIV Model 400 
Circular Dichroism Spectrometer (Aviv Biomedical Inc., Lakewood, NJ, USA) equipped 
with a Neslab Endocal RTE-5DD refrigerated circulating water bath (Thermo Scientific, 
Waltham, MA, USA).   All measurements were carried out in HBS-P buffer, pH 7.4, at 
25 ºC with a peptide concentration of 25 µM in a quartz cell with 1 mm path length.  
Samples were prepared by dilution of concentrated stock solutions of the peptides.  The 
scans were recorded with 0.5 nm steps, 1 second averaging time, with an average of three 
scans per measurement.  Mixed samples were allowed to equilibrate for 5 minutes before 
spectral acquisition.  Data was converted from machine units (θ) in millidegrees to mean 
residue ellipticity (MRE) in degrees * cm2 * dmol-1 using the following equation: 
 MRE = θ * (0.1 * MRW) / (l * Conc) 
where MRW is the mean residue weight (MRW = protein mean weight in atomic mass 
units/daltons) / number of residues) for the protein,  path length (l) in cm and peptide  
concentration (Conc) in mg/ml.  Calculation of alpha helical content was estimated as a 
percentage of alpha helical content with 100% helix formation calculated as below: 
 100% helix  =  40,000 * ((n – 4) / n) 
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where n = number of amino acids (120).  It is important to note that using mean residue 
ellipticity is not an exact helical determination, but it can still provide a standard means 
for estimation and comparison of helical content (280). 
  
FRET spectroscopic assay 
 The peptides were labeled with the FRET components (Alexa Fluor® 488 and 
QSY® 7) via a maleimide reaction.  This reaction covalently labels free thiol (-SH) 
moieties at neutral pH as outlined in Figure 5.  E42C was labeled at the N-terminus, 
whereas R39C was labeled at the C-terminus.  A small amount of the peptide was 
dissolved in HBS-P buffer and the absorption value of the peptide was measured.  This 
was diluted in HBS-P buffer to reach the desired concentration of 50 to 100 µM.  A ten-
fold molar excess of TCEP · HCl (500 µM – 1 mM) was added for 15 minutes to reduce 
any disulfide bonds present (28).  Following this step, a ten-fold molar excess of QSY® 7 
/ Alexa Fluor® 488 (500 µM – 1 mM) to peptide was added and the reaction was left for 2 
hours at room temperature (R39C) or overnight at 4°C (E42C).  Then a ten-fold molar 
excess of reduced glutathione (5mM – 10 mM) to FRET component was added, 
conjugating any remaining Alexa Fluor® 488 or QSY® 7 to glutathione via a thioether 
bond.  
 Purification of the maleimide reactions was carried out using RP-HPLC in a C18 
column as described in the above synthetic peptide production section.  RP-HPLC 
separated compounds based on their hydrophobic character with a linear gradient of two 
solvents, H2O or acetonitrile with 0.1% trifluoroacetic acid (TFA).  The RP-HPLC was 
set to measure the absorption at wavelengths of 220 nm, 280 nm and 488 nm, the 
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absorbencies for peptide backbone, tryptophan residues and Alexa Fluor® 488 
respectively.  Peaks were collected, pooled between runs and frozen in a -80°C freezer 
overnight, then lyophilized until future use.  
 Using the extinction coefficients of 90,000 cm-1 * M-1 at 560 nm for QSY® 7 and 
65,000 cm-1 * M-1 at 488 nm for Alexa Fluor® 488, 1:1 molar ratios (5 µM) of the HPLC 
peaks in HBS-P buffer were added to 96 well plates, incubated for 10 minutes and read 
on a FluoroMax-3 fluorescence plate reader (Horiba Group, Irvine, CA, USA).  The 
excitation was set to 488 nm and emission was collected at wavelengths 525 nm through 
565 nm, in 5 nm increments with 3 second accumulation times.  The emission spectra 
collected corresponded to the region in which fluorescence quenching would be most 
apparent.  All experiments were performed in triplicate, HBS-P buffer was added to the 
QSY fractions as a control. 
 
SPR biosensor experiments 
 All kinetic experiments were performed at 25°C.  The anchor peptides R39C, 
R39H10 and R39Pra were covalently coupled to a CM5 sensor chip on the Biacore 3000 
SPR optical biosensor (Biacore Inc., Piscataway, NJ, USA) in accordance with ligand 
immobilization via thiol-disulfide exchange at a flow rate of 5 μl/min (121).  The 
carboxymethyldextran sensor surface was first activated with a 2 minute injection of the 
zero-length heterobifunctional crosslinker EDC/NHS (50 mM/200 mM).  Sulfhydryl-
reactive groups were then introduced with a 4 minute injection of 80 mM PDEA in 
PDEA buffer.  Following surface activation, desired ligand densities of the anchor 
peptides were attached, mediated through the thiol moiety on the terminal cysteine 
residue in the case of R39C and R39H10 or the central thiol on R39Pra shown in Figure 
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29.  Preconcentration buffer was used to dilute stock anchor solutions, effectively 
concentrating the anchor at the PDEA activated carboxymethyldextran surface.  Residual 
active PDEA molecules were blocked with a 4 minute injection of cysteine-salt solution 
(50 mM L-cysteine with 1 M NaCl in L-Cys buffer).  One reference surface was created 
by omitting the injection of anchor peptide, presenting an L-cysteine surface to the probe 
peptide analyte.  Another reference surface was generated by omitting the injection of 
PDEA and injecting recombinant human interleukin 5 (IL5), allowing coupling via 
primary amine groups on the 31 kDa protein (116, 241).  Remaining activated groups on 
this surface were blocked by injection of 1.0 M ethanolamine hydrochloride pH 8.5. 
 Interaction analysis of ligand/analyte (anchor/probe) was carried out at a flow rate 
of 50 µl/min, with a running buffer of either HBS-P (normal) or HBS-P with 1 mM 
CoCl2 (metallized).  Both buffers contain a 0.005% (v/v) of surfactant P-20 to reduce non-
specific interactions.  Regeneration of the sensor surface between cycles was achieved 
with two 15-second pulses of either SPR Regen I or SPR Regen II buffer.  Each cycle 
included an injection of buffer prior to probe peptide, to correct for non-specific mass 
transfer effects.  Extended dissociation data were acquired using a 90 second injection of 
50 nM E42C followed by a 90 minute dissociation phase.    
 
SPR data analysis 
 The double reference subtraction method of Rich and Myszka was employed prior 
to SPR analysis (225).  Each sensorgram obtained was corrected for bulk refractive index 
changes by subtracting the response from both control cysteine and/or IL5 derivatized 
surfaces.  An injection of running buffer (0 nM probe peptide) was also subtracted before 
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data analysis.  This experimental sensorgram was fit globally using the 1:1 Langmuir 
kinetic model corrected for mass transfer (247) found within BIAevaluation software 
version 4.0 (Biacore, Piscataway, NJ, USA).  In the case of R39Pra anchored to the 
sensor surface, separate 1:1 Langmuir association and dissociation models, also found 
within the BIAevaluation software, were used to estimate values for kinetic parameters.  
Extended dissociation constants for metallization comparison were obtained from a 
separate 1:1 Langmuir kinetic dissociation model. 
 
Synthesis of carbon nanotube arrays 
 Highly ordered carbon nanotube arrays were grown in the Xu lab via a chemical 
vapor deposition (CVD) process within self-organized alumina oxide (AAO) templates as 
previously described (155, 205).  The arrays used in these experiments were etched with 
6% (w/v) H3PO4 / 1.8% (w/v) CrO3 solution in H2O to remove the surrounding matrix and 
expose the CNT tips.  The tips were then oxidized to carboxylates using 6 M H2SO4/ 3 M 
NO3 at 37ºC for 1 hour.  Arrays were washed thoroughly in water, air dried and stored at 
room temperature until further use.  The hexagonal AAO template defined the geometric 
features of the carbon nanotubes, which for this work were 60 nm in diameter, a total 
length of 20 μm, and a center-to-center spacing of 110 nm between adjacent tubes.  For 
covalent functionalization, an exposed length of 40-60 nm was used corresponding to an 
8 hour etch.  
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Au nanoparticle conjugation to E42C 
 E42C peptides were functionalized to 10, 15 and 20 nm Au nanoparticles via 
chemisorption of the terminal cysteine residue of the peptide as follows.  Au colloidal 
nanoparticles in H2O were stabilized with BSP according to previous methods (162).  
Briefly, 20 ml of colloid was mixed with 5-10 mg of BSP for over ten hours.  NaCl was 
added until the solution changed from burgundy red to blue.  This mixture was 
centrifuged at 500 x g for 10 minutes to pellet the nanoparticles, and the supernatant was 
carefully discarded.  The pellet was resuspended in 25% (w/v) BSP in 20 ml H2O.  50 μl 
of the stabilized 60 nM Au colloidal suspension was reacted with a 3-fold molar excess 
of E42C at room temperature overnight. 
 
Disulfide exchange attachment to CNT tips 
 The etched and oxidized CNT array was reacted in PDEA buffer supplemented 
with 80 mM PDEA, 200 mM EDC and 50 mM NHS, for 1 hour at room temperature.  A 
H2O wash was followed by reaction with 20 μM R39C in H2O for 1 hour at room 
temperature.  Remaining thiol-active pyridyldithiol groups were blocked using a 50 mM 
L-cysteine, 1 M NaCl solution in L-Cys buffer as shown in Figure 32.  The CNT array 
was washed several times in H2O, then reacted with E42C-Au (prepared as described 
above) in 500 μl of H2O for 1 hour.  A final wash was carried out in H2O and the 
substrates were air dried before imaging. 
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Click chemistry attachment to CNT tips 
 Etched and oxidized CNT substrates were first reacted with 50 mM NHS / 200 
mM EDC for 15 minutes, washed with H2O, then followed by 80 mM homo-azido 
alanine for 15 minutes.  Unreacted esters on the CNT array were blocked with 1 M 
ethanolamine HCl, pH 8.0 for 30 minutes at room temperature and then rinsed in H2O.  
Attachment of R39Pra was carried out using 10 µM of peptide with 1 µM CuSO4 and 5 
µM sodium ascorbate in 2:1 H2O:tert-butanol for 16 hours at 37°C, shaken continuously.  
This is schematically demonstrated in Figure 34.  Clicked substrates were washed in 
DMF with 10% HCl, then H2O, then DCM and air dried.  For imaging of the clicked 
substrates, chemisorption of Au nanoparticles to the thiol located on the central heptad 
repeat of R39Pra was done with a 1:1 mixture of stabilized nanoparticles and H2O 
overnight at room temperature.  For nanoparticle blocking conditions, the thiol on R39Pra 
was carboxymethylated with 1 M iodoacetic acid in H2O with 5 µl DIEA for 30 minutes 
at room temperature, then washed in H2O before stabilized nanoparticle incubation.  The 
following morning, the functionalized CNT arrays were rinsed in H2O and incubated with 
Au labeled E42C as described above.  The CNT substrates were washed and stored in 
H2O until imaging.  
 
Scanning electron microscopy 
 All SEM images were collected in collaboration with the Xu lab at Brown 
University, or in the Materials Characterization Facility of Drexel University on a Zeiss 
Supra 600 scope.  For the micrograph collection, the working distances varied from 3 to 7 
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mm and the electron beam strength was between 5 -15 kV.  All images were obtained 
using an InLens detector. 
  
Mass spectrometry 
All MALDI TOF MS and ESI MS analyses were  performed at Wistar Proteomics 
Institute.  For the metallization of the peptides, roughly 1-5 pmol/µl of the E42C and 
R39C peptides in H2O the presence and absence of 1 mM CoCl2 was used.   
 
IMAC Co2+ binding assay 
 IMAC experiments were performed on an ATKATM FPLC system (GE Healthcare 
Bio-Sciences Corp., Piscataway NJ, USA) using a HiTrap Chelating Sepharose 5 ml 
column at 4°C.  All steps were run with a flow rate of 5 ml/min.  The column was 
charged with 3 ml of 100 mM CoCl2 in water and washed with three column volumes 
(CV) of water before being equilibrated with 3 CV of IMAC buffer A.  Roughly 125 
nmoles (determined via UV absorbance) of each peptide (E42C, R39C and 12p1) was 
injected onto the activated column and washed with 2 CV of buffer A to remove non-
specifically bound peptides.  Bound species were eluted with a linear gradient of 0-100% 
IMAC buffer B over 10 CV.  UV absorbance at 280 nm (tryptophan peak) was used to 
monitor eluted peptides and controls. 
 
Isothermal titration calorimetry 
 Isothermal titration calorimetry experiments were performed at 25°C on a 
MicroCal VP-ITC system operating Origin 7SR2 software (Northampton, MA, USA).  
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One 1 μl followed by forty-four 5 µl injections of 67 μM CoCl2 in HBS-P were titrated 
into 15 µM E42C.  In the case of R39C, one 1 μl followed by twenty-eight 10 µl 
injections of 2 mM CoCl2 in HBS-P were titrated into 75 μM of peptide.  To correct for 
any signal caused by buffer injections, HBS-P alone was also injected into R39C and 
E42C.  These buffer-generated isotherms were subtracted from the peptide-generated 
isotherms to correct for any heat of dilution artifacts.  Stoichiometric fits were obtained 
with the aforementioned Origin software using a one set of sites model. 
 
Cyclic voltammetry on macroscale gold electrodes 
 All experiments were performed in collaboration with the Yeh lab at the 
University of Pittsburgh.  A gold disc electrode was polished using 0.05 μm alumina, 
sonicated in water for 10 min and etched clean by scanning from 0 to 1.5 V at 100 mV/s 
in 0.1 M H2SO4 for 15 min.  The freshly cleaned Au electrodes were then immersed into a 
5 µM R39C or R39H10 solution in 25/25 buffer, pH 7.5 overnight to immobilize the 
anchor peptides onto the electrode surface.  Following anchor peptide attachment, the 
electrode was immersed in the probe peptide E37Ferro solution (5 μM in 25/25 buffer, 
pH 7.5) for 15 min.   
For the probe peptide E42C fused to a recombinant redox enzyme, NADH 
peroxidase (Npx) was produced and characterized as previously reported (206, 231).  0.1 
mg of Npx was first dissolved in 0.4 mL TRIS buffer (0.1 M, pH 8.0) with 1.0 M 
guanidine.  Then 2 nmols of H2O2 were added and incubated at 0°C for 30 min.  10 nmol 
of peptide E42C and Npx were mixed and reacted at 4°C overnight to form peptide-Npx 
complex.  The crude peptide-Npx removed excess peptide with a YM-30 concentrator 
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and exchanged into 1 ml of 1 X PBS buffer pH 7.4 via a Micro Bio-Spin (bio-Rad) and 
was verified using SDS Page gel electrophoresis (44).  Then the R39C or R39H10 
modified electrode was immersed in the peptide-Npx solution (~6 μM in 25/25 buffer, 
pH 7.5) for 15 min.  For metallization experiments, the electrode was then incubated with 
either 1 mM CoCl2 or 1 mM (Ru(NH3)6)Cl2 for 10 min.   
Electrochemical experiments were performed with a three electrode system and 
tested for redox of either the ferrocene or the Npx enzyme.  The modified gold disc as the 
working electrode underwent cyclic voltammetry scans from 0 to 700 mV for E37Ferro 
or from -400 to 600 mV for E42C-Npx in the aforementioned buffer. 
 Creation of a prostate serum antigen (PSA) biosensor using R39H10 as a linker 
was performed as follows.  Freshly cleaned Au electrodes were immersed into a 5 µM 
R39H10 solution in 25/25 buffer, pH 7.5 overnight to immobilize the peptide R39C onto 
the electrode surface.  The carboxyl groups on the anti-PSA antibody were then 
covalently linked to the N-terminus amine of R39H10 using 0.4 M EDC and 0.1 M NHS 
over one hour.  Glucose oxidase (GOx) was reacted to PSA using the same EDC/NHS 
conditions overnight and blocked with 1 M ethanolamine HCl.  The R39H10-antiPSA 
coated electrode was immersed into PSA-GOx solution and then used as a PSA biosensor 
in conjunction with cyclic voltammetry and scanned from 0 to 700 mV. Electron transfer 
rate constants were calculated from the area under the oxidative curve according to 
published methods (291, 295). 
  
 
 
  
49
 
Cyclic voltammetry on nanoscale gold electrodes 
 All experiments were performed in collaboration with the Kelley lab at the 
University of Toronto. Gold nanoelectrode ensembles (NEE) were synthesized as 
previously described (180) in the Xu lab at Brown University.  Deposition of the anchor 
peptide was done with 5 µM R39Pra or R39H10 and 500 nM mercaptohexanol (MCH) in 
25/25 buffer at room temperature, overnight.  These electrodes were then washed in 
25/25 buffer twice for five minutes.  Subsequent hybridization of the probe component to 
the immobilized anchor was carried out using 5 µM E37Ferro in 25/25 buffer at room 
temperature for 1 hour.  Metallization of the peptides was done with incubation of 1 mM 
CoCl2 for 30 min before or after hybridization.  The NEEs were washed with 25/25 
buffer twice before usage.  Electrochemical experiments were performed with a three 
electrode cyclic voltammetry system.  The modified NEE as the working electrode was 
scanned with cyclic voltammetry from 0 to 450 mV in 25/25 buffer, or 25/25 buffer with 
either 2 mM (R39Pra) or 250 µM (R39H10) ferrocyanide from 0 to 600 mV to confirm 
hybridization.  
 
Plasmid design for recombinant coiled coil production 
 The recombinant DNA sequence for rE42-His was of synthetic origin and 
previously cloned into the pGEM® vector by Kalyan Tirupula and Karyn McFadden.  
This was incorporated into the pET-28c+ vector using the restriction endonucleases NotI 
and SalI with a kanamycin resistance gene.  The DNA sequence was confirmed, with 
successful protein expression and purification by Adrian Harrington.  The details of the 
of this expression vector, including restriction sites is found in Figure 11. 
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Figure 11.  The E. coli expression vector pET-28a-c(+).  This image created by EMD 
was reprinted with the permission of EMD.  
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Transformation of Escherichia coli 
 Competent E. coli cells for overproduction of both DNA and protein were 
transformed as follows: A 20 µl aliquot of competent cells were removed from the –80°C 
freezer and thawed on ice, then gently mixed by swirling the 1.5 ml microcentrifuge tube.  
1 µl of the purified plasmid DNA at 60 ng/µl (determined by UV absorbance) was added 
to the tube containing the cells and swirled.  This mixture was incubated for 20 minutes 
on ice, placed in a water bath at 42°C for 45 seconds, then back on ice for 2 minutes.  500 
µl of SOC media at room temperature was added and incubated at 37°C for 30-60 min.  
Following incubation, 20 µl was pipetted into the center of an LB agar plate 
supplemented with 10 µg/ml kanamycin.  The glass spreader was removed from 100% 
ethanol, flame evaporated with a Bunsen burner and cooled on the sides of the agar 
before spreading the cells over the entirety of the agar surface.  Transformed colonies 
containing the antibiotic resistance gene were grown overnight at 37°C and stored at 4°C 
for up to one month. 
 
Plasmid scale-up and DNA purification 
 For preparation of plasmid DNA, a single, well-isolated colony of plasmid-
transformed E. coli strain XL-10 TM Gold from a LB agar plate was added to 5 ml of LB 
medium, both containing 10 µg/ml kanamycin as the selection antibiotic.  The culture 
was grown overnight in an orbital shaker at 37°C.  The culture was removed and the cells 
pelleted by centrifugation at 10,000 x g for 5 minutes.  DNA was purified using a 
Wizard® Plus Miniprep DNA purification system following the centrifugation protocol, 
summarized in Figure 12.  The cell supernatant was removed and the pellet was 
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resuspended with 250 µl of Cell Resuspension Solution and pipetted up and down 
repeatedly to ensure complete mixing.  Then 250 µl of Cell Lysis Solution was added and 
the 1.5 ml microcentrifuge tube was inverted 4 times.  10 µl of Alkaline Protease 
Solution was added to the mixture, inverted four times, and incubated at room 
temperature for 5 minutes.  This step inactivates any endonucleases and other released 
proteins during the bacterial cell lysis that can adversely affect the quality of the DNA to 
be isolated.  Following this step, 350 µl of Neutralization Solution was added.  Again the 
tube was inverted four times.  This mixture was centrifuged at 14,000 x g on a tabletop 
microcentrifuge for ten minutes which resulted in a white pellet.  The clear lysate was 
transferred to a Spin Column placed inside a 2 ml Collection Tube, referred to as the spin 
assembly.  The Spin Column contains a proprietary porous membrane filter that binds 
DNA.  The spin assembly was centrifuged at 14,000 x g for 1 minute at room temperature 
to capture the DNA.  The Collection Tube was emptied and spin assembly was rebuilt.  
The Spin Column was washed with 750 µl of Column Wash Solution that was previously 
diluted with 95% ethanol and the spin assembly was centrifuged for 1 minute at 14,000 x 
g.  The flowthrough was discarded and the washing process was repeated, but using 250 
µl of the Column Wash Solution and centrifuging for 2 minutes.  The Spin Column was 
transferred to a sterile 1.5 ml microcentrifuge tube and 100 µl of Nuclease-free H2O was 
added to the Spin Column.  The assembly was centrifuged at 14,000 x g a final time and 
the DNA in the flowthrough product was retained, the concentration was determined.  
The pure DNA was stored at -20°C. 10 µl of the DNA was sent to Genewiz (South 
Plainfield, NJ, USA) using the T7 promoter for sequence confirmation. 
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Figure 12.  DNA purification using a miniprep system.  The * symbol indicates that this 
step proceeds with the aid of centrifugation. 
 
 
Recombinant protein expression 
 A single transformed colony of the protein expression strain BL21(DE3)RIL was 
isolated and added to 5 ml of LB broth and incubated in a shaker for 4 hours at 37°C.  
This was scaled up to a 150 ml or 1 L culture, grown at the aforementioned conditions 
until an optical density at λ  = 600 nm of 0.6 (OD600 = 0.6) was reached.  At this OD the 
induction of protein expression was initiated with the addition of 400 µM IPTG and 
incubated overnight in the shaker at 27°C.  The following morning, the cells were 
pelleted at 3000 x g for 20 minutes removing the supernatant, then resuspended in NTA 
column running buffer.  Lysis of the cells proceeded for 5 minutes, 15 seconds on, 30 
seconds off, at a power setting of 5.5 on ice using a Sonicator 3000 equipped with a 
microtip (Misonex, Farmingdale, NY, USA).  The lysed cells were spun at 17,000 x g 
and the supernatant was collected and subject to one-step His tag purification. 
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Auxotrophic protein expression 
 A modified bacterial host was prepared by transformation of the precursor BL21 
strain B834(DE3) (292) with rE42-His plasmid as described above.  These protease-
deficient hosts are methionine auxotrophs and allow high specific-activity labeling of 
target proteins with non-canonical analogues.  The growth rate of the methionine 
auxotrophs in M9 media is roughly half that of those grown in LB media.  An overnight 
culture of the transformed bacteria was grown in 2 ml of M9AA medium.  Upon reaching 
an OD600 of 0.8, the cells were twice pelleted for 10 minutes at 1000 x g and washed with 
20 ml of M9 minimal media, then resuspended in M9AA media without methionine and 
grown at 37°C for 20 minutes.  5 ml aliquots of this culture were prepared and 
supplemented with 500 mg/L homo-azido alanine or methionine.  A culture lacking 
methionine or homo-azido alanine served as the negative control.  Protein expression was 
then induced with 400 µM IPTG overnight in the shaker at 37°C to produce rE42-A(N3)-
His.  Protein collection, purification and analysis were performed as described for the 
non-auxotrophic systems. 
  
Recombinant protein purification 
 rE42-His and rE42-A(N3)-His were purified using Ni-NTA agarose resin as 
follows:  2 ml of Ni-NTA resin with a binding capacity of 5 mg/ml was added to a 5” 
disposable chromatography column.  The resin was packed and equilibrated with 5 
column volumes (CV) of NTA column running buffer.  The supernatant containing the 
over-expressed rE42coil was passed over the column and the flow through was passed 
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over the column for a second time.  Then the column was washed with 10 CVs of NTA 
column running buffer.  Following this, the NTA column elution buffer was added and 
0.5 ml fractions were collected.  Fractions that had absorbance at 220 nm for rE42-His 
and rE42-A(N3)-His were retained and analyzed by SDS Page gel electrophoresis and 
surface plasmon resonance screening.   
 
Oligonucleotide site directed mutagenesis 
 A glycine residue was replaced with a tryptophan residue in the rE42-His 
sequence to create the expression plasmid for rE42-W-His using the following protocol: 
Complementary oligonucleotide strands containing the desired mutation from glycine to 
tryptophan were synthesized from Invitrogen.  The forward primer was 5’-
CCGTCGACGGCCTGGGGCTCAGAAGTACGAGCA-3’ and the reverse primer was 
5’-TGCTCGTACTTCTGAGCCCCAGGCCGTCGACGG-3’.  The bold, underlined 
regions indicate where the primer would encode the three base pair codon for tryptophan. 
The complementary design of the forward primer can be seen in Figure 13.  5 µl of 10X 
Pfu reaction buffer was combined with 1.0 µl of the rE42His plasmid DNA, 1.25 µl of 
each of the forward and reverse primer, 1 µl of the dNTP mix (10 mM of dATP, dTTP, 
dCTP and dGTP in H2O), and brought to a final volume with mQ H2O in a thin-walled 
PCR tube.  To this solution, 1 µl of PfuUltraTM High Fidelity DNA polymerase (2.5 U/µl) 
and placed in an icycler (Biorad, Hercules, CA, USA).  The solution was reacted for 30 
seconds at 95°C for the first cycle, then 11 successive cycles at 95°C for 30 seconds, 
55°C for 1 minute and 68°C for 14 minutes.  Following temperature cycling, the reaction 
was placed on ice for 2 minutes then reacted with 1 µl of the Dpn I restriction enzyme 
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(10 U/µl) and mixed.  The reaction mixtures were pelleted using a microcentrifuge for 1 
minute at 17,000 x g and incubated at 37°C for 1 hour to digest the non-mutated parental 
DNA.  Upon subsequent transformation, the nicked mutant plasmid was ligated, 
representing the sole transformed product. DNA sequencing at Genewiz (South 
Plainfield, NJ, USA) confirmed correct placement of the tryptophan mutation using the 
forward and reverse T7 promoter. 
 
 
 
Figure 13.  Forward primer for oligonucleotide-directed mutagenesis.  The forward 
primer containing a mismatched base pair is used to produce a desired change in the 
DNA sequence, encoding a tryptophan (TGG) in a location that would normally encode a 
glycine (GGG).  The primer has sufficient overlap with the template strand on both the 5’ 
or 3’ end to hybridize under thermal cycling conditions. 
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CHAPTER 3: SPECIFIC AIM 1 
 
 Synthetic design, production and characterization of multifunctional coiled coil 
components.  We utilized rational design, solid phase peptide synthesis and reverse phase 
high performance liquid chromatography for the creation of milligram quantities of 
heterodimeric coiled coil anchor/probe peptides for experimentation.  Peptide assembly 
was then characterized by circular dichroism, Förster resonance energy transfer and 
surface plasmon resonance biosensing. 
 
This chapter addresses the hypothesis that multifunctional coiled coil linkers based 
on our rational synthetic design would function as heterodimeric coiled coils.  The 
goal for our design is to form a specific, ultrastable, yet regenerable complex in which the 
anchor peptide can be covalently immobilized to the sensor surface and the probe 
sequence can be non-covalently captured in solution. 
 
Solid phase peptide synthesis and peptide purification 
 There are two pathways for the production of peptides in high yield, synthetic and 
recombinant.  A leading synthetic technique, solid phase peptide synthesis (SPPS) is a 
convenient, cost effective methodology to obtain high purity peptides in milligram yields.  
The lyophilization and storage at -20°C of these peptides can extend their shelf-life 
beyond that of typical antibodies or other proteins without loss of function.  SPPS also 
enables the greatest control over the design of peptide sequences that include non-
canonical residues and alternative terminations.  Although it is possible to obtain peptides 
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via SPPS of up to 100 amino acids in length, the general rule of thumb is to keep 
synthetic designs shorter than 50 amino acids due to inefficiencies in stepwise elongation.  
Peptide designs over 50 amino acids should investigate recombinant design and 
production. 
 SPPS is a fundamental technique in the synthetic acquisition of peptides with 
controlled sequences.  Pioneered by Merrifield in 1963, peptides are grown sequentially 
through the stepwise addition of selectively-protected amino acids to a solid support 
matrix, called the resin (181).  The central dogma of SPPS is a repeated cycle of coupling 
followed by deprotection.  The free N-terminal amine of a solid-phase attached peptide is 
coupled to a single N-protected amino acid unit.  This unit is then deprotected, revealing 
a new N-terminal amine to which a further amino acid may be attached.  Because the 
growing peptide is immobilized onto the resin, a filtration process can remove liquid-
phase reagents and by-products of synthesis.  The two major protection strategies of 
SPPS are Fmoc (9-fluorenylmethoxycarbonyl) (31) and Boc (t-butyloxycarbonyl) (181) 
chemistries.  Both Fmoc and Boc provide high-yield peptide formation in SPPS, however 
Fmoc protection is preferred because it provides a chemically milder deprotection and 
cleavage strategy (13).  Figure 14 displays the protection strategies that are available for 
Fmoc protected chemistry. 
 Once the stepwise elongation of the peptide has reached completion, the final 
step, cleavage from both the solid support and removal of side chain protections is 
primarily done via acidolysis.  Fmoc chemistries use acids such as trifluoroacetic acid 
(TFA), and advantage over the older Boc protection strategy, which requires the much 
stronger hydrofluoric acid (HF).  The stringent precautions required with HF use are the   
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reason that Fmoc chemistry is generally preferred for routine synthesis.  Often water, 
phenols and thiols are added as scavengers to the cleavage solution, protecting the 
synthesized peptide from charged carbon ions, called carbocations, generated during 
cleavage. Such carbocations can cause side reactions within the freshly exposed side 
chain moieties of the peptide.  The cyclical process of Fmoc SPPS is outlined in Figure 
15. 
 
 
 
 
Figure 14.  List of amino acids and their side chain protections that are useful in the TFA 
cleavage employed in Fmoc SPPS.  The “R” in the structures denotes the location at 
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which the side chain protection would occur.  The exception is the Fmoc group which is 
universally used to protect the α-amine on each amino acid. 
 
 
 
 
Figure 15.  Schematic of the basic steps in solid phase peptide synthesis using Fmoc 
protected amino acids. Figure reproduced with permission from Applied Biosciences. 
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 The driving factor for having an acceptable yield and purity in SPPS is having an 
extremely high efficiency for each coupling/decoupling step.  Table 3 depicts final yields 
for several amino acid peptides and demonstrates that a 99% or better efficiency is a 
necessity for long peptides.  To ensure each amino acid is coupled to completion, a molar 
excess (2 ~ 10 fold) is used for coupling amino acids together, further optimized by a 
series of well-characterized coupling and deprotection agents.  Several techniques to 
monitor the coupling reaction after each step are often employed, most notably the 
Ninhydrin test for quantization of free amines (234) or monitoring the release of Fmoc 
protections as a function of conductivity (192). 
 
 
Table 3.  Summary of peptide yields with different peptide lengths and efficiencies per 
coupling/deprotection step in solid phase peptide synthesis. 
 Efficiency in Coupling/Deprotection Step 
 90% 95% 99% 99.9% 
Peptide Length (amino acids) Final Peptide Yield 
10 34.9% 59.9% 90.4% 99.0% 
20 12.2% 35.8% 81.8% 98.0% 
30 4.2% 21.5% 74.0% 97.0% 
40 1.5% 12.9% 66.9% 96.1% 
50 0.5% 7.7% 60.5% 95.1% 
 
 
 
 The crude peptide that has been cleaved from the resin in SPPS contains many by-
products which represent deletions and truncations within a desired sequence, as well as 
removed FMOC side-chain protection strategies.  Oxidation of the peptide may also 
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occur during the cleavage and deprotection process resulting in unwanted products.  
Reverse phase high performance liquid chromatography (RP-HPLC) is a technique 
commonly employed that separates contaminate by-products from that of the desired 
peptide.  
 RP-HPLC separates peptides based on their hydrophobic characteristics.  The 
peptide binds on the column mainly through a combination of hydrophobic and other 
apolar interactions and is eluted by increasing the hydrophobicity (i.e. decreasing the 
ionic strength) of solvent flowing over the column.  Generally the column is packed with 
silica that has been covalently functionalized using silanes with a series of hydrocarbon 
alkane chains.  These hydrocarbon chains range in length from four carbons to eighteen 
carbons.  Since the elution of the peptide is largely a function of hydrophobicity, the 
longer chain hydrocarbon columns are better for small, highly charged peptides.  On the 
other hand, large hydrophobic peptides are better eluted on short hydrocarbon columns.  
However, these columns are often used interchangeably with little differences in elution 
profiles.  Additional hydrophobic moieties supported on silica are aromatic hydrocarbons 
such as phenyl groups. 
 Typical RP-HPLC runs consist of two buffers, H2O and Acetonitrile (ACN) 
supplemented with 0.1% v/v Trifluoracetic acid (TFA) that are mixed over a linear 
gradient with a flow rate which will give roughly a 1.0% change per minute.  TFA is 
added to the solvents as an anionic ion-pairing agent for better peak resolution.  Beyond 
its high volatility and UV transparency, the hydrophobic and negatively charged 
trifluoroacetate ion (TFA−) is able to interact with basic, positively charged amino acid 
side-chains (Arg, Lys and His) as well as free N-alpha amino groups.  TFA enhances the 
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column interaction of peptides, especially those of positive charge, even though the use 
of TFA will lead to slightly longer elution times (42). 
 The flow rate is limited by the size of the column used; larger columns can handle 
higher flow rates and are higher throughput, but generally have poorer separation 
profiles. Columns sizes are grouped from smallest to largest into analytical, semi-
preparative and preparative forms and typical flow rates are 1, 5 and 10 ml/min 
respectively.  It is also important to note that the use of high pH buffers should be 
avoided as they can denature the silica-based columns (167). 
 Using SPPS and RP-HPLC, we have made three anchor components, R39C, 
R39H10 and R39Pra, for a variety of immobilization orientations and metallization 
pathways utilizing the self-assembling coiled coil motif.  R39C is a thirty-nine amino 
acid anchor coiled coil component with a molecular weight of 4815 Daltons and a 
sequence of NH2-W-(RVRALRE)2-(RVHALRH)-(RVRALRE)2-GGC-COOH.  The N-
terminus tryptophan adds an aromatic side chain for absorbance at λ = 280 nm and easy 
determination of peptide concentration via spectroscopy.  The C-terminus has a cysteine 
which presents a single thiol for covalent attachment to sensor surfaces. In the central 
heptad there are two histidine residues as a potential metallization site for a single 2+ 
metal ion. 
 R39H10 has 39 amino acids, a molecular weight of 4772 Daltons and a sequence 
of NH2-W-(RVHALRH)5-GGC-COOH. R39H10 is similar to R39C with a N-terminal 
tryptophan and a C-terminal cysteine, but contains a metal chelating site within each of 
its five heptads.  This would allow five potential sites of metallization with 2+ 
coordinated metal ions as opposed to the single site present in R39C.    
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 R39Pra is another 39 amino acid peptide, but with a molecular weight of 4776 
and the sequence NH2-GWG-(RVRALRE)2-(RVCALRE)-(RVRALRE)2-G(propargyl)-
COOH.  The cysteine in the central heptad repeat presents a thiol directed immobilization 
site in the middle of the peptide, as opposed to those at the C-terminus in R39C and 
R39H10.  The C-terminus contains a non-native amino acid called propargylglycine.  The 
normal side chain of hydrogen is replaced by a triple bonded carbon in the form of 
substituted acetylene, also known as an alkyne.  This propargyl functionality can be 
targeted for covalent immobilization via a copper catalyzed reaction with an azide moiety 
to form a 1,2,3 triazole.  Again, the tryptophan near the N-terminus provides the aromatic 
ring for UV absorbance.  
 Similarly two probe sequences, E42C and E37Ferro were created using SPPS, 
albeit E37Ferro was eventually obtained as a custom peptide synthesis from Anaspec, 
San Jose CA, USA.  E42C is a forty-two amino acid coiled coil probe component with a 
molecular weight of 4787.3 Daltons and a sequence of NH2-CGGWGG-(EVRALEE)2-
(EVHALEH)-(EVRALEE)2-COOH.  The N-terminus has a cysteine which presents a 
single thiol for further covalent attachment to nanoparticles and redox enzymes.  The 
tryptophan adds an aromatic side chain for absorbance at λ = 280 nm and easy 
concentration determination via spectroscopy.  In the central heptad there are two 
histidine residues as a potential metallization site for a single 2+ metal ion. 
 E37Ferro is a thirty seven amino acid coiled coil probe component with a 
molecular weight of 4550.8 Daltons and a sequence of NH2-Ferrocene-(EVRALEE)5-
COOH.  The N-terminus has a ferrocene group attached to provide a model compound 
for reduction and oxidation in amperometric applications.  The ferrocene is also a 
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chromophore, having a molar extinction coefficient of 96 cm-1 M-1 at 442 nm.  Pictorial 
representations with a summary of the anchor peptides produced by SPPS can be seen in 
Figures 16, 17 and 18 for R39C, R39H10, and R39Pra respectively.  The probe peptides 
can be seen in Figure 19 for E42C and Figure 20 for E37Ferro. 
 
 
 
 
Figure 16.  Characteristics (left), RP-HPLC (top right) and mass spectrogram (bottom 
right) of the anchor coil R39C.  The major elution peak at 26 minutes was found to 
correspond to a mass of 4814.25, which is close to the expected mass of 4815 Daltons.  
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Figure 17.  Characteristics (left), RP-HPLC (top right) and mass spectrogram (bottom 
right) of the anchor coil R39H10.  The major elution peak at 26.5 minutes was found to 
correspond to a mass of 4773.2, which is close to the expected mass of 4771.6 Daltons. 
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Figure 18.  Characteristics (left), RP-HPLC (top right) and mass spectrogram (bottom 
right) of the anchor coil R39Pra.  The elution peak at 18.7 minutes was found to 
correspond to a mass of 4767.3, which is close to the expected mass of 4765.6 Daltons. 
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Figure 19.  Characteristics (left), RP-HPLC (top right) and mass spectrogram (bottom 
right) of the probe coil E42C.  The major elution peak at 31.2 minutes was found to 
correspond to a mass of 4789.2, which is close to the expected mass of 4787.3 Daltons. 
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Figure 20.  Characteristics (left), RP-HPLC (top right) and mass spectrogram (bottom 
right) of the probe coil E42C.  The major elution peak at 21.5 minutes was found to 
correspond to a mass of 4550.6, which is close to the expected mass of 4550.8 Daltons. 
The E37Ferro peptide was obtained from Anaspec, San Jose, CA. 
 
 
 Synthetic and recombinant production of coiled coils provide dual pathways 
towards the construction of these self-assembling interfaces for use in advanced 
biosensors.  We initially focused our efforts into synthetic production because small 
peptides are often degraded within cells used as recombinant expression systems.  
Synthetic production was generally successful for the anchor sequences that were rich in 
arginine residues, but often resulted in fragmented products for the probe sequences rich 
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in glutamic acid residues.  In addition, synthetic production readily inserted non-native 
residues such as propargylglycine for alternative attachment chemistries in the case of 
R39Pra. 
 The anchor and probe peptides each have a five heptad repeat design in which the 
a and d positions within each heptad are occupied by the hydrophobic amino acids valine 
and leucine respectively.  These residues assemble into a hydrophobic seam that forms 
the major interface to the a’ and d’ positions on complementary probe peptide via a 
characteristic “knobs into holes” packing first postulated by Crick (56).  We chose these 
core residues because β-branched hydrophobic residues (valine, isoleucine, leucine) are 
the most stabilizing at position a (278, 306).  In position d, leucine has demonstrated the 
highest stabilization effect (184, 271).  
 Specificity of dimerization is often determined by the residues that border the 
hydrophobic interface.  In the anchor peptides R39C, R39H10 and R39Pra the e and g 
positions are occupied by the positively charged amino acid arginine (R).  Negatively 
charged glutamic acids (E) are found at e and g positions on the complementary probe 
peptides E42C and E37Ferro.  This electrostatic combination has shown to have slightly 
higher dimerization stability when compared to other residues that can form salt bridges 
in the e and g heptad positions, like lysine and glutamic acid (26).  Thus heterodimer (R-
E) formation is energetically favored because of the oppositely charged anchor and probe 
peptides, while homodimer (E-E, or R-R pairings) formation is energetically unfavorable 
due to the like charge repulsion (199, 201).  It may be possible to force some homodimer 
formation under extremely high salt conditions ( > 2 M NaCl).  These high salt solutions 
would effectively screen the electrostatic interactions (i.e. a reduction in the Debye 
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length) and favor only the hydrophobic interactions, resulting in a mixture of 
homodimers and heterodimers in solution.  
 Increased helicity of individual peptide components has also shown to increase 
the dimerization stability of coiled coils (26, 71).  For R39C and R39Pra, arginine and 
glutamic acid (R-E) pairings in the b and f heptad positions are designed to stabilize the 
alpha helix formation by forming an intrahelical salt bridge between i and i+4 residues.  
To increase helicity in the probe peptide components E42C and E37 Ferro, E-R pairings 
at b and f heptad positions, as well as an R-E pairing e and b heptad positions, were 
included into the rational design.  Remaining residues in heptad positions that do not 
contribute to intrahelical salt bridge formation can also serve to increase helical 
propensity.  Both anchor and probe peptide heptad designs have alanine residues in the c 
heptad position, which has the highest propensity to be located in an alpha helix (71, 165, 
196). 
 
Determination of coiled coil formation by circular dichroism 
 Circular dichroism (CD) is a type of spectroscopy based on the differential 
absorption of left-handed and right-handed circularly polarized light.  Preferential 
absorption of either the left or right circularly polarized light by the sample is recorded by 
as a reduction in the intensity of the transmitted light.  In protein samples, the major 
optical absorption groups are the amide bonds of the peptide backbone and the aromatic 
side chains.  However at wavelengths below 250 nm, the peptide backbone with 
characteristic torsion angles (φ,ψ) constitutes the dominant absorption species.  Repeating 
torsion angle values result in the formation of regular secondary structures such as alpha 
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helices or beta sheets.  Due to the ordered nature of the backbone chromophore, the far-
UV CD spectrum of peptides and proteins can reveal important characteristics of their 
secondary structure (78).  CD spectra acquired from 200-260 nm can be readily used to 
estimate secondary structure populations of alpha helices, random coils, beta sheets (41),  
as well as supercoiled alpha helices (50), indicative of coiled coil formation.  Figure 21 
is an example of the characteristic signals that are acquired in the presence of common 
secondary structures. 
 Depending on their sequence, individual coiled coil components have been shown 
to be either structured or unstructured by CD (71).  Nevertheless, dimer formation of 
coiled coils imparts significant additional helical structure and supercoiling (50, 71, 76).  
As seen in Figure 22, the individual CD spectra of the anchor coil R39C and the probe 
coil E42C at 25 µM depicted characteristic secondary structure of alpha helices with a 
characteristic primary minimum located at 208 nm and a secondary minimum found at 
222 nm.  By converting to the mean residue ellipticity values, these spectra are not 
affected by concentration of the molecules in solution.  The percentage of alpha helices 
was determined at the 222 nm minima, with R39C having a measured value of 12,820 
deg*cm2/dmol and E42C having a measured value of 20,713 deg*cm2/dmol.  Using a 
100% alpha helix value of 35,900 deg*cm2/dmol for R39C and 36,200 deg*cm2/dmol for 
E42C, these values corresponded to a 36% helical content for the anchor sequence of 
R39C and a 57% helical content for the probe sequence E42C.  A combination of 
intrahelical salt bridges and alanine residues are most likely to impart the helical structure 
displayed in the individual R39C and E42C CD spectra.  The higher helical content for 
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E42C can be explained by the potential formation of two i,  i+4 intrahelical salt bridges 
as opposed to the single i, i+4  site in R39C.  
 
 
 
Figure 21.  CD spectra for common secondary structures.  Dotted line depicts an alpha 
helix obtained from sperm whale myoglobin with two characteristic minima at 208 nm 
and 222 nm.  The solid line is for a beta sheet from a poly(Lys-Leu-Lys-Leu)n peptide in 
salt solution, while the dashed line is an unordered structure of poly(Pro-Lys-Leu-Lys-
Leu)n in salt free conditions.  Figure reproduced with permission from (23).  
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 When the R39C/E42C peptides are added together to form a coiled coil in a 12.5 
µM solution, the CD spectra demonstrates switching of the primary and secondary 
minima positions, shifted roughly 1 nm towards higher wavelengths.  The increase in the 
signal acquired at 222 nm, with a significant decrease in the signal at 208 nm is also 
characteristic of left handed supercoiling (50).  Together the data serve as a primary 
indication that the anchor and probe components do indeed form a coiled coil, as their 
designed sequence would predict.  A curious event occurred upon successive scans as the 
signal for the combined peptides was not stable, but shifted towards increasingly positive 
mean residue ellipticity with time.  The shape of the curve however was retained.  There 
was notable precipitate at the bottom of the cuvette indicating aggregation of the R39C 
and E42C peptides beyond a simple dimer complex.  This aggregation in solution would 
account for the signal shift, but would invalidate any estimation of helical content.  This 
event was not previously reported with five heptad repeat designs for heterodimeric 
coiled coils that did not introduce intrahelical salt bridges or metal binding sites (95). 
These additional design contraints may be the cause of aggregation in our coiled coils. 
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Figure 22.  Circular dichroism spectra from 200 nm to 260 nm for the R39C and E42C 
peptides alone and mixed together in HBS-P buffer.  The concentration of the peptides 
alone was 25 µM and together 12.5 µM.  An average of three scans was used for each 
plot.  HBS-P alone was subtracted for each curve and plotted in terms of mean residue 
ellipticity to determine alpha helical content at 222 nm.  
 
 
Parallel versus anti-parallel determination by FRET 
 Because it is possible for dimer coiled coils to exist in parallel (N to C, N to C) 
and anti-parallel (N to C, C to N) orientations, it is important to know which end of the 
coiled coil peptide you would like to attach to the sensor element and/or biological 
element.  Sequence alignment of the R39C/E42C coiled coil heptad repeats in either 
parallel or anti-parallel orientations has ten favorable hydrophobic interactions in the a 
and d positions, as well as ten favorable electrostatic interactions in the e and g positions, 
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as demonstrated in Table 4.  The main difference between the two alignments is that in 
the parallel formation all hydrophobic pairings are in the a-a’ or d-d’ positions, as 
opposed to only a-d’ or d-a’ position pairings in the anti-parallel alignment.  We chose to 
test the parallel versus anti-parallel orientation of the R39C/E42C anchor/probe pairing 
using fluorescence/quenching FRET pair.  
Förster or fluorescence resonant energy transfer (FRET) describes a radiationless 
energy transfer mechanism between two chromophores.  FRET is a distance dependent 
interaction between the electronic excited states of two dye molecules in which excitation 
is transferred from a donor molecule to an acceptor molecule without the emission of a 
photon.  The efficiency of FRET is dependent on the inverse sixth power of the 
intermolecular separation, making it extremely useful for obtaining measurements on the 
scale of biological molecules (256, 257, 294).  Thus, FRET is an invaluable technique for 
investigating a variety of biological phenomena that produce a change in molecular 
proximity, especially for macromolecular assemblies (284), including dimerization of 
alpha helices (3).  
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Table 4.  Parallel versus anti-parallel alignments show that the either alignment would 
have the exact same number of hydrophobic (light yellow) and electrostatic (cyan) 
interactions and thus either orientation could be expected.   
Parallel  Anti-parallel 
        
position E42C R39C  position E42C R39C position 
 N-term    N-term   
 c    c   
 g    g C-term  
 g    g c  
 w    w g  
 g N-term   g g  
 g w   g e  
g e r  g e r e 
a v v  a v l d 
b r r  b r a c 
c a a  c a r b 
d l l  d l v a 
e e r  e e r g 
f e e  f e e f 
g e r  g e r e 
a v v  a v l d 
b r r  b r a c 
c a a  c a r b 
d l l  d l v a 
e e r  e e r g 
f e e  f e h f 
g e r  g e r e 
a v v  a v l d 
b h h  b h a c 
c a a  c a h b 
d l l  d l v a 
e e r  e e r g 
f h h  f h e f 
g e r  g e r e 
a v v  a v l d 
b r r  b r a c 
c a a  c a r b 
d l l  d l v a 
e e r  e e r g 
f e e  f e e f 
g e r  g e r e 
a v v  a v l d 
b r r  b r a c 
c a a  c a r b 
d l l  d l v a 
e e r  e e r g 
f e e  f e w f 
g k g  g k N-term  
 C-term g   C-term   
  c      
  C-term      
20 favorable interactions  20 favorable interactions 
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 Since we have one C-terminus thiol on R39C and one N-terminus thiol on E42C, 
parallel alignment in our system is desired. Anti-parallel coiled coil formation may block 
the interaction of the coils if they are to add a protein/peptide component on the N-
terminus of the E42 sequence.  By labeling the free thiol on each peptide with a FRET 
pair, we hypothesize that this may provide insight into the coiled coil formation, as 
envisioned in Figure 23.  Our specific goal is to determine whether the peptides form a 
parallel or anti-parallel coiled coil.  This information would allow us to build sensor 
components that would be synthetically or recombinantly fused to the coiled coil probe 
sequence in the proper orientation.  We chose the fluorophore Alexa Fluor® 488 (204) 
and the fluorescence quencher QSY® 7, which have an overlap region that produces 
distance dependent fluorescence quenching with a 50% quenching at a distance of 6.1 nm 
(R0 = 6.1 nm) (168).  Since the length of the labeled coils (7.5 nm) is greater than that of 
the FRET pair (R0= 6.1 nm), this may prove to be a useful determinant of orientation.  
The molecular structures, spectral absorption curves and Alexa Fluor® 488 emission 
curve for the FRET pair are presented in Figure 24.   
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Figure 23.  Different alignments of R39C (blue) and E42C (red) would place free thiol 
groups away (parallel) or next to one another (anti-parallel).  These alignments would 
dictate the self-assembly of larger proteins (cyan) on sensor surfaces that were fused to 
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the probe coil E42C.  Our hypothesis was to test parallel versus anti-parallel formation in 
our dimer coiled coil using a FRET assay. 
 
 
 
Figure 24.  Molecular structure and fluorescence characteristics of the Alexa Fluor® 488 
and QSY® 7 dyes.  Excitation of the Alexa Fluor® 488 with λ = 488 nm leads to an 
emission profile represented by the solid green line, which overlaps with the excitation of 
the QSY® 7 (dotted blue line).  If these molecules are in close proximity (< 6.0 nm), 
QSY® 7 would quench the fluorescence of Alexa Fluor® 488, most apparent in the 520 to 
600 nm region. 
 
 
 Each of the E42C and R39C peptides were labeled with one or the other of the 
fluorophore quencher FRET pair, Alexa Fluor® 488 and the quencher QSY® 7, using a 
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maleimide conjugation to target the C-terminal thiol on R39C and the N-terminal thiol on 
E42C in the presence of the reducting agent TCEP to ensure reactive thiols.  The reaction 
was quenched with an excess of reduced glutathione and purified via RP-HPLC.   For this 
reaction many species were predicted: peptides labeled with FRET pairs, glutathione 
conjugated to FRET pairs as well as the individual components: glutathione, peptides and 
FRET pairs.  The RP-HPLC chromatograms for the Alexa Fluor® 488 C5 maleimide 
labeled E42C resulted in three peaks collected for further analysis, whereas five peaks 
were collected for the Alexa Fluor® 488 C5 maleimide labeled R39C.  Labeling the 
anchor E42C with QSY® 7 resulted in three peaks, and R39C with QSY® 7 achieved four 
peaks.  These data are displayed in Figure 25.  Because the peak locations for QSY E2 
and QSY E3 fractions eluted at the exact time as the peaks for QSY R3 and QSY R4, 
they were assumed to be the same material (i.e. could not be the FRET labeled peptides) 
and not used for FRET spectra collection.  
 Using spectrophotometer to determine concentration, 1:1 molar ratios for the RP-
HPLC peaks were added together and incubated for ten minutes.   The plate was excited 
at 488 nm and the fluorescence collected from 525 nm to 565 nm in 5 nm increments, 
depicted in Figure 26.   No precipitate was observed with the combined E-R HPLC peaks 
at the bottom of the wells, contrary to the unlabeled versions of the peptides.  It appears 
that the addition of a molecule on the termini of the peptides inhibits the aggregation that 
was observed in the circular dichroism experiments with micromolar concentrations.  
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Figure 25.  HPLC chromatographs for the peptide labeled with the FRET pairs Alexa 
Fluor® 488 and QSY® 7.  Top: peptides labeled with Alexa Fluor® 488, left 
chromatogram corresponds to the E42C, right to R39C.  Bottom chromatograms are the 
QSY® 7 labeled peptide solutions, left: E42C and right: R39C.  
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Figure 26.  Emission spectra for the 1:1 mixture (2.5 µM each component) of the 
fluorophore labeled peptide and the quencher labeled peptide.  All data points were taken 
in triplicate with the standard error shown.  
 
 
 As seen in Figure 26 there was little non-resonant quenching in the fluorescence 
curves for the FRET labeled R39C and E42C peptide components.  Although not entirely 
conclusive on its own merit, these data support a model of parallel formation.  There is a 
little fluorescence quenching in the QSY E1 and QSY E2 samples when using the 488 R5 
HPLC fractions, denoted by the slightly sharper sigmoidal profile as compared to the 
other curves.  However, we feel this is not substantial because it falls within the standard 
  
84
 
error and is seen with both QSY fractions.  This minimal quenching is most likely the 
unlabeled or glutathione quenched dye component.  
 We can further justify the formation of a parallel formation of the coiled coil 
through reasoning.  The hydrophobic parings would be valine-valine (a-a’) and leucine-
leucine (d-d’) in the parallel formation, both of which are energetically more stable than 
those of valine-leucine (a-d’ and d-a’) pairings in the anti-parallel formation (1, 2).  
Furthermore, this individual pairing preference would be additive over the 10 
hydrophobic pairings for the five heptad repeat design.  Another possibility contributing 
to parallel formation and the absence of FRET signal is steric hindrance.  The native 
peptides may well form coiled coils that exist in both parallel and anti-parallel 
orientations.  By labeling the ends with bulky organic dyes, the equilibrium of the 
parallel/anti-parallel orientation may be pushed towards keeping the dyes at opposite 
ends.  In this case, the formation that would create the least steric hindrance would be that 
of a parallel coiled coil.  
 
Surface plasmon resonance optical biosensing 
 Optical biosensor platforms such as Biacore provide label-free biomolecule 
interaction analysis with comprehensive data, including the quantitative kinetic analysis 
in terms of association (kon) and dissociation rate (koff) constants which can be used to 
calculate affinity constants (121, 123).  Biacore monitors the critical angle of incident 
light that is responsible for the phenomenon of surface plasmon resonance (SPR), which 
is a collective oscillation of electrons at the surface of a thin metal film under conditions 
of total internal reflection (141, 142, 203).  When a molecular interaction occurs between 
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a sensor surface immobilized ligand and a solution based analyte, the refractive index is 
altered at the interface, shifting the critical angle for SPR, which is directly related to the 
amount of interactants.  The data are reported as a sensogram, plotted as sensor response 
units (1 RU = 1 pg / mm2) per unit time.  Because the SPR response is related to the 
change in surface mass concentration, the response is dependent on the molecular weight 
of the analyte in relation to the number of ligand sites on the surface.  A useful parameter 
is Rmax, the maximum binding capacity of the surface ligand for the analyte in RU and is 
defined as: 
 Rmax = MWanalyte / MWligand * ligand response * valence 
where MW is the molecular weight in Daltons, ligand response is the amount of 
immobilized ligand in RUs, and valence is the number of analyte molecules that can bind 
to one ligand molecule.  
 A typical biosensor experiment consists of building the experimental and 
reference sensor surface then testing several analyte concentrations.  A sensor surface 
regeneration step is required between each concentration test to dissociate any molecular 
interactions between cycles. A typical run at a single concentration is outlined in Figure 
27.  Using the association and dissociation data over several cycles of different 
concentrations, the software is able to calculate the kinetics of assembly for the molecular 
interaction.  The simplest model for a biosensor interaction is a 1:1 binding between A, 
the analyte, and B, the immobilized ligand: 
  kon 
 A + B   ↔  AB 
  koff 
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The rate equation for the formation of the AB complex is: 
 d[AB]/dt = kon [A][B] – koff [AB] 
In context of Biacore, B is the ligand immobilized on the sensor surface, [B] is the 
baseline signal, and [AB] is the response (R) of the complex formed at time t.  In terms of 
the resonance signal change, the rate equation becomes: 
 dR / dt = kon [A] (Rmax – R) – koff R 
and with rearrangement comes to: 
 dR / dt = kon [A]Rmax – (kon [A] + koff )R 
where Rmax is the maximum binding signal of the surface as defined previously, with 
[A]/[B] as the ligand response.  The term ks defined as ( kon [A] + koff ) and can be 
determined from the slopes of dR / dt versus R at different values of [A].  Subsequently, 
kon can then be determined from the slope of ks versus [A].  In the dissociation process, 
[A] = 0 and the equation simplifies to: 
 dR / dt =  – koff R 
or 
 ln (R0 / Rn) = koff (tn – t0) 
where R0 is the response at t0 at the beginning of the dissociation.  Thus, koff can be 
obtained from the slope of the ln (R0 / Rn) versus (tn – t0). 
 This is analogous to the 1:1 Langmuir binding model, which treats the 
immobilized ligand as a solid phase component, assuming rapid mixing of analyte and 
single step binding without conformational reordering (29).  This model was eventually 
corrected for mass transfer limitations by Sigmundsson et. al. in 2002 (247) and was used 
to estimate the kinetic parameters for the anchor/probe interactions.  
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Figure 27.  A schematic representation of a single concentration of analyte (red probe 
coil) on a SPR biosensor.  The sensor surface, covalently functionalized with the ligand 
(blue anchor coil) has running buffer flowed over the surface.  The running buffer is 
changed to a solution containing a known concentration of the analyte which is injected 
over the surface and allowed to associate.  The buffer is switched back to running buffer 
and the analyte is allowed to dissociate from the ligand.  The buffer is switched again to a 
regeneration solution that removes all remaining ligand/analyte pairing and the surface is 
ready for a new analyte concentration.   
  
  
 In using anchor/probe elements such as our coiled coil, we want to build a system 
in which the koff is low, meaning our captured anchor component remains in place during 
the course of experimentation.  We also can utilize the optical biosensor to test suitable 
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regeneration conditions so that we may rebuild biological components on surfaces if the 
previously captured components have been degraded.  We utilized SPR biosensing to 
validate the self-assembly of our designed anchor and probe coils and derive the 
association (kon) and dissociation (koff) kinetic parameters as well as the equilibrium 
dissociation constants (KD).  Figure 28 displays a characteristic sensorgram between 
R39H10 and E37Ferro and their residuals used to derive kinetic parameters and a 
measurement for quality of fit to the 1:1 model respectively.  The complete values for the 
different anchor/probe combinations are summarized in Table 5.  All synthetic 
anchor/probe combinations displayed a fast association (~105 M-1 s-1) and a slow 
dissociation (10-4 s-1) in HBS-P buffer leading to an affinity in the low nanomolar to high 
picomolar range.  These values are in good agreement with 5 heptad repeat coiled coil 
interactions (49, 59, 95, 188, 242).  
 
 
 
Figure 28.  (left) Characteristic sensorgram of E37Ferro over immobilized R39H10 and 
(right) a plot of the residuals used to evaluate the fit of the 1:1 Langmuir global 
interaction model. 
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Table 5.  Kinetic parameters acquired by surface plasmon resonance biosensing.  
Standard deviations were obtained from a minimum of three experiments, while KD was 
calculated as the ratio of koff to kon. *The anchor R39Pra did not fit the global 1:1 
Langmuir binding model used with R39C and R39H10; local fits were used to estimate 
these parameters. 
Anchor/Probe  R39C R39H10 R39Pra* 
 kon [M-1 s-1] 3.27E+05 ± 0.97 4.01E+05 ± 0.86 1.00E+05 ± 1.59 
E42C koff [s-1] 1.64E-04 ± 0.99 2.23E-04 ± 0.64 3.23E-04 ± 1.60 
 KD  [M-1] 5.0E-10 5.6E-10 3.23E-09 
        
 kon [M-1 s-1] 4.24E+05 ± 0.44 4.77E+05 ± 0.57 1.57E+05 ± 1.07 
E37Ferro koff [s-1] 1.42E-04 ± 0.86 2.35E-04 ± 0.17 6.18E-04 ± 0.98 
 KD  [M-1] 3.3E-10 4.9E-10 3.9E-09 
 
 
 The anchor peptides R39C and R39H10 were covalently immobilized via the C-
terminal cysteine, while R39Pra was immobilized through a cysteine in the central 
heptad.  Roughly 100 RUs of each anchor was immobilized as the ligand to obtain high 
quality kinetic information.  Both of the probe sequences acting as analytes bound with 
high affinity to all three of the anchor components.  Curiously, only the anchor sequence 
of R39Pra did not fit a global 1:1 Langmuir model.  The binding of probe sequences to a 
centrally immobilized anchor (R39Pra) displays more complex kinetics than can be 
described with a simple 1:1 interaction.  This may be due to a higher stoichiometry 
afforded by the central attachment position or conformational rearrangement that has not 
been seen with terminal immobilization of R39C and R39H10.  Nevertheless, it was 
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previously unknown whether or not a coiled coil interaction could be assembled on a 
sensor surface immobilized via a central thiol group.  As outlined in Figure 29, this result 
opens opportunities for two different immobilization displays (perpendicular and parallel 
to the surface) that both have the ability to assembly probe components with the desired 
affinity.  An additional advantage is that when a user so desires, the probe component can 
be washed from the surface using one of two regeneration conditions and the 
immobilized anchor is free to capture once again (49, 60, 242, 269).   
 
 
 
Figure 29.  Differential display of anchor immobilization.  To the left, pyridyldithiol 
chemistry can orient R39C or R39H10 perpendicular to the sensor surface.  To the right, 
the same chemistry can orient R39Pra in a parallel fashion.  Both orientations displayed 
suitable kinetics for solution-based self-assembly and regeneration. 
 
 
 Altogether, our designed coiled coil peptides display a very tight binding which 
rightfully earned the description “peptide Velcro”.  The heterodimerization kinetics of 
our multifunctional coiled coils are a direct result of the rational design, employing valine 
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and leucine residues in the a and d positions of the heptad repeats to form the 
characteristic hydrophobic seam along the long axis of the peptides.  This hydrophobic 
interaction is stabilized and given dimerization specificity with the electrostatic 
interactions of e and g border residues between complementary probe and anchor 
heptads.  As a result, it is not surprising that the kinetic values are close to other reported 
five heptad repeat coiled coils (59).   
Pertaining to biosensors, our anchor/probe combinations exhibit a beneficial 
combination of fast association and slow dissociation, effectively capturing a probe 
component and having a stable interaction throughout experimentation. This concept 
becomes more apparent upon comparing the sensorgrams of a His tag-NTA complex and 
our coiled coil anchor/probe motif, shown in Figure 29.  Although the association rate is 
comparable, the faster dissociation of the His tag-NTA complex would manifest itself in 
leaching of the captured biomolecule from the sensor (191).  The same leaching problem 
would also be evident when using an anti-pentaHis monoclonal antibody in lieu of NTA 
to capture His tag fusions (242).  Because of the slow dissociation of the coiled coil 
anchor/probe system, this surface leaching would be minimized.   
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Figure 30.  Comparison of sensorgrams of a His tag-NTA interaction (left) and our 
coiled coil anchor/probe system (right).  The association rates are similar, but the 
dissociation of the His tag-NTA complex is much greater than that of our anchor 
(R39C)/probe (E42C) sequence.  Figure modified with permission from (191) and (49). 
 
 
 In conclusion, we utilized rational design, solid phase peptide synthesis and 
reverse phase high performance liquid chromatography for the creation of milligram 
quantities of multifunctional heterodimeric coiled coil anchor/probe peptides for further 
experimentation.  Self-assembly of designed heptads was successfully characterized by 
circular dichroism which validated coiled coil formation, Förster resonance energy 
transfer which determined a parallel orientation for self-assembly, and surface plasmon 
resonance biosensing which demonstrated a low nanomolar to high picomolar interaction 
between anchor and probe components, and thus completing the objectives of Specific 
Aim 1.   
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CHAPTER 4: SPECIFIC AIM 2 
 
 Anchor/probe coiled coil assembly on biosensor substrates.  We demonstrated 
two distinct pathways for the covalent attachment of anchor peptides and the subsequent 
self-assembly and isotropic display of complementary probe peptides on nanoscale 
biosensor substrates.  This versatile system was constructed on highly ordered carbon 
nanotube arrays, macroscale electrodes as well as nanoscale electrode ensembles of gold 
composition and carboxymethyldextran sensor surfaces of surface plasmon resonance 
biosensors. 
 
This chapter addresses the hypothesis that our multifunctional coiled coil linkers 
function as isotropically displayed anchor/probe systems with noble metal binding 
capabilities on nanoscale substrates.  The focus will be on the tip immobilization of 
anchor components onto carbon nanotube array substrates and the subsequent assembly 
of probe peptides. 
 
Carbon nanotubes 
 Impressive advances in the discovery and controlled growth of carbon nanotubes 
(CNTs) provide a major focus for device development in current nanotechnology.  Since 
the discovery of CNTs (115), or perhaps the more applicable “rediscovery” of CNTs 
(185), many synthesis techniques have been devised that produce CNTs in bulk scale 
quantities including: arc discharge (72, 124), laser ablation (264), and chemical vapor 
deposition (CVD) (156).  The controlled growth of CNTs into ordered compositions 
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forms the basis for many array-based CNT biosensors, and a template-based form of 
CVD growth has been the leading synthesis technique. 
  Highly-ordered arrays of vertically-oriented CNTs are typically grown via 
thermal decomposition of carbon precursors onto seeded metallic nanoparticles within a 
nanoscale anodic aluminum oxide (AAO) template.  The anodizing voltage used to create 
the pores in the AAO template forces the CNTs to grow in predefined geometries.  AAO 
template nanotubes are characterized by a narrow size distribution, large-scale 
periodicity, and high densities with diameters ranging from ten to hundreds of 
nanometers and lengths up to 100 µm (155, 205).   
 Using CVD, higher-ordered CNT arrays are also possible, including Y-junction 
CNTs within the nanopore array (154). Meng et. al. extended the capability of AAO 
template synthesis by creating controllable, hierarchical Y-junction CNTs and Ni 
nanowires via sequential reduction in anodizing voltage (179). Similarly, Au Bouchon 
reported orthogonal multi-branching growth via plasma-enhanced CVD and a self-
seeding Ni catalyst (14).  Another group devised a scheme for multi-branching through 
control of the gas flux and composition, avoiding templates or additives (286).  These 
advances have yet to flourish in CNT array biosensors, but the ability to create these 
branched CNT structures may provide opportunities for more advanced biosensor 
capabilities in the future. 
  Beyond the benefit of highly-controlled geometrical arrays of metallic nanotubes, 
CNTs grown in AAO templates are also electrically insulated from each other (155, 301).  
This feature may ultimately enable high-density, multiplexed CNT array biosensors using 
individual CNTs in parallel as a sensing platform.  This is a particularly difficult 
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challenge; the current sensitivity limits necessitate that many individual nanotubes within 
the array be wired together via metallic deposition.  Nevertheless, these ordered CNT 
compositions provide an opportunity to form conductive arrays to detect biologically-
derived electronic signals with high sensitivity and specificity (129, 252, 291).  
 Attachment of biological molecules to CNTs has been hotspot for recent research 
(38, 39, 89, 129, 190, 282).  In array based CNT biosensors, selective etching of the 
template is often used to expose individual CNTs from within the AAO matrix. 
Subsequent acid treatment is used to open nanotube selectively at regions of high 
curvature to present reactive carboxylate groups for further chemical and biological 
attachment (274).  Figure 31 is a typical micrograph of an AAO template CNT array that 
is commonly used as a biosensor platform that has been etched for 8 hours to expose the 
CNTs. 
 A key need is to develop conductive, functional linkers to interface individual 
CNTs to soluble biologically important targets.  Proteins and peptides represent the most 
diverse library of recognition elements, and thus tools to functionalize CNT arrays with 
such molecules are of crucial importance.  Again, our synthetic and/or recombinant 
coiled coils with displayed peptides and proteins provide one such strategy for interface 
linkers.  Tip-directed attachments, as apposed to side wall sites on the CNTs, were 
previously shown to achieve a higher quality of biologically derived signals (291), due to 
enhanced solvent access.  The CNT tip-directed immobilization of anchor peptides 
afforded a means to orient and display probe peptides and proteins that would satisfy the 
design principles for next generation nanoscale biosensors.  
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Figure 31.  SEM micrograph of a typical AAO template CNT array that has had its 
supporting matrix removed in a 6% (w/v) H3PO4 / 1.8% (w/v) CrO3 solution in H2O to 
expose the tips of the CNTs. The micrograph clearly demonstrates a high degree of 
geometric order over long distances imparted by the hexagonal AAO template CVD 
synthesis. 
 
 
 We demonstrated CNT tip-specific conjugation of our de novo designed, 
multifunctional coiled coil peptides via two different covalent immobilization pathways.  
We employed scanning electron microscopy (SEM) to directly visualize the experimental 
immobilization of CNT array substrates at nanometric resolution.  Because proteins and 
peptides generally do not have electron densities sufficient to provide SEM contrast at the 
nanometer scale, we labeled free thiols on the coiled coil peptides with gold 
nanoparticles.  Electron-dense Au nanocrystals scatter electrons in sufficient quantities 
  
97
 
for the SEM detector to reconstruct an image, and thus commonly serve as a biological 
contrast agent when combined with an SEM imaging modality (30).  
 
Disulfide exchange immobilization pathway 
 The first covalent strategy was similar to the chemistry developed to attach free 
thiols on biomolecules to the carboxymethyldextran matrix commonly used in SPR 
sensor surfaces (121).  Using pyridyldithiol chemistry, we immobilized the anchor 
peptide R39C to the tips of the CNT array.  The process of this immobilization pathway 
is outlined in Figure 32 below. 
 
 
 
Figure 32.  Schematic diagram illustrating the sequence of functionalizing a CNT array 
with the R39C coiled coil anchor using a disulfide exchange reaction. (a) Template 
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etching and oxidation (b) are used to create reactive carboxyls. (b) Solution applied 
EDC/NHS/PDEA chemistry allows for covalent attachment of anchor peptides through a 
mixed disulfide reaction.  (e) Residual pyridyldithiol sites are blocked with a cysteine-salt 
solution. 
 
 
 When imaged, the subtrates depicted in Figure 33 highlighted the successful 
implementation of the disulfide exchange immobilization pathway onto CNT tips.  Upon 
addition of the labeled E42C peptide probe to the R39C functionalized CNT substrate, 
Au nanoparticles were clearly resolved in the micrograph (Figure 33B).  An average of 
2.09 ± 1.2 attachment sites per CNT (n = 60) was observed; this can be explained by the 
limited number of carboxylate groups that are present for activation following relaxation 
of the etched tip.  A smaller number of Au nanoparticles were resolved on the side walls 
of the individual CNTs.  This can be attributed to the presence of side wall defects on the 
rolled graphine interface that also provide reactive carboxylate groups.  Control 
experiments in which the E42C peptide was presented to the CNT array without the 
R39C peptide indicated minimal non-specific interactions (Figure 33C).  Those that were 
present can be explained either by (1) electrostatic interactions between the carboxylates 
and the four basic residues found on the E42C peptide or (2) alignment of the peptide’s 
hydrophobic seam along the vertical axis of the CNT side walls, which are also 
hydrophobic surfaces.  In Figure 33A, the tips were functionalized with R39C and 
exposed to Au nanoparticles that where not conjugated with E42C.  This negative control 
indicated that nanoparticle visualization is dependent upon the reaction between E42C 
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and R39C, and not due to interactions between R39C and the Au nanoparticle.  From 
these results, it is evident that with simple H2O washing, a functionalization scheme 
without high salt concentrations is capable of clean, site-directed assembly on the CNT 
tips. 
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Figure 33.  Disulfide exchange immobilization of the anchor R39C coiled coil and E42C 
assembly onto highly ordered CNT arrays. (A) SEM image of the covalent 
immobilization of anchor peptide R39C in H2O onto etched tips of the CNT array and 
unconjugated nanoparticles. (B) Upon addition of the Au-labeled E42C probe peptide 
again in H2O, the tips of the carbon nanotubes demonstrate site-specific assembly of the 
coiled coil peptides. (C) Without the covalent attachment of the anchor peptide, Au-
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labeled E42C show minimal non-specific adsorption to the CNT array following simple 
substrate washing with H2O.  The control image of unlabeled Au nanoparticles and R39C 
indicates interaction is specific between R39C and E42C, not R39C and nanoparticle. 
 
 
 Overall, the results in Figure 33 are very promising.  The high stability of the coil 
coiled interaction enables visual evidence of assembly to remain even under the high 
vacuum environment of SEM.  Assembly occurred even without the presence of salt in 
the buffer, a requirement for DNA linkers.  It is important to note that this first covalent 
immobilization strategy relies on a disulfide bridge which is susceptible to breakage 
under electrochemical experimental conditions, a double-edged sword.  If desired, this 
bond can be broken using reduction agents or an applied voltage.  Unfortunately, the 
applied voltage in routine amperometric detection creates a major limitation for use of 
this covalent immobilization pathway in amperometric biosensors.  Other redox 
insensitive methodologies to functionalize CNTs that use adsorption (291), covalent 
attachment (88, 89, 104) or elevated temperatures (153) are often incompatible with 
isotropically and functionally oriented proteins and peptides.  A major challenge was now 
to incorporate an anchor immobilization strategy that was not redox sensitive, but still 
fulfilled the design principles outlined in Figure 3. 
 
“Click” immobilization pathway 
  “Click” chemistry to form a 1,2,3 triazole between an azide and an alkyne 
emerged as a promising alternative.  This metal catalyzed reaction is broad in scope, 
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species and regioselectivity, while using inoffensive solvents and reaction conditions 
(108, 232, 267).  The use of self-assembled monolayers (SAMs) with azide termination 
on gold electrodes has been reported (46, 47), as well as a novel means to selectively 
address and pattern the functionalization through electrochemical activation/deactivation 
of the metal catalysis (66).  This robust linkage is also electrochemically stable, 
producing electron transfer rates in excess of 60,000 s-1 in certain assemblies (65).  Bulk 
CNTs have been solubilized by crosslinking polymer at 80°C with an uncatalyzed 
reaction between azide and alkyne moieties (153).  Using copper catalysis, this chemistry 
becomes applicable to proteins and peptides at tolerable temperatures (~37°C), 
effectively labeling proteins  (159) and carbohydrates in vivo (235).  The subsequent 
application of “click” chemistry was investigated as a novel pathway to covalently 
immobilize the anchor peptide R39Pra to CNT array tips and further self-assemble probe 
components like E42C.  
 Again, highly ordered CNT arrays were synthesized and prepared as previously 
reported (155).  To incorporate azide functionality on the CNT tip surface we attached 
azido-homo alanine (134) via standard EDC/NHS chemistry; solid phase peptide 
synthesis of R39Pra incorporated the non-canonical amino acid propargylamine at the C-
terminus providing a single reactive alkyne.  The copper-catalyzed click reaction between 
the azide and alkyne proceeded overnight at 37°C.  The schematic outlining this protocol 
can be seen in Figure 34. For imaging purposes, a 10 nm nanoparticle was chemisorbed 
to the central thiol of R39Pra to provide SEM contrast.   
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Figure 34.  Schematic diagram illustrating the sequence of functionalizing a CNT array 
with the R39Pra anchor using a 1,3 Huisgen dipolar cycloaddition to form a 1,2,3 
triazole. (a) Template etching and oxidation (b) are used to create reactive carboxyls. (c) 
Applied EDC/NHS/homo-azido alanine presents a reactive azide; (d) residual sites are 
blocked with an ethanolamine solution.  (e) Covalent immobilization was achieved with a 
copper-catalyzed 1,2,3 triazole formation between the azide of homo-azido alanine and 
the alkyne of R39Pra.  
 
 
 Using the “click” immobilization pathway, SEM imaging seen in Figure 35 
indicated nanoparticles located 89% at the tips of the nanotubes as opposed to the 
sidewalls.  An average of 3.20 ± 1.0 (n = 60) nanoparticles were observed per CNT. 
Control images in Figure 36 which a CNT array without homo-azido alanine 
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functionality, or the R39Pra peptide’s single thiol was blocked using iodoacetic acid, 
indicated specific, tip-directed attachment and R39Pra-mediated nanoparticle capture 
respectively.  Following covalent immobilization, the anchor peptide retained ability to 
capture the probe peptide E42C labeled with 20 nm nanoparticles, as shown in Figure 37.  
Efforts to prove assembly using different diameter nanoparticles on both anchor and 
probe components at the same time failed, possibly due to steric hindrance imposed by 
the large size of the nanoparticles as compared to the peptides.  Together, the results of 
the “click” immobilization pathway provide similar quantity and site-specificity in tip-
directed CNT array immobilization, with the added benefit of forming a redox insensitive 
covalent linkage.  Additionally, the ability to assemble noble metal particles within the 
anchor sequence enables another option for advanced metallization capabilities. 
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Figure 35.  Click conjugation of the anchor peptide R39Pra to the tips of a CNT 
array.  The thiol located on the central heptad was labeled with 10 nm gold 
nanoparticles to provide SEM contrast. 
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Figure 36.  Controls for the click chemistry attachment of the anchor peptide R39Pra.  In 
the top image the CNT array did not have the homo-azido alanine functionality on the 
tips, all other steps of the click immobilization pathway were retained.  In the bottom 
image, the R39Pra anchor was immobilized to CNT tips, but the central thiol was blocked 
with 1 M iodoacetic acid before incubation with 10 nm gold nanoparticles. 
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Figure 37.  Assembly of E42C labeled with 20 nm gold nanoparticles onto a clicked 
anchor peptide R39Pra with a blocked thiol group.  
 
 
 Interfacing carbon nanotubes isotropically through a single chemically reactive 
site with anchor peptides enables the further capture of probe peptides onto these useful 
biosensor substrates.  Using a mixed disulfide reaction, R39C was attached to the CNT 
tips, while the copper-catalyzed 1,3 Huisgen dipolar cycloaddition attached R39Pra to the 
tips of CNTs.  Both chemistries resulted in the successful capture of nanoparticle labeled 
E42C, indicating that cargo, including biological molecules, can be site-specifically 
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delivered to distinct nanoscale regions of biosensor surfaces including the tips of highly 
ordered carbon nanotube arrays.    
 Beyond SPR and CNT substrates, another extremely common biosensor surface is 
that of gold.  Gold has a high conductivity with the added benefit of anti-corrosive 
behavior in most solutions.  Because the anchor peptides R39C, R39H10 and R39Pra 
each have a single thiol, their extension to biosensors that have gold surfaces for 
immobilization is readily available.  By taking advantage of the strong chemisorption of 
thiols to gold, conductive noble metal surfaces can be functionalized with our anchor 
peptides, which will be demonstrated in the subsequent chapter using cyclic voltammetry 
and ferrocyanide solutions.  If chemisorption of thiols to gold is not a desirable 
functionalization pathway, one alternative is to covalently anchor and orient R39Pra 
using a “click” mediated chemistry on gold using azido-terminated SAMs (46, 47).  
    In summary, the anchor/probe approach can easily be extended to almost the 
entire scope of biosensor platforms.  Biosensor surfaces such as CNT tips and SPR 
biosensors that present reactive carboxylates can be reacted to coiled coil anchor 
components using the disulfide methodology.  If one so desired to remove the anchor 
component, the resultant disulfide bond can be broken using reducing conditions.  
Chemical conversion of the carboxylate on the sensor surface to an azide extends the 
application of our anchor/probe capture and display system, providing an alternative, 
redox-insensitive pathway for covalent functionalization.  Finally, the rational design of 
the anchor peptides also incorporated single cysteines which are useful for assembly onto 
gold substrates.   
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CHAPTER 5: SPECIFIC AIM 3 
 
Signal acquisition using coiled coil directed assembly of redox targets.  We 
utilized several combinations of coiled coil directed assemblies in an attempt to acquire 
redox signals on gold electrodes.  Using a bi-histidine scaffold, metallization sites were 
incorporated into the coiled coil peptide design to facilitate electron transduction through 
the linker via chelation of metal ions.  Electroactive targets, including ferrocene and the 
redox enzyme Npx, were chemically fused to the probe peptides, assembled into coiled 
coils and tested by cyclic voltammetry on macro- and nanoscale gold electrodes in two 
orientations with and without metallization.  Recombinant expression was also utilized to 
broaden the scope of our anchor/probe system towards a variety of redox targets and 
mediators using a cassette vector expression system. 
 
This chapter addresses the hypothesis that our anchor/probe approach places an 
insulative gap between assembled redox targets and sensor surfaces.  The 
metallization of side chains or perpendicular/parallel orientation of assembly may provide 
conductive pathways for electron transport. 
 
Electrochemical biosensing 
 Electrochemical biosensors are generally based on enzymatic catalysis of a 
substrate conversion that produces a flow of ions.  One electrochemical subtype, 
amperometric biosensors, functions via the production of a current when a potential is 
applied between two electrodes.  These sensors are constructed of three electrodes: a 
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reference electrode, an active electrode and a sink electrode.  The target analyte 
participates in the reaction on the active electrode surface, and the ions produced create a 
potential that is subtracted from the reference electrode to generate a signal.  The use of 
specific proteins, called redox enzymes, as the source of electronic signals in response to 
a specific ligand or other physiological signal is fundamental for amperometric 
biosensors (281).   
As presented in Figure 3, contact with sensor surfaces may alter or even destroy 
native protein conformations, significantly altering redox capabilities of these enzymes.  
Nanoscale surfaces, such as nanoparticles and CNTs, may limit these detrimental effects 
because of: 1) regions of high curvature that energetically limit biomolecule adsorption, 
and 2) reduced steric hindrance of the substrate to its binding site on the enzyme.  These 
promising nanomaterials have demonstrated increased sensitivity when used in 
conjunction with amperometric biosensors (288, 291, 295). 
 Covalently functionalizing redox enzymes with a conductive spacer to span 
electrode surfaces with the use of inter-digitated redox mediators, such as ferrocene, has 
shown to increase amperometric signals (239).  The reduction in oxidation potential 
found with ferrocene mediators also limits interference due to extraneous materials.  
Again, the typical heterogeneous immobilization of the enzyme at random orientations 
with respect to the active site can result in decreased rates of electron transfer (177, 295).  
Thus, the conductive spacers used to link enzymes to the sensor substrates in 
amperometric biosensors should be linked in an isotropically-controlled manner (299).  A 
pathway towards achieving isotropic, yet reversible redox target display on nanoscale 
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biosensors is to incorporate potentially conductive wiring of enzymes via metallized 
coiled coils.  
 
Metallization by a bi-histidine scaffold 
 A significant challenge in peptide and protein design is to create stable and 
universal scaffolds into which tailored functions can be introduced, in this case for 
biosensors.  Biological materials are poor conductors of electron flow (92), and thus the 
further an anchor/probe system displays the redox moiety from the electrode the less 
likely a electrochemical signal can be acquired.  This is a major limitation of monoclonal 
antibody recognition interfaces.  Their large size insulates detection of the redox reaction 
from the transducer elements and often require electron mediators (297).  Smaller affinity 
tags, such as the His tag-NTA anchor/probe combination have been successfully 
employed (268), but may suffer from surface leaching due to fast dissociation constants.  
Metallization of peptides provides an attractive route for the creation of metallic wires 
that may enhance the efficiency of electron transport through the linker, similar to that 
created by the metallization of DNA (290).  
 Metal-binding proteins in nature have many biological roles, most notably the 
transport of oxygen by hemoglobin that coordinates iron with its heme group (17).  Ex 
vivo applications have provided progress in the field of metal binding motifs that lead to 
protein purification and folding (6, 211), even those that induce coiled coil formation 
(133, 157).  A particularly useful motif was found within the DNA-binding zinc finger 
that used histidine residues in the i and i + 4 positions to chelate 2+ metal ions in an alpha 
helix (209).  This bi-histidine motif can be applied to the b and f positions within a 
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heptad repeat of a coiled coil (87, 140), providing an attractive pathway forward for 
coiled coils that may act as molecular wires (49, 299) without interference to assembly.   
Starting from the peptide backbone of the crystal structure of the coiled coil 
GCN4 (198), a modeled bi-histidine motif was created by adding the side chains of E42C 
and R39C for a single heptad using the Rasmol software (19, 236).  The result depicted in 
Figure 38 demonstrated a 7 Å cleft between the two imidazole rings of the histidine 
residues located on the solvent exposed face of the coiled coil dimer.  This orientation 
was expected to coordinate a 2+ metal ion such as cobalt.  We then used a combination of 
mass spectrometry, isothermal titration calorimetry and an IMAC assay to investigate the 
cobalt binding properties in our anchor/probe system.  Following these experiments, the 
kinetics of assembly was determined in both normal and metallized buffer conditions. 
 
 
 
Figure 38.  Rasmol model of the central heptad of the E42C and R39C dimer coiled coil.  
The histidine residues are highlighted in green and are located on the solvent exposed 
face of the assembly.  This site was expected to metallized the peptide with a divalent 
cation. 
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Mass spectrometry 
Mass spectrometry (MS) is an analytical technique that utilizes charged species 
generated from a species of interest, separated on the basis of their mass-to-charge ratio 
(m/z).  MS has progressed over the years in two key arenas, summarized in several 
reviews (5, 166, 248).  The first is the ability to create charged species from the molecule 
of interest, and the second is the mass range in which particles can be detected.  
Nowadays, charged species are typically generated either with high energy bombardment 
coupled with an inorganic matrix (107, 126, 127, 227, 258), or mixed with ionic liquids 
followed by subsequent solvent evaporation by spraying through a small nozzle, termed 
electrospray ionization (70, 73, 79, 251).  Detection techniques rely on either quadrupole 
interference, which uses radio frequencies in an electric field to filter out unstable ionic 
oscillations (248), or time-of-flight techniques that determines the time that a charged 
species under an applied potential takes to reach a detector (261).     
Matrix-assisted laser desorption ionization time-of-flight (MALDI TOF) MS was 
performed at Wistar Proteomics Institute, Philadelphia PA, on roughly 1 pmol/µl of the 
E42C and R39C peptides in H2O the presence and absence of 1mM CoCl2, ZnCl2 or 
NiCl2.  This technique was employed because collected spectra have a reduced risk of 
fragmentation and a single charged state. The results of the MALDI TOF MS for E42C in 
metallized and non-metallized conditions are displayed in Figure 39.  The results of the 
mass spectrometry for E42C did show a mass shift of 56 Daltons, similar to that of a 
cobalt ion of 58 Daltons.  Buffers containing salts, such as 1 mM CoCl2 are a technical 
limitation in MALDI TOF MS and may be the cause of the poor signal in the metallized 
buffer conditions.  When electrospray ionization (ESI) MS was tried, the peptides failed 
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to indicate any mass shifts that could be attributed to divalent metal cation coordination.  
However, the presence of the original mass peak in the metallized E42C, combined with 
the fact that the R39C peptide did not demonstrate any mass shift, may indicate an 
interaction, albeit weak, between metal ions and the bi-histidine scaffold.  The mass 
spectrometry data alone were insufficient to support any conclusions on metal binding.  
Hence, additional experimentation was needed to understand the cobalt metal binding of 
these peptides, if any would occur. 
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Figure 39. MALDI TOF MS results of peptide metallization.  Top mass spectrograph 
demonstrates a starting mass of 5885, whereas the lower graph has a definitive peak at 
5941.  The 56 Dalton shift in the mass peaks is apparent upon the inclusion of 1 mM 
CoCl2 into the buffer, and has similar mass to that of the cobalt ion at 58 Dalton.   
 
 
Immobilized metal affinity chromatography assay 
 Pioneered by Porath et. al. in 1975 (217), immobilized metal affinity 
chromatography (IMAC) has a long history in the separation of recombinant produced 
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peptides and proteins (161, 216).  The resin is covalently functionalized with a 
nitrilotriacetic acid (NTA) or variety thereof (109), an organic chemical that forms 
coordination compounds with metal ions.  Common metal ions employed in IMAC are 
nickel, cobalt and zinc.  Once metallized, the affinity resin non-covalently binds to a 
series of histidine residues within the sequence of the recombinantly produced target.  
Addition of imidazole, a pentamer ring that mimics the side chain of histidine, competes 
with the polyhistidine tag and elutes the protein from the metallized resin.  This so called 
one-step purification technique has become an invaluable tool for protein production and 
purification for over 25 years (34).  Furthermore addition of a chelating agent like EDTA 
or EGTA can regenerate the bound metal ion from the NTA group. 
 As described above, IMAC is extremely useful for one step affinity purifications.  
To bolster the MS data, we employed the same technology to investigate whether or not 
the bi-histidine motif in our peptides had the ability to bind to a divalent metal cation 
displayed on a commercial IMAC column.  The ability of each peptide to complex with 
cobalt ions was determined by an IMAC assay in which cobalt ions were coordinated to 
iminodiacetic acid on a column of sepharose beads.  E42C or R39C, when injected onto 
the column, remained bound upon washing with two column volumes (10 ml) of buffer. 
When a linear buffer transition containing 200 mM imidazole (which competes with 
histidinyl side chains for metal ion binding) was initiated, the peptides eluted from the 
cobalt-charged column at roughly 40 mM imidazole, as seen in Figure 40.  When the 
peptides were injected over the IMAC column without coordinated cobalt, R39C and 
E42C did not bind.  These data further supported the claim that this bi-histidine motif can 
bind divalent metal cations.  In addition, the IMAC assay provided an estimate imidazole 
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concentration that is required to disrupt a single bi-histidine interaction with a divalent 
cobalt ion, although further experimentation was now required to investigate the 
stoichiometry and affinity of such metal ions.   
 
 
 
Figure 40.  Immobilized metal binding chromatography (IMAC) assay for determination 
of cobalt binding.  Left) The top is a schematic representation of the captured peptide 
through the bi-histidine motif and the bottom represents imidazole elution via 
competition.  Right) Chromatograms from E42C, R39C and the control peptide 12p1 are 
overlaid for 5 ml/min flow rates.  The running buffer was 20 mM TRIS, 200 mM NaCl 
pH 8.0.  The peptides were injected onto the cobalt affinity column, washed in buffer, 
and eluted with a 0-100% linear gradient of running buffer supplemented with 200 mM 
imidazole.  E42C and R39C were retained until 40 mM imidazole was reached, while 
12p1 did not bind to the cobalt on the column.  In absence of cobalt, all three peptides 
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were recovered from the flow through.  Imidazole concentration on the right y-axis is 
indicated by the dotted line. 
 
 
Isothermal titration calorimetry 
 Isothermal titration calorimetry (ITC) is a quantitative technique that can directly 
measure the binding affinity (Ka), enthalpy changes (ΔH), and binding stoichiometry (n) 
of the interaction between two or more molecules in solution.  An isothermal titration 
calorimeter is composed of two identical cells made of a highly efficient thermal 
conducting material such as Hasteloy®, surrounded by an adiabatic jacket.  Sensitive 
thermopile/thermocouple circuits are used to detect temperature differences between a 
reference cell and a sample cell containing the macromolecule.  In a typical experiment, 
ligand is titrated into the sample cell, causing heat to be either taken up (endothermic) or 
released (exothermic).  In an exothermic reaction, the temperature in the sample cell 
increases upon addition of ligand.  This causes the feedback power to the sample cell to 
be decreased in order to maintain an equal temperature between the two cells.  In an 
endothermic reaction, the opposite occurs; the feedback circuit increases the power in 
order to maintain a constant temperature.  The schematic diagram for a typical ITC 
instrument is found below in Figure 41. 
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Figure 41.  Schematic diagram of an ITC instrument in which two cells are contained 
within an adiabatic jacket.  Thermo-sensitive detectors monitor temperature differences 
between the reference and sample cells.  Depending on the nature of the interaction, for 
each injection, power will be adjusted to the feedback heater to maintain a constant 
temperature.  The heat per unit time is the observable signal and is a direct measure of the 
heat evolved in a biomolecular interaction. 
 
 
 ITC measurements consist of the time-dependent input of power required to 
maintain equal temperatures between the sample and reference cells.  As a result, the raw 
data for an experiment consists of a series of spikes of heat flow, with every spike 
corresponding to an injection.  These spikes are individually integrated with respect to 
time, giving the total heat effect per injection.  The injections are then analyzed to give 
the thermodynamic parameters of the interaction under study.  It is critical that injected 
and sample cell materials underwent dialysis in the same buffer and then were degassed 
to minimize errors (212, 276). 
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 In an effort to understand the kinetics and stoichiometry of cobalt binding, an ITC 
experiment was designed to inject cobalt into the peptides, E42C and R39C.  ITC further 
indicated saturable binding of cobalt to both R39C and E42C in buffered solution with a 
cobalt:peptide stoichiometry of approximately 1:1 as seen in Figure 42.  From the fits of 
the software, the affinity was estimated in the 10-100 µM range; the poor fits of the 
software limited a more accurate estimation.  The control peptide used in the 
aforementioned IMAC assay demonstrated no binding under the same conditions.  
Attempts to add CoCl2 to equimolar amounts of pre-complexed R39C and E42C were 
unsuccessful, probably due to the aggregation of unlabeled anchor/probe complexes, as 
seen in CD experimentation.  Because of this limitation, the assembly of these peptides in 
the presence of divalent cobalt ions was then investigated by SPR analysis. 
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Figure 42.  Isotherms of cobalt titrated into R39C (left) and E42C (right).  Peptide 
concentrations were determined via UV absorbance, whereas cobalt concentration was 
determined by weight and subsequent dilution in HBS-P.  The affinity of the cobalt ion 
for each peptide was estimated to be ~10 - 100 µM with a stoichiometry of ~ 0.8 - 1.  The 
single set of sites model was unable to accurately predict these values using the Origin 
software. 
 
 
Surface plasmon resonance analysis 
 Surface plasmon resonance was utilized as a tool to investigate the effects of 
metallization with a bi-histidine motif on the kinetic assembly of the coiled coil peptides.   
Kinetic parameters obtained for the interaction between R39C covalently anchored to the 
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sensor surface and E42C in HBS-P (normal) and HBS-P with 1 mM CoCl2 (metallized) 
buffers are shown in Table 6.  Two reference surfaces were utilized for data subtraction, 
a cysteine surface presenting small polar groups, and a more complex surface, the 31 
kDalton protein human interleukin 5.  Because of the critical importance of the 
dissociation rate and its role in minimization of surface leaching, interactions with 90 
minute dissociation periods were examined.  From these data, metallization appears to 
have little effect on both association and dissociation rates, retaining a high affinity 
interaction between anchor and probe components. 
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Table 6.  Summary of SPR acquired kinetic parameters in normal and metallized 
conditions.  Association (kon) and dissociation (koff) constants were obtained via double 
referencing from both cysteine and non-specific protein, interleukin 5 (IL5), surfaces 
globally fitting to a 1:1 Langmuir interaction model corrected for mass transfer.  0, 10, 
20, 50 and 100 nM E42C solutions in normal and metallized buffers (HBS-P / HBS-P 
with 1mM CoCl2 respectively) were allowed to accumulate for 180 seconds and 
dissociate for 360 seconds.  Equilibrium constants (KD) were calculated from koff / kon 
using the average values determined in the table.  For the 90 minute dissociation fits, the 
dissociation constant (independent of concentration) was obtained with a 50 nM injection 
of E42C using the cysteine reference surface.  n.d. stands for not determined. 
 1:1 with Mass Transfer with Cysteine Reference (fc1) 
BUFFER  1 2 3 4 avg stdev 
 kon (1/Ms) 3.15E+05 2.77E+05 3.02E+05 3.63E+05 3.14E+05 ± 0.36 
Normal koff (1/s) 3.68E-05 2.11E-06 1.65E-07 1.88E-07 9.82E-06 ± 0.18 
 KD (M)     3.12E-11  
 kon (1/Ms) 3.62E+05 2.34E+05 1.53E+05 9.25E+05 4.19E+05 ± 3.48 
Metallized koff (1/s) 9.52E-05 8.27E-05 5.29E-05 2.74E-04 1.26E-04 ± 1.00 
 KD (M)     3.02E-10  
        
 1:1 with Mass Transfer with 100 RU Interleukin 5 Reference (fc2) 
  1 2 3 4 avg stdev 
 kon (1/Ms) 2.17E+05 3.80E+05 2.80E+05 4.32E+05 3.27E+05 ± 0.97 
Normal koff (1/s) 4.04E-04 2.30E-07 2.52E-04 1.19E-08 1.64E-04 ± 0.99 
 KD (M)     5.01E-10  
 kon (1/Ms) 1.59E+05 2.01E+05 1.65E+05 1.80E+05 1.76E+05 ± 0.19 
Metallized koff (1/s) 6.29E-05 1.63E-04 1.24E-04 3.16E-04 1.66E-04 ± 1.08 
 KD (M)     9.45E-10  
        
 90 minute Dissociation with Cysteine Reference (fc1) 
  1 2 3 4 avg stdev 
Normal koff (1/s) 1.79E-04 1.71E-04 1.04E-04 n.d. 1.51E-04 ± 0.41 
Metallized koff (1/s) 2.28E-04 3.16E-04 2.15E-04 n.d. 2.53E-04 ± 0.55 
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In combination, the MALDI TOF MS, IMAC and ITC data further the literature 
that histidine residues in the i and i+4 positions, like those in R39C, R39H10 and E42C, 
can bind divalent metal cations of cobalt.  In addition, this pathway for incorporation of 
metal ions has minimal effects on kinetic assembly of the anchor/probe combination as 
determined by SPR.  Hence, metallization using this bi-histidine motif is a successful 
methodology to capture metal ions in our self-assembling coiled coil motif; employing 
such metallized coiled coils as self-assembling, conductive linkers in amperometric 
biosensors is a desired objective of this thesis. 
 
Cyclic voltammetry 
 Cyclic voltammetry (CV) is a solution-based electrochemical methodology that is 
commonly used to investigate the electronic properties of species in solution, as well as at 
the electrode/electrolyte interface; the later is commonly probed in amperometric 
biosensors in which redox enzymes are immobilized at the interface.  In a CV 
experiment, a sweeping potential is applied to the system and the current response of a 
redox reaction is measured and plotted against the applied voltage. The sweeping 
potential is increased linearly (forward scan) over a user-defined range and at the 
switching potential, decreased lineraly (reverse scan) over the same range.  Thus, species 
formed by oxidation on the forward scan can be reduced on the reverse scan, providing a 
fast and simple method for characterization of a redox-active system.  In addition to 
providing an estimate of the redox potential, CV can also provide information about the 
electrode area and the rate of electron transfer between the electrode and the analyte.  A 
three-electrode method (reference electrode, working electrode, and auxiliary electrode) 
  
125
 
is the most widely used because the reference potential can be held constant during the 
measurement.  
 The addition of the enzymatic substrate to many redox enzymes produces a flow 
of electrons, that when harnessed produce detectable nanoscale derived currents under an 
applied potential.  The ability to facilitate electron conductance from redox enzymes into 
biosensor platforms via an isotropic means has been shown to enhance the performance 
of the biosensor (288, 295, 299).  The key element for determination of electron transfer 
in our coiled coil linkers is the acquisition of a redox signal.  This represents a substantial 
challenge in a system that is expected to present an insulative barrier between redox 
species and the working electrode interface.  Our first approach utilized a modular, self-
assembling anchor/probe coiled coil peptide to attach a model redox target (ferrocene) 
that is covalently displayed at the terminus of the probe peptide (E37Ferro).  We chose 
this synthetic route because ferrocene is a well behaved redox system with the chelated 
iron undergoing a completely reversible transition from the Fe2+ to the Fe3+ states around 
a potential of 350 mV.  Using this model system we tested a variety of coiled coil 
assemblies to check for attainable redox signals. 
 The anchor sequences electrochemically investigated have two immobilization 
orientations through the varied thiol placements within the heptad repeats.  R39C and 
R39H10 have a single C-terminal thiol for chemisorption to gold electrodes.  This 
orientation should enable a perpendicular orientation that holds the ferrocene moiety 
away from the electrode surface.  R39Pra contains a single cysteine in the central heptad 
repeat in a position that does not theoretically and experimentally interfere with the 
assembly of the probe peptides.  Using this anchor on gold electrodes, probe assembly 
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should occur in a parallel orientation to the sensor surface, potentially decreasing the 
ferrocene distance to the electrode surface.  When using the single thiol to covalently 
immobilize each anchor, the E37Ferro probe peptide was shown by kinetic surface 
plasmon resonance to have a high picomolar to low nanomolar affinity (Table 5).  
Furthermore, it retains the attractive biosensor capture and display quality of typical 
coiled coils, possessing a fast association rate, a slow dissociation rate and enabling 
complete regeneration and rebuilding of the sensor surface. 
 These peptides also contain sequences for metallization sites; the concept being 
that peptides by themselves are not conductive, but incorporating metal ions and 
nanoparticles may provide a conductive path to bridge the gap between the active site of 
the enzyme and the electrode.  R39C has two histidine residues in the central heptad at i 
and i + 4 positions for the attachment of a single 2+ coordinated metal ion.  When 
chelated at the central heptad, this single metal ion would bisect the distance between 
active site and electrode surface.  In case this single metal ion cannot effectively span the 
insulative gap, the R39H10 anchor has ten histidine residues, two in each heptad repeat.  
This should increase the metallization of the peptide by providing five divalent metal 
cation sites evenly spaced along the vertical axis of the anchor.  
 
Electrochemistry on macroscale and nanoscale electrodes 
 Our initial efforts focused on using the anchor component R39C which had a C-
terminal cysteine for thiol chemisorption to gold sensor surfaces.  In collaboration with 
the Yeh group at University of Pittsburgh, PA, the R39C anchor peptide was 
electrochemically tested with E37Ferro using CV.  This CV experimental set-up used 
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three electrodes, the working electrode containing our anchor/probe system with 
ferrocene as the redox target, an Ag/AgCl reference electrode and a platinum auxiliary 
electrode.   
As Figure 43 depicts, redox peaks attributed to ferrocene were not observed after 
forming the R39C-E37Ferro complex on the electrode surface.  No redox peaks were 
observed after R39C-E37Ferro modified electrode was further reacted with CoCl2.  The 
same result was achieved when incubating with (Ru(NH3)6)Cl2 and H2O2.  Thus, the 
assembly orientation and metallization of this peptide/anchor system was insufficient to 
achieve a redox signal from the ferrocene labeled peptide, E37Ferro, when captured using 
the R39C in non-metallized and metallized conditions on macroscale gold disc 
electrodes.  
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Figure 43.  Cyclic voltammetry of R39C and E37Ferro on a macroscale gold electrode.  
(a) Schematic diagram of the peptide assembly in which R39C is anchored via a C-
terminal thiol to the gold electrode and is able to capture E37Ferro in the presence and 
absence of a divalent cation.  (b) CV scans in non-metallized conditions.  (c) CV scans of 
assembled peptides in 1 mM CoCl2.  (d) CV scans of assembled peptides in the presence 
of 1 mM (Ru(NH3)6)Cl2 and 100 µM H2O2.  All CV scans were carried out in 25/25 
buffer with a scan rate of 100 mV/s. 
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 The negative results for R39C/E37Ferro may be due the fact that the gold 
electrode platform was not sufficiently sensitive to acquire the tethered ferrocene signal.  
To investigate a more sensitive system, we collaborated with the Kelley group at the 
University of Toronto, Canada.  This group has pioneered the use of nanoelectrodes 
(NEEs) fabricated out of gold nanoposts for the ultra-sensitive amperometric detection of 
biological molecules (DNA) using another divalent cation system, (Ru(NH3)6)Cl2 in 
combination with H2O2 (83).  The enhanced signals are partially attributed to the larger 
surface area afforded by the three dimensional nanostructures, although nanostructures of 
gold and other metals have a lesser-understood electrocatalytic effect as well (219, 249, 
289, 295).  
 Electrochemical experiments were again performed with a three electrode system. 
The anchor/probe modified NEE was the working electrode, Ag/AgCl electrode was used 
as the reference electrode, and platinum wire was the auxiliary electrode.  When 
repeating the R39C/E37Ferro system on NEEs, no redox peaks corresponding to the 
ferrocene in R39C/E37Ferro system were achieved.  From this we concluded that either 
with or without a single metal ion, the anchor/probe pairing of R39C and E37Ferro is not 
able to facilitate the flow of electrons to and from ferrocene. 
 Using the NEE platform to detect redox signals from E37Ferro, we then 
attempted to increase the number of metallization sites in the anchor peptide from one 
(R39C) to five (R39H10).  Thus, the electron generated by the redox of ferrocene may 
“hop” the gap to the electrode surface, following the pathway of chelated metal ions 
along the axis of the anchor peptide.  As seen in Figure 44 we did not observe the 
ferrocene signal after hybridization when incubated with cobalt either before or after 
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coiled coil formation, respectively.  It was possible that the immobilized R39H10 was not 
capturing the E37Ferro in solution, a contrasting view when compared to the nanomolar 
affinity obtained by SPR experiments.   
To investigate this possibility, the reporter ferrocyanide was added to the solution 
and CV performed.  When the cyclic voltammetry experiment was repeated in 2 mM 
ferrocyanide, as seen in Figure 44 (e) the redox signal decreased after hybridization.  On 
the positively charged R39H10 immobilized surface, the ferrocyanide anion is 
electrostatically attracted towards the surface and able to undergo a reversible redox 
reaction.  However, this signal is essentially muted upon the addition of E37Ferro.  This 
suggests that the surface is more negatively charged upon coiled coil formation, and the 
ferrocyanide anion is repulsed away from the surface and cannot approach the electrode 
surface for a redox transition.  Therefore, the addition of ferrocyanide served as an 
indicator that E37Ferro was hybridized on the surface.  Additionally, this experiment 
further highlights the difficulty in linking redox active moieties away from the solution-
electrode interface.  The acquisition of a ferrocyanide signal is effectively all or none 
over the distance of electrostatic attraction/repulsion, especially an interaction that is 
already partially screened via the millimolar concentration of electrolyte in solution. 
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Figure 44.  Cyclic voltammetry of R39H10 and E37Ferro on nanoscale gold electrodes.   
(a) Schematic depiction of a gold nanopost and SEM image of the NEE electrode before 
functionalization.  (b) Schematic diagram of the peptide assembly in which R39H10 is 
anchored via a C-terminal thiol to the gold electrode, while E37Ferro is captured in the 
  
132
 
presence and absence of a divalent cation.  (c) CV scans of R39H10 alone, R39H10 and 
E37Ferro complexes, and the subsequent addition of 1 mM CoCl2 to these complexes.  
(d) CV scans of R39H10, R39H10 with 1 mM CoCl2, and R39H10-Co2+ with E37Ferro. 
(e) CV scans of R39H10 and R39H10-E37Ferro in the presence of 2 mM ferrocyanide.  
All CV scans were carried out in 25/25 buffer with a scan rate of 100 mV/s. SEM image 
is reproduced with permission from (83).  
 
 
 Unfortunately, varying the number of metal ion coordinations between 0, 1 and 5 
sites was insufficient to channel electrons in the reduction/oxidation process of ferrocene.  
Perhaps the ferrocene target is too far away from the surface in a perpendicular 
orientation to the gold electrode surface.  By attaching the anchor through a central 
heptad cysteine in R39Pra, an orientation that would enable parallel surface assembly 
should occur and greatly decrease the distance (from roughly 6 nm to 2 nm) between the 
ferrocene and the electrode.  Again to achieve high sensitivity, the NEEs were the chosen 
platform for CV experimentation.   
 The results in Figure 45 demonstrated a lack of redox peaks attributed to 
ferrocene with the R39Pra anchor and R39Pra/E37Ferro anchor/probe combination.  
With the addition of ferrocyanide to the electrolyte solution, the redox signal was muted 
upon the formation of the coiled coil, indicating surface assembly.  There were no 
metallization sites for this anchor/probe pairing. As an aside, a future experiment could 
incorporate redox mediators in this scheme using the C-terminal alkyne on the R39Pra, 
undergoing a subsequent click reaction with azide-terminated moieties. However, it 
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would be preferred if the anchor or probe had a terminal azide, as the commercial 
availability of ethynylferrocene would enable a rapid pathway towards inclusion of such 
a redox mediator. We will demonstrate the azide incoporation capability later on in this 
chapter with recombinant production. 
 
 
 
Figure 45.  Cyclic voltammetry of R39Pra and E37Ferro on nanoscale gold electrodes.  
(a) Schematic diagram of the peptide assembly in which R39Pra is anchored via a central 
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thiol to the gold electrode and is able to capture E37Ferro.  (b) CV scans of R39Pra alone 
and R39Pra-E37Ferro complex.  (c) CV scans of R39Pra and R39Pra-E37Ferro in the 
presence of 250 µM ferrocyanide.  All CV scans were carried out in 25/25 buffer with a 
scan rate of 100 mV/s. 
 
 
 The model redox system installed in probe peptide E37Ferro failed to acquire any 
signals attributed to ferrocene. Figures 43 and 44 indicated that the metallization of our 
peptides were insufficient to aquire redox signals.  The varied assembly orientation of 
Figure 45 was also unable to achieve ferrocene redox signals at the working electrodes.  
The histidine metallization strategy has been employed successfully in the work of Yeh 
et. al. 2006, albeit with several minor differences (299).  The peptide linkers were a 
single strand thus not of modular assembly design, and contained 1, 2 or 4 metallic 
coordination sites.  These peptides were also slightly shorter 33 residues vs 37 or 39 
residues, corresponding to a length of a four heptad coiled coil instead of our modular, 
five-heptad anchor/probe design. Conductance through these linkers was only seen with 
the peptide with 4 coordination sites and cobalt ions.  This published result is in 
agreement with our negative data obtained without metallization and the single 
metallization site, but not R39H10 with five sites.  Our linkers may simply require more 
than the five metal sites on just the anchor; the probe component may also require 
significant metallization.   
 Secondly, the linkage strategy employed a gold nanoparticle of roughly 1.4 nm 
diameter.  Using nanoparticles of this size has been demonstrated to substantially 
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increase enzymatically derived signals through an electrocatalytic mechanism (288, 289, 
295).  Hence our system may require both metal ions and a noble metallic nanoparticle to 
achieve signals, although the electrodes based on NEEs should effectively provide these 
electrocatalytic gold nanostructures. 
 Finally, the electroactive moiety was a 49 kDalton bacterial flavoenzyme, NADH 
peroxidase (Npx), which continually provides a source of electrons in the presence of its 
substrate, hydrogen peroxide (298).  In comparison, ferrocene is only able to provide a 
single electron event and would generate substantially smaller signals.  One potential 
route to achieve signals in our anchor/probe system would be to covalently fuse the Npx 
to the E42C peptide via chemical means, providing a continuous source of electrons with 
the addition of H2O2.   
To test this hypothesis, Npx was covalently linked to the N-terminal thiol on 
E42C through the sulfonic acid group near the active site and NADH cofactor, as shown 
in Figure 46.  The result is an electrochemically stable thioester formation.  This E42C-
Npx construct was then tested for redox activity on the macroscale electrodes, again in 
collaboration with the Yeh lab at the University of Pittsburgh.  The results of the E42C-
Npx with the R39C and R39H10 anchors are presented in Figure 47 and Figure 48 
respectively.  Unfortunately, evidence for redox signal acquisistion was not obtained with 
either anchor.  This implies that our vertically oriented coiled coils and subsequent 
metallization of these coiled coils are not capable of facilitating electron flow between 
Npx and the electrode. 
It is possible that the chemical fusion of the E42C peptide to a position near the 
active site of Npx sterically blocks the modular coiled coil assembly.   This is unlikely 
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due to the fact that four of the heptad repeats on E42C-Npx would likely still be able to 
interact with the anchor component.  In this manner, our coiled coil formation would 
have similar steric constraints to the single-stranded, Yeh peptide. Minus a single heptad 
repeat, a high-affinity interaction would still be expected to form between a five heptad 
anchor and four heptad probe (59).  The actual kinetics of assembly may differ 
substantially, but the steady state would almost certainly favor coiled coil formation.  It 
appears that the insulative distance between the enzyme and the electrode surface 
imparted by our modular anchor/probe approach appears to be too large to overcome, 
even with multiple metallization sites on the anchor and single site on E42C.  
  
 
 
Figure 46. E42C-Npx construction.  (a) Crystal structure of NADH peroxidase, (Npx, 
green) with cofactors FADH (blue) and its NADH (magenta) in the active site (298).  A 
single sulfonic acid moiety (red) is present near the active site for thioester formation 
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with the N-terminus of E42C.  (b) SDS Page gel electrophoresis demonstrated formation 
of the chemically fused E42C-Npx construct. 
 
 
 
Figure 47.  Cyclic voltammetry of R39C and E42C-Npx construct on macroscale gold 
electrodes.  (a) Schematic diagram of the peptide assembly in which R39C is anchored 
via a C-terminal thiol to the gold electrode and is able to capture E42C-Npx in the 
presence and absence of a divalent cation.  (b) CV scans of assembled peptides in 1 mM 
CoCl2.  (d) CV scans of assembled peptides in the presence of 1 mM (Ru(NH3)6)Cl2 and 
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100 µM H2O2.  All CV scans were carried out in KAc (pH 5.4) buffer with a scan rate of 
100 mV/s. 
 
 
 
Figure 48.  Cyclic voltammetry of R39H10 and E42C-Npx construct on macroscale gold 
electrodes.  (a) Schematic diagram of the peptide assembly in which R39H10 is anchored 
via a C-terminal thiol to the gold electrode and is able to capture E42C-Npx in the 
presence and absence of a divalent cation.  (b) CV scans of assembled peptides in the 
presence of 1 mM (Ru(NH3)6)Cl2 and 100 µM H2O2.  All CV scans were carried out in 
KAc buffer (pH =5.4) with a scan rate of 100 mV/s. 
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Our data, combined with the literature, suggested that leaving only a single 
metallization site on the probe component is the primary reason for the lack of signal 
acquisition in our experiments.  When a probe peptide (E42H10) containing five 
additional sites was created to mirror the R39H10 sites, the anchor/probe system failed to 
assemble with desired affinity as determined by SPR analysis.  The next experiments 
were done with the single, uncomplexed anchor component as the metallizable linker. 
In collaboration with the Yeh lab, another electrochemical experiment was 
devised in which the modular assembly of anchor/probe components was eliminated.  In 
this biosensor, the R39H10 peptide was covalently anchored to the macroscale gold 
electrode via chemisorption of the C-terminal thiol. Using standard EDC/NHS chemistry, 
the N-terminus amine of R39H10 was linked to -COOH moieties on a commercially 
available antibody for prostate specific antigen (PSA).  The antigen target PSA was 
conjugated to the redox enzyme glucose oxidase (GOx) using the same EDC/NHS 
chemistry.  The biosensor schematic and the CV scans for the PSA biosensor are found in 
Figure 49.  The voltammagram demonstrated an oxidative peak upon the addition of the 
PSA-GOx around 0.58 V vs. Ag/AgCl, which is similar to the value reported for CNT-
sidewall immobilization (291).  With the addition of a divalent metal cation, the GOx 
current increased.  Using the area under the oxidation peaks (291, 295, 299), the electron 
transfer rate constant (Ket) was calculated for the R39H10 linker in normal and metallized 
conditions.   
In the same PSA biosensor setup, the R39H10 anchor component was compared 
to the metal binding peptide of Yeh et. al. 2005 (299). The results in Table 7 
demonstrated a small increase in calculated electron transfer rate constants (from 0.11 s-1 
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to 0.19 s-1) upon the metallization of the R39H10 linker. This is much smaller when 
compared to the increase in calculated electron transfer rate constants (0.11 s-1 to 0.50 s-1) 
of the Yeh peptide under metallized conditions. Because both linkers have the same intial 
electron transfer rate constants, the increase in signal enhancement upon metallization 
may be due to an increased metal binding strength or stoichiometry found within the Yeh 
peptide. Another potential difference that must be noted is that the Yeh peptide also has 
many loci for anti-PSA attachment through EDC/NHS chemistry, not just the terminus. 
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Figure 49.  Cyclic voltammetry of R39H10-antiPSA and PSA-GOx construct on 
macroscale gold electrodes.  (a) Schematic diagram of the peptide assembly in which 
R39H10 is anchored via a C-terminal thiol to the gold electrode covalently linked to the 
antiPSA antibody, enabling capture of the PSA-GOx (green-magenta) construct.  (b) CV 
scans of assembled biosensor in the presence and absence of PSA-GOx target.  (c) CV 
scans of biosensor in the presence of 1 mM (Ru(NH3)6)Cl2 and 100 µM H2O2.  All CV 
scans were carried out in KAc buffer (pH = 5.4) with a scan rate of 100 mV/s.  The 
structures were generated with the pdb files for GOx (105) and PSA (33) using Pymol 
(62). 
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Table 7.  Electron transfer rate constants (Ket) with and without metal ions for R39H10 
or the Yeh peptide when used as the linker in the amperometric PSA biosensor. 
Linker Ket (s-1) 
R39H10 0.11 
R39H10-(Ru(NH3)6)2+ 0.19 
Yeh peptide 0.11 
Yeh peptide-(Ru(NH3)6)2+ 0.50 
 
 
The positive signal acquisition and enhancement via linker metallization provided 
valuable insight for future investigations and/or developments using our coiled coil 
linkers.  In the PSA biosensor, the anchor component has the freedom to remain floppy, 
which may allow for a more efficient metal incorporation by the bi-histidine motif.  
Another likely possibility is that this flexibility enabled the PSA-GOx molecule, captured 
by the antibody, to approach the surface and undergo a redox transition. The slight 
increase in electron transfer rate constants under metallization conditions may also be 
explained simply by the increase in conductivity caused by the presence of higher ionic 
concentrations at the electrode surface. If these statements are true, the metallization of 
the R39H10 linker with (Ru(NH3)6)2+ cations provided an alternative electron pathway 
with less resistance, and the divalent coordination of bi-histidine motifs effectively served 
to increase the signals derived from an amperometric biosensor. 
It remains unfortunate that the modular design, which would enable sensor 
surface regeneration, did not acquire any redox signals.  Alternative strategies to 
incorporate stronger metal binding or other redox mediators into probe sequences remain 
a significant challenge for future coiled coil linkers when applied to amperometric 
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biosensors.  For this reason, combined with the beneficial ability to tag redox proteins at 
a single location, the recombinant production of probe peptides was investigated. 
 
Recombinant production of proteins  
 Recombinant protein production harnesses the cell’s innate ability to create 
proteins from DNA sequences.  At the heart of all recombinant expression systems is the 
plasmid vector that is used to transfer genes encoding proteins from one organism to 
another.  A plasmid is a DNA molecule, separate from the chromosomal DNA in the cell 
that is capable of autonomous replication.  Commercial plasmids have a short region 
containing several commonly used enzymatic restriction sites allowing for the easy 
insertion of DNA fragments encoding for the protein sequence.  They also contain a gene 
encoding for antibiotic resistance.  The plasmid is incorporated into bacterial cells in a 
process called transformation and begins to express the plasmid gene for antibiotic 
resistance.  In this manner, only those cells that have incorporated the functional plasmid 
are able to survive in growth media supplemented with antibiotic.  
Vectors also have a DNA sequence that acts to initiate protein expression upon 
the proper stimulus, this step is referred to as “induction”.  In lac operon expression 
systems, the protein expression inducer isopropyl-β-D-thiogalactopyranoside (IPTG) is 
used.  IPTG is not susceptible to intracellular degradation, thus adding IPTG to 
transformed cells intiates continuous expression of the protein encoded by the vector, as 
seen in Figure 50 below. 
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Figure 50.  T7 derived vector utilizing the lac operon (light blue) as the initiator of 
protein expression.  A) Without IPTG (light blue triangle) there is no expression of the 
encoded gene (green).  B) Upon the addition of IPTG, protein expression occurs. 
 
 
Site directed mutagenesis 
 Mutant proteins with single amino acid substitutions in plasmid encoded proteins 
can be readily produced by oligonucleotide-directed mutagenesis.  Suppose that we want 
to replace a particular glycine residue with tryptophan. This mutation can be made if we 
have a plasmid containing the gene for the recombinant product and we know the DNA 
sequence around the site to be altered.  If the glycine of interest is encoded by GGG, we 
need to change the first G to a T to get tryptophan, which is encoded by TGG. This type 
of mutation is called a point mutation because only one base is altered.  The key to this 
mutation is to prepare an oligonucleotide primer that is complementary to this region of 
the gene except that it contains TGG instead of GGG.  The two strands of the plasmid are 
separated, and the primer is then annealed to the complementary strand.  The mismatch of 
1 base pair is tolerable if the annealing is carried out at an appropriate temperature.  After 
annealing to the complementary strand, the primer is elongated by DNA polymerase, and 
the double-stranded circle is closed by adding DNA ligase.  Subsequent replication of this 
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duplex yields two kinds of progeny plasmid, half with the original GGG sequence and 
half with the mutant TGG sequence. Removal of the parental DNA is carried out with 
incubation of the restriction enzyme DpnI, which targets a common methylated DNA 
sequence.  Since DNA is readily methylated in bacterial host, only the parental plasmid 
has methylated DNA.  Thus parental plasmid is enzymatically digested and only the 
mutated plasmid will remain.  Expression of the mutated plasmid containing the new 
TGG sequence will produce a protein with the desired substitution of tryptophan for 
glycine at a unique site.  This process is summarized in Figure 51.  
 
 
 
Figure 51.  The steps in oligonucleotide-directed mutagenesis.  A) Forward and reverse 
primers are designed against the parental plasmid encoding the gene of interest in which a 
mutation is desired.  B) The plasmid is denatured and the primers are allowed to anneal 
followed by C) DNA polymerase elongation of the mutant primers.  D) The parental 
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plasmid is degraded by a restriction enzyme that targets methylated DNA and E) the new 
mutated plasmid is repaired within competent bacteria. 
 
 
Methionine auxotrophic expression 
Auxotrophic expression can be utilized to create recombinant proteins with side 
groups that are not normally present in the 20 amino acids.  The simplest strategy for the 
production of proteins containing non-canonical amino acids in E. coli relies on the use 
of auxotrophic expression hosts deficient in the biosynthetic machinery needed to 
produce one or more of the twenty native amino acids.  The pioneering work of Cowie 
and Cohen demonstrated in bacteria the selective incorporation of selenomethionine as 
surrogate for methionine in protein biosynthesis (45, 53, 54).  This substitution has 
largely been incorporated into the field of protein crystallography (106, 151), however 
novel applications for the incorporation of other non-canonical amino acids are emerging 
(134, 135, 158).  The process is a simple starve then feed cycle.  Transformed bacteria are 
inoculated into minimal medium containing all twenty amino acids and allowed to amass 
enough cellular material for protein synthesis.  Then the extracellular amino acids are 
removed by centrifugation and washing, whereas the internal stocks are depleted by 
growth at 37 °C for 10-30 minutes.  Protein expression is then initiated by addition of an 
appropriate inducer in media containing 19 amino acids and the non-canonical version of 
methionine.  This auxotrophic production selectively replaces methionines in the protein 
sequence with non canonical versions.  
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Recombinant design of coiled coil probe sequences 
 The recombinant design of coiled coils enables large-scale (grams) production of 
probe peptides as well as larger constructs in which the probe peptide sequence of E42 is 
fused to other protein targets.  In this manner, such fused proteins and peptides could be 
captured onto a biosensor surface using a modular self-assembling, anchor/probe 
approach.  In addition, changing a single residue at a particular location is easily 
accomplished using site-directed mutagenesis of the DNA vector; SPPS requires a 
completely new peptide to be synthesized from the beginning. Although recombinant 
production does not allow the sequence versatility as compared to the SPPS strategy, 
incorporation of non-canonical residues such as homo-azido alanine is possible using 
methionine auxotrophs. Including azides in the sequence provides a direct pathway for 
installing stoichiometrically defined redox centers at controlled positions within the 
sequence using click chemistry. The recombinantly produced probe peptides are 
summarized in Figure 52, Figure 53 and Figure 54 for rE42-His, rE42-A(N3)-His and 
rE42-W-His respectively. The preliminary work presented below provides a unique 
opportunity for the continuation of the thesis work presented so far. 
The initial construct for rE42-His was developed as a starting point to create a 
coiled coil expression tag (35, 60, 269) that retained the modular and well-characterized 
assembly of the synthetic anchor/probe design. A 6x His tag was inserted into the design 
for ease of purification on a Ni-NTA column. A throbin cleavage site was also 
incorporated so that the 6x His tag could be removed if so desired. This sequence retained 
a high-affinity interation with the anchor coil sequence as determined by SPR and ITC 
experimentation (data not shown).   
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To test the ability of the rE42-His construct to produce under auzotrophic 
conditions, this same construct was expressed using a methionine auxotroph strain that 
incoporated three homo-azido alanine residues in place of the encoded methionines.  This 
expression system would enable the insertion of specific sites (azides) for further 1,2,3 
triazole functionalization (134) using molecules with substituted alkynes.     
However the lack of a chromophore, like a tryptophan residue, in the first and 
second generation constructs limited the facile and accurate determination of the 
concentration by absorption spectroscopy.  The last construct, rE42-W-His was created 
via site-directed mutagenisis to insert a single tryptophan for simple concentration 
measurements. This same methodology can be employed to create insertions of 
methionine residues for the auxotrophic expression of the probe coiled coil. In this 
manner, more than one ferrocene group could be inserted at desired sites in the probe 
coiled coil, providing stoichometric control and placement of redox mediators in linkers 
that have been previously shown to bolster amperometric detection (145, 297). 
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Figure 52.  Characteristics (left), sequence (bottom left) and SDS Page gel (right) of the 
probe coil rE42-His.  The vector encoding rE42-His was expressed in E. coli and purified 
using immobilized metal affinity chromatography and resulted in a large band at the 
desired molecular weight of roughly 9 kDa. 
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Figure 53.  Characteristics (top), sequence (bottom left) and SDS Page gel (bottom right) 
of the probe coil rE42-A(N3)-His.  The vector encoding rE42-His was expressed in 
methionine auxotroph E. coli using and purified using immobilized metal affinity 
chromatography and resulted in a band at the molecular weight of roughly 11 kDa.  
Elution Fraction 2 resulted in the highest amount bound by SPR analysis (data not 
shown). 
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Figure 54.  Characteristics (top) and sequence (bottom left) of the probe coil rE42-W-
His.  Although the DNA sequence was confirmed, this recombinant probe has not been 
expressed to date. 
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CONCLUSIONS 
 
 This thesis project focused on the development of coiled coils to form modular, 
self-assembling linkers in an effort to conductively interface redox-active probes to 
macroscale and nanoscale biosensor platforms with a high degree of control over 
orientation and solvent access with the potential for multiplexing.  This demanding and 
multidisciplinary project required the knowledge of multiple academic fields, as well as 
proficiency in a wide array of scientific instrumentation.  In addition, this project 
provided the opportunity to join forces with an extremely diverse and excellent group of 
scientific collaborators. 
The coiled peptide components were designed as a modular linker system and 
produced by synthetic peptide synthesis.  These multifunctional peptides were then 
purified to acceptable yields in milligram quantities.  The heterodimerization sequences 
successfully demonstrated coiled coil formation in a parallel fashion by spectroscopic 
means.  Their value as modular, oriented, self-assembling and regenerable biosensor 
interfaces was kinetically shown with surface plasmon resonance biosensing.  Following 
this detailed biophysical characterization, the anchor/probe configuration was primed for 
functional investigation on actual substrates.     
To demonstrate their application in nanoscale biosensor substrates, the coiled coil 
anchors were site-specifically immobilized to the tips of carbon nanotube arrays using 
two separate chemistries.  The first chemical pathway relied on a terminal thiol for 
disulfide formation. The second pathway incorporated a rapidly emerging chemistry 
between azides and alkynes.  These chemistries did not interfere with the assembly of the 
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probe components and their ability to deliver and display cargo in the form of gold 
nanoparticles. 
The anchor/probe design also incorporated metallization sites which demonstrated 
the ability to complex divalent metal cations.  When tested by cyclic voltammetry, the 
modular anchor/probe format did not achieve the desired signal acquisition in either non-
metallized or metallized conditions. When the self-assembly of the anchor probe format 
was removed and a single strand was tested in a PSA biosensor, cyclic voltammetry 
experimentation indicated increased electron transfer rate constants upon metallized 
conditions.   
In addition to synthetic production, the recombinant production of probe peptides 
was also investigated.  These dual production paths offer the means to incorporate 
stoichiometrically-defined redox centers on the probes and spatially- and 
stoichiometrically-controlled metal conducting sites in the linker.  Together with the body 
of work presented here, the results leave the potential for future investigations to 
transform an otherwise insulative linkage into a conductive one. 
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FUTURE DIRECTIONS 
 
 
 
This research has led to several major accomplishments that were summarized in 
the conclusions above. It is clear that the high affinity interaction of coiled coils have 
many potential applications in self assembling systems, including interfacing biological 
components onto sensor surfaces. On the other hand, several scientific hurdles have 
emerged with this body of work and present challenging opportunities for future studies 
in the following topics: 
• A lack of sufficient redox mediator incorporation 
• Recombinant probe designs fused to redox enzymes 
• Electrochemical limitations in nanoscale biosensors 
 
The results of this thesis demonstrated a variety of anchor/probe assembly 
orientations and cobalt metallization strategies that were unsuccessful in acquiring signals 
from redox targets.  One potential reason for this result can be attributed to the weak 
affinity of the cobalt ions to the bi-histidine motif.  Affinitys estimated on the individual 
peptides indicated that these metal ions may fall off during the course of experimentation. 
Furthermore, cobalt incorporation data were unable to determine if metal ion chelation 
occurred when the peptides were assembled together.  The coiled coil assembly of 
peptides may even decrease the chelation capabilities of the bi-histidine motif. To rectify 
the problem of weak incorporation of redox mediators, covalent means should be 
investigated to insert such redox mediators. This strategy would be an alternative that 
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may perform with increased fidelity and conductance over the cobalt efforts described 
within this thesis.   
 The covalent capture of gold nanoparticles onto solvent exposed cysteines 
residues would take advantage of the strong chemisorption between thiols and gold 
surfaces, effectively resolving the weak affinity limitations of the bi-histidine motif.  
These noble metal nanoparticles are perhaps the best redox mediators available, and can 
be investigated in conjunction with CNT array biosensors.  The initial work of the 
anchor, R39Pra, introduced a covalent linkage site which had demonstrated a high degree 
of specific gold nanoparticle incorporation in combination with the redox insensitive 
click immobilization pathway. This anchor would be to capture gold nanoparticles of 
controlled diameter via immobilization to the central thiol group.  The bigger 
nanoparticles would be the most likely to mediate redox signals along the anchor peptide 
linkers. The caveat would be that larger nanoparticles would most likely increase steric 
hindrance of the anchor/probe coiled coil formation, schematically demonstrated in 
Figure 55a.  The initial preliminary work, with R39Pra clicked to CNT arrays and 
subsequent addition of E37Ferro demonstrated acquisition of redox signals that could be 
attributed to ferrocene with CV experimentation, as seen in Figure 55b.  However, these 
signals were not able to be reproduced or further validated due to the lack of CNT 
substrates and the batch to batch variability between CNT arrays.  Testing this hypothesis 
in detail would be a promising pathway towards channeling electrons to and from a 
biosensor platform.   
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Figure 55.  Future experimentation with the clicked R39Pra anchor and subsequent gold 
nanoparticle incorporation.  a)  Hypothetical trade-off between nanoparticle size to 
increase redox mediation down the linker and the steric hindrance imposed against 
anchor probe formation.  b)  Initial signal acquisition of two CNT array substrates that 
were 1,2,3 triazole functionalized with R39Pra and nanoparticle modified.  Upon addition 
of E37Ferro, redox peaks were observed for the ferrocene moiety upon CV 
experimentation.    
 
 
 The second means that should be investigated, be it in a parallel effort or not, is 
the chemical and recombinant fusion of redox proteins to the probe components.  The 
relative population of redox enzymes that have a free cysteine residue near the active site 
(e.g. Npx) is extremely limited.  Recombinant means to incorporate reactive cysteines 
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and/or homo-azido alanine would provide a pathway for isotropic covalent linkage of the 
redox enzyme near the active site to a probe coil. This same site-directed mutagenesis 
methodology for single-residue manipulation could also incorporate these reactive 
moieties on the solvent exposed face of the probe coil for covalent metallization or 
multiple ferrocene incorporation.  Alternatively, N- or C-termini fusions of redox 
proteins to probe coils could also provide a means for isotropic display of redox targets 
on sensor surfaces. Ultimately, advances in probe design would also be of scientific 
merit. 
 As a technique, I believe the electrochemical means of detection is fundamentally 
flawed for the development of nanoscale biosensors.  Thermal noise of electronic systems 
will drown the signal produced from the one or two electrons that are generated from a 
single redox event.  The potential solutions to this problem are (1) to cool the system to 
extremely low temperatures, or (2) provide thousands of redox molecules in parallel to 
overcome the baseline noise. The latter is the only solution currently employed, as 
biological recognition would not occur in feasible time-scales at supercooled 
temperatures.  For these sensors to enable single molecule sensitivitity, or even tens of 
molecules, an alternative transduction platform or a signal amplification scheme would 
be required.  CNT sensors that are based on FET (field effect transistor) technology can 
overcome the nanoscale limitations of amperometric detection, and may one day provide 
a biomolecule transduction platform with single molecule sensitivity. 
 Because of the inherent thermal noise in amperometric detection, we devised a 
plan to increase the sensitivity of the transduction scheme using ultra-stable and ultra-
bright fluorophores.  Single molecule fluorescence is a fundamental technique that can be 
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applied to biosensing to readily achieve single biomolecule sensitivity, and ultimately 
nanoscale biosensors. In this role, our anchor/probe coiled coil system would be used as a 
fluorophore delivery/targeting methodology.  The concept is that the anchor probe would 
be conjugated to the fluorophore and would target the recombinantly expressed protein 
fused to a probe sequence.  This proposed idea and research plan is discussed in further 
detail in Appendix 2: Cell Probes Grant. This exciting frontier provides a unique 
pathway forward using coiled coils for delivery and targeting applications in the growing 
field of nanoscale biomedical engineering. 
  
159
 
LIST OF REFERENCES 
 
 
 
 
1.  Acharya, A., V. Rishi, and C. Vinson. 2006. Stability of 100 homo and 
heterotypic coiled-coil a-a' pairs for ten amino acids (A, L, I, V, N, K, S, T, E, and 
R). Biochemistry 45:11324-32. 
2. Acharya, A., S. B. Ruvinov, J. Gal, J. R. Moll, and C. Vinson. 2002. A 
heterodimerizing leucine zipper coiled coil system for examining the specificity 
of a position interactions: amino acids I, V, L, N, A, and K. Biochemistry 
41:14122-31. 
3. Adair, B. D., and D. M. Engelman. 1994. Glycophorin A helical transmembrane 
domains dimerize in phospholipid bilayers: a resonance energy transfer study. 
Biochemistry 33:5539-44. 
4. Alivisatos, A. P., W. Gu, and C. Larabell. 2005. Quantum dots as cellular probes. 
Annu Rev Biomed Eng 7:55-76. 
5. Andersen, J. S., B. Svensson, and P. Roepstorff. 1996. Electrospray ionization and 
matrix assisted laser desorption/ionization mass spectrometry: powerful analytical 
tools in recombinant protein chemistry. Nat Biotechnol 14:449-57. 
6. Arnold, F. H., and B. L. Haymore. 1991. Engineered metal-binding proteins: 
purification to protein folding. Science 252:1796-1797. 
7. Arya, H., Z. Kaul, R. Wadhwa, K. Taira, T. Hirano, and S. C. Kaul. 2005. 
Quantum dots in bio-imaging: Revolution by the small. Biochem Biophys Res 
Commun 329:1173-7. 
8. Aslan, K., I. Gryczynski, J. Malicka, E. Matveeva, J. R. Lakowicz, and C. D. 
Geddes. 2005. Metal-enhanced fluorescence: an emerging tool in biotechnology. 
Curr Opin Biotechnol 16:55-62. 
9. Aslan, K., P. Holley, L. Davies, J. R. Lakowicz, and C. D. Geddes. 2005. 
Angular-ratiometric plasmon-resonance based light scattering for bioaffinity 
sensing. J Am Chem Soc 127:12115-21. 
  
160
 
10. Aslan, K., J. R. Lakowicz, and C. D. Geddes. 2005. Plasmon light scattering in 
biology and medicine: new sensing approaches, visions and perspectives. Curr 
Opin Chem Biol 9:538-44. 
11. Aslan, K., J. R. Lakowicz, H. Szmacinski, and C. D. Geddes. 2004. Metal-
enhanced fluorescence solution-based sensing platform. J Fluoresc 14:677-9. 
12. Aslan, K., M. Wu, J. R. Lakowicz, and C. D. Geddes. 2007. Fluorescent core-
shell Ag@SiO2 nanocomposites for metal-enhanced fluorescence and single 
nanoparticle sensing platforms. Journal of the American Chemical Society 
129:1524-+. 
13. Atherton, E., H. Fox, D. Harkiss, C. Logan, R. Sheppard, and B. Williams. 1978. 
A Mild Procedure for Solid Phase Peptide Synthesis: Use of 
Fluorenylmethoxycarbonylamino-acids. J. Chem. Soc., Chem. Commun 13:537-
539. 
14. Aubuchon, J. F., L. H. Chen, C. Daraio, and S. Jin. 2006. Multi-branching carbon 
nanotubes via self-seeded catalysts. Nano Lett 6:324-8. 
15. Bachmair, A., D. Finley, and A. Varshavsky. 1986. In vivo half-life of a protein is 
a function of its amino-terminal residue. Science 234:179-86. 
16. Behnia, R., and S. Munro. 2005. Organelle identity and the signposts for 
membrane traffic. Nature 438:597-604. 
17. Berg, J., J. Tymoczko, and L. Stryer. 2006. Biochemistry, 6 ed. W.H.Freeman & 
Co Ltd, New York. 
18. Berg, K., P. K. Selbo, L. Prasmickaite, T. E. Tjelle, K. Sandvig, J. Moan, G. 
Gaudernack, O. Fodstad, S. Kjolsrud, H. Anholt, G. H. Rodal, S. K. Rodal, and A. 
Hogset. 1999. Photochemical internalization: a novel technology for delivery of 
macromolecules into cytosol. Cancer Res 59:1180-3. 
19. Bernstein, H. J. 2000. Recent changes to RasMol, recombining the variants. 
Trends Biochem Sci 25:453-5. 
20. Biorn, A. C., S. Cocklin, N. Madani, Z. Si, T. Ivanovic, J. Samanen, D. I. Van 
Ryk, R. Pantophlet, D. R. Burton, E. Freire, J. Sodroski, and I. M. Chaiken. 2004. 
  
161
 
Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions. 
Biochemistry 43:1928-38. 
21. Bjorck, L., and G. Kronvall. 1984. Purification and some properties of 
streptococcal protein G, a novel IgG-binding reagent. J Immunol 133:969-974. 
22. Bouchard, M. J., R. J. Puro, L. Wang, and R. J. Schneider. 2003. Activation and 
inhibition of cellular calcium and tyrosine kinase signaling pathways identify 
targets of the HBx protein involved in hepatitis B virus replication. J Virol 
77:7713-9. 
23. Brahms, S., and J. Brahms. 1980. Determination of protein secondary structure in 
solution by vacuum ultraviolet circular dichroism. J Mol Biol 138:149-78. 
24. Brask, J., H. Wackerbarth, K. J. Jensen, J. Zhang, I. Chorkendorff, and J. Ulstrup. 
2003. Monolayer assemblies of a de novo designed 4-alpha-helix bundle 
carboprotein and its sulfur anchor fragment on Au(111) surfaces addressed by 
voltammetry and in situ scanning tunneling microscopy. J Am Chem Soc 125:94-
104. 
25. Brizzard, B. L., R. G. Chubet, and D. L. Vizard. 1994. Immunoaffinity 
purification of FLAG epitope-tagged bacterial alkaline phosphatase using a novel 
monoclonal antibody and peptide elution. Biotechniques 16:730-5. 
26. Burkhard, P., S. Ivaninskii, and A. Lustig. 2002. Improving coiled-coil stability 
by optimizing ionic interactions. J Mol Biol 318:901-10. 
27. Burkhard, P., J. Stetefeld, and S. V. Strelkov. 2001. Coiled coils: a highly 
versatile protein folding motif. Trends Cell Biol 11:82-8. 
28. Burns, J., J. Butler, J. Moran, and G. Whitesides. 1991. Selective Reduction of 
Disulfides by Tris(2-carboxyethy1)phosphine. J Org Chem 56:2648-50. 
29. Canziani, G., W. Zhang, D. Cines, A. Rux, S. Willis, G. Cohen, R. Eisenberg, and 
I. Chaiken. 1999. Exploring biomolecular recognition using optical biosensors. 
Methods 19:253-269. 
30. Carell, T., C. Behrens, and J. Gierlich. 2003. Electrontransfer through DNA and 
metal-containing DNA. Org Biomol Chem 1:2221-8. 
  
162
 
31. Carpino, L., and G. Han. 1972. The 9-Fluorenylmethoxycarbonyl Amino-
Protecting Group. J. Org. Chem. 37:3404-3409. 
32. Carr, C. M., and P. S. Kim. 1993. A spring-loaded mechanism for the 
conformational change of influenza hemagglutinin. Cell 73:823-32. 
33. Carvalho, A. L., L. Sanz, D. Barettino, A. Romero, J. J. Calvete, and M. J. 
Romao. 2002. Crystal structure of a prostate kallikrein isolated from stallion 
seminal plasma: a homologue of human PSA. J Mol Biol 322:325-37. 
34. Chaga, G. S. 2001. Twenty-five years of immobilized metal ion affinity 
chromatography: past, present and future. J Biochem Biophys Methods 49:313-
34. 
35. Chao, H., D. L. Bautista, J. Litowski, R. T. Irvin, and R. S. Hodges. 1998. Use of 
a heterodimeric coiled-coil system for biosensor application and affinity 
purification. J Chromatogr B Biomed Sci Appl 715:307-29. 
36. Chao, H., M. E. Houston, Jr., S. Grothe, C. M. Kay, M. O'Connor-McCourt, R. T. 
Irvin, and R. S. Hodges. 1996. Kinetic study on the formation of a de novo 
designed heterodimeric coiled-coil: use of surface plasmon resonance to monitor 
the association and dissociation of polypeptide chains. Biochemistry 35:12175-85. 
37. Chapman-Smith, A., D. L. Turner, J. E. Cronan, Jr., T. W. Morris, and J. C. 
Wallace. 1994. Expression, biotinylation and purification of a biotin-domain 
peptide from the biotin carboxy carrier protein of Escherichia coli acetyl-CoA 
carboxylase. Biochem J 302 ( Pt 3):881-7. 
38. Chen, R., Y. Zhang, D. Wang, and H. Dai. 2001. Noncovalent Sidewall 
Functionalization of  Single-Walled Carbon Nanotubes for Protein 
Immobilization. J. Am. Chem. Soc. 123:3838-3839. 
39. Chen, R. J., S. Bangsaruntip, K. A. Drouvalakis, N. W. Kam, M. Shim, Y. Li, W. 
Kim, P. J. Utz, and H. Dai. 2003. Noncovalent functionalization of carbon 
nanotubes for highly specific electronic biosensors. Proc Natl Acad Sci U S A 
100:4984-9. 
40. Chen, Y., and A. Periasamy. 2006. Intensity range based quantitative FRET data 
analysis to localize protein molecules in live cell nuclei. J Fluoresc 16:95-104. 
  
163
 
41. Chen, Y. H., J. T. Yang, and K. H. Chau. 1974. Determination of the helix and 
beta form of proteins in aqueous solution by circular dichroism. Biochemistry 
13:3350-9. 
42. Chicz, R. M., and F. E. Regnier. 1990. High-performance liquid chromatography: 
effective protein purification by various chromatographic modes. Methods 
Enzymol 182:392-421. 
43. Chung, J., H. H. Deutsch, and F. S. Kalthoff. 1996. IL-4-dependent proliferation 
of BA/F3 cells expressing a growth-negative mutant of the human IL-4 receptor is 
restored by enforced expression of Bcl-2. J Leukoc Biol 59:586-90. 
44. Cleveland, D. W., S. G. Fischer, M. W. Kirschner, and U. K. Laemmli. 1977. 
Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by 
gel electrophoresis. J Biol Chem 252:1102-6. 
45. Cohen, G. N., and D. B. Cowie. 1957. [Total replacement of methionine by 
selenomethionine in the proteins of Escherichia coli.]. C R Hebd Seances Acad 
Sci 244:680-3. 
46. Collman, J. P., N. K. Devaraj, and C. E. Chidsey. 2004. "Clicking" functionality 
onto electrode surfaces. Langmuir 20:1051-3. 
47. Collman, J. P., N. K. Devaraj, T. P. Eberspacher, and C. E. Chidsey. 2006. Mixed 
azide-terminated monolayers: a platform for modifying electrode surfaces. 
Langmuir 22:2457-64. 
48. Contarino, M. R., M. Sergi, A. E. Harrington, A. Lazareck, J. Xu, and I. Chaiken. 
2006. Modular, self-assembling peptide linkers for stable and regenerable carbon 
nanotube biosensor interfaces. J Mol Recognit 19:363-71. 
49. Contarino, M. R., M. Sergi, A. E. Harrington, A. Lazareck, J. Xu, and I. Chaiken. 
2006. Modular, self-assembling peptide linkers for stable and regenerable carbon 
nanotube biosensor interfaces. J Mol Recognit. 
50. Cooper, T. M., and R. W. Woody. 1990. The effect of conformation on the CD of 
interacting helices: a theoretical study of tropomyosin. Biopolymers 30:657-76. 
  
164
 
51. Cornelis, S., I. Fache, J. Van der Heyden, Y. Guisez, J. Tavernier, R. Devos, W. 
Fiers, and G. Plaetinck. 1995. Characterization of critical residues in the 
cytoplasmic domain of the human interleukin-5 receptor alpha chain required for 
growth signal transduction. Eur J Immunol 25:1857-64. 
52. Courty, S., C. Bouzigues, C. Luccardini, M. V. Ehrensperger, S. Bonneau, and M. 
Dahan. 2006. Tracking individual proteins in living cells using single quantum 
dot imaging, p. 211-228, Measuring Biological Responses with Automated 
Microscopy, vol. 414. 
53. Cowie, D. B., and G. N. Cohen. 1957. Biosynthesis by Escherichia coli of active 
altered proteins containing selenium instead of sulfur. Biochim Biophys Acta 
26:252-61. 
54. Cowie, D. B., G. N. Cohen, E. T. Bolton, and H. De Robichon-Szulmajster. 1959. 
Amino acid analog incorporation into bacterial proteins. Biochim Biophys Acta 
34:39-46. 
55. Crick, F. H. 1952. Is alpha-keratin a coiled coil? Nature 170:882-3. 
56. Crick, F. H. 1953. The packing of alpha-helicies: simple coiled-coils. Acta 
Crystallogr 6:689. 
57. Cronan, J. E., Jr. 1990. Biotination of proteins in vivo. A post-translational 
modification to label, purify, and study proteins. J Biol Chem 265:10327-33. 
58. Das, J., K. Jo, J. W. Lee, and H. Yang. 2007. Electrochemical immunosensor 
using p-aminophenol redox cycling by hydrazine combined with a low 
background current. Anal Chem 79:2790-6. 
59. De Crescenzo, G., J. R. Litowski, R. S. Hodges, and M. O'Connor-McCourt. 
2003. Real-time monitoring of the interactions of two-stranded de novo designed 
coiled-coils: effect of chain length on the kinetic and thermodynamic constants of 
binding. Biochemistry 42:1754-1763. 
60. De Crescenzo, G., P. Pham, Y. Durocher, and M. O'Connor-McCourt. 2003. 
Transforming  growth factor-beta (TGF-beta ) binding to the extracellular domain 
of the type II TGF-beta   receptor: receptor capture on a biosensor surface using a 
new coiled-coil capture system  demonstrates that avidity contributes significantly 
to high affinity binding. Journal of Molecular Biology 328:1173-1183. 
  
165
 
61. de Wildt, R. M., C. R. Mundy, B. D. Gorick, and I. M. Tomlinson. 2000. 
Antibody arrays for high-throughput screening of antibody-antigen interactions. 
Nat Biotechnol 18:989-94. 
62. DeLano, W. L. 2002. The PyMOL Molecular Graphics System. DeLano 
Scientific, Palo Alto. 
63. Derfus, A. M., W. C. W. Chan, and S. N. Bhatia. 2004. Intracellular delivery of 
quantum dots for live cell labeling and organelle tracking. Advanced Materials 
16:961-+. 
64. Derfus, A. M., W. C. W. Chan, and S. N. Bhatia. 2004. Probing the cytotoxicity 
of semiconductor quantum dots. Nano Letters 4:11-18. 
65. Devaraj, N. K., R. A. Decreau, W. Ebina, J. P. Collman, and C. E. Chidsey. 2006. 
Rate of interfacial electron transfer through the 1,2,3-triazole linkage. J Phys 
Chem B Condens Matter Mater Surf Interfaces Biophys 110:15955-62. 
66. Devaraj, N. K., P. H. Dinolfo, C. E. Chidsey, and J. P. Collman. 2006. Selective 
functionalization of independently addressed microelectrodes by electrochemical 
activation and deactivation of a coupling catalyst. J Am Chem Soc 128:1794-5. 
67. Diehl, M. R., K. Zhang, H. J. Lee, and D. A. Tirrell. 2006. Engineering 
cooperativity in biomotor-protein assemblies. Science 311:1468-71. 
68. Dietz, H., M. Bertz, M. Schlierf, F. Berkemeier, T. Bornschlogl, J. Junker, and M. 
Rief. 2006. Cysteine engineering of polyproteins for single-molecule force 
spectroscopy. Nature Protocols 1:80-84. 
69. Doerr, A. 2005. Protein microarray velcro. Nat Methods 2:642-3. 
70. Dole, M., L. Mack, R. Hines, R. Mobley, L. Ferguson, and M. Alice. 1968. 
Molecular Beams of Macroions. Journal of Chemical Physics 49:2240-2249. 
71. Dwyer, J. J., K. L. Wilson, D. K. Davison, S. A. Freel, J. E. Seedorff, S. A. 
Wring, N. A. Tvermoes, T. J. Matthews, M. L. Greenberg, and M. K. Delmedico. 
2007. Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent 
activity against enfuvirtide-resistant virus. Proc Natl Acad Sci U S A 104:12772-
7. 
  
166
 
72. Ebbesen, T. W., and P. M. Ajayan. 1992. Large-scale synthesis of carbon 
nanotubes. Nature 358:220. 
73. Edmonds, C. G., and R. D. Smith. 1990. Electrospray ionization mass 
spectrometry. Methods Enzymol 193:412-31. 
74. Ellenberger, T. E., C. J. Brandl, K. Struhl, and S. C. Harrison. 1992. The GCN4 
basic region leucine zipper binds DNA as a dimer of uninterrupted alpha helices: 
crystal structure of the protein-DNA complex. Cell 71:1223-37. 
75. Ellis, R. J. 2001. Macromolecular crowding: obvious but underappreciated. 
Trends Biochem Sci 26:597-604. 
76. Engel, M., R. W. Williams, and B. W. Erickson. 1991. Designed coiled-coil 
proteins: synthesis and spectroscopy of two 78-residue alpha-helical dimers. 
Biochemistry 30:3161-9. 
77. Evan, G., Lewis GK, Ramsay G, and B. JM. 1985. Isolation of monoclonal 
antibodies specific for human c-myc proto-oncogene product. Mol. Cell Biochem. 
5:3610-3616. 
78. Fasman, G. 1996. Circular Dichroism and the Conformational Analysis of 
Biomolecules Plenum Press, New York. 
79. Fenn, J. B., M. Mann, C. K. Meng, S. F. Wong, and C. M. Whitehouse. 1989. 
Electrospray ionization for mass spectrometry of large biomolecules. Science 
246:64-71. 
80. Ferrer, M., and S. C. Harrison. 1999. Peptide ligands to human immunodeficiency 
virus type 1 gp120 identified from phage display libraries. J Virol 73:5795-802. 
81. Frank, R. 1992. Spot-synthesis : an easy technique for the positionally 
addressable, parallel chemical synthesis on a membrane support. Tetrahedron 
48:9217-9232. 
82. Frank, S., A. Lustig, T. Schulthess, J. Engel, and R. A. Kammerer. 2000. A 
distinct seven-residue trigger sequence is indispensable for proper coiled-coil 
formation of the human macrophage scavenger receptor oligomerization domain. 
J Biol Chem 275:11672-7. 
  
167
 
83. Gasparac, R., B. J. Taft, M. A. Lapierre-Devlin, A. D. Lazareck, J. M. Xu, and S. 
O. Kelley. 2004. Ultrasensitive electrocatalytic DNA detection at two- and three-
dimensional nanoelectrodes. J Am Chem Soc 126:12270-1. 
84. Geddes, C., K. Aslan, I. Gryczynski, J. Malicka, and J. Lakowicz. 2004. Noble 
metal nanostructures for metal-enhanced fluorescence, Review Chapter, p. 365, 
Annual Reviews in Fluorescence. Kluwer Academic/Plenum Publishers, New 
York. 
85. Geddes, C., K. Aslan, I. Gryczynski, J. Malicka, and J. Lakowicz. 2005. Radiative 
Decay Engineering, p. 405, Topics in Fluorescence Spectroscopy. Kluwer 
Academic/Plenum Publishers, New York. 
86. Geddes, C., and J. Lakowicz. 2002. Journal of Fluorescence 12:121. 
87. Gelinsky, M., and H. Vahrenkamp. 2002. Zinc complexes of a helical 22-mer 
peptide with two histidine donors. European Journal of Inorganic Chemistry 
9:2458-2462. 
88. Georgakilas, V., K. Kordatos, M. Prato, D. M. Guldi, M. Holzinger, and A. 
Hirsch. 2002. Organic functionalization of carbon nanotubes. J Am Chem Soc 
124:760-1. 
89. Georgakilas, V., N. Tagmatarchis, D. Pantarotto, A. Bianco, J. P. Briand, and M. 
Prato. 2002. Amino acid functionalisation of water soluble carbon nanotubes. 
Chem Commun (Camb):3050-1. 
90. Giepmans, B. N., S. R. Adams, M. H. Ellisman, and R. Y. Tsien. 2006. The 
fluorescent toolbox for assessing protein location and function. Science 312:217-
24. 
91. Ginger, D. S., H. Zhang, and C. A. Mirkin. 2004. The evolution of dip-pen 
nanolithography. Angew Chem Int Ed Engl 43:30-45. 
92. Gomez-Navarro, C., F. Moreno-Herrero, P. J. de Pablo, J. Colchero, J. Gomez-
Herrero, and A. M. Baro. 2002. Contactless experiments on individual DNA 
molecules show no evidence for molecular wire behavior. Proc Natl Acad Sci U S 
A 99:8484-7. 
  
168
 
93. Goncalves, E., E. Kitas, and J. Seelig. 2005. Binding of oligoarginine to 
membrane lipids and heparan sulfate: structural and thermodynamic 
characterization of a cell-penetrating peptide. Biochemistry 44:2692-702. 
94. Gonzalez, L., Jr., J. J. Plecs, and T. Alber. 1996. An engineered allosteric switch 
in leucine-zipper oligomerization. Nat Struct Biol 3:510-5. 
95. Graddis, T. J., D. G. Myszka, and I. M. Chaiken. 1993. Controlled formation of 
model homo- and heterodimer coiled coil polypeptides. Biochemistry 32:12664-
12671. 
96. Graddis, T. J., D. G. Myszka, and I. M. Chaiken. 1993. Controlled formation of 
model homo- and heterodimer coiled coil polypeptides. Biochemistry 32:12664-
71. 
97. Green, N. M. 1975. Avidin. Adv Protein Chem 29:85-133. 
98. Griffin, B. A., S. R. Adams, and R. Y. Tsien. 1998. Specific covalent labeling of 
recombinant protein molecules inside live cells. Science 281:269-72. 
99. Gwenin, C. D., M. Kalaji, P. A. Williams, and R. M. Jones. 2007. The 
orientationally controlled assembly of genetically modified enzymes in an 
amperometric biosensor. Biosens Bioelectron 22:2869-75. 
100. Gygi, S. P., G. L. Corthals, Y. Zhang, Y. Rochon, and R. Aebersold. 2000. 
Evaluation of two-dimensional gel electrophoresis-based proteome analysis 
technology. Proc Natl Acad Sci U S A 97:9390-5. 
101. Harbury, P. B., P. S. Kim, and T. Alber. 1994. Crystal structure of an isoleucine-
zipper trimer. Nature 371:80-3. 
102. Harbury, P. B., T. Zhang, P. S. Kim, and T. Alber. 1993. A switch between two-, 
three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. Science 
262:1401-7. 
103. Harris, L. J., E. Skaletsky, and A. McPherson. 1998. Crystallographic structure of 
an intact IgG1 monoclonal antibody. J Mol Biol 275:861-72. 
  
169
 
104. Heald, C. G., G. G. Wildgoose, L. Jiang, T. G. Jones, and R. G. Compton. 2004. 
Chemical derivatisation of multiwalled carbon nanotubes using diazonium salts. 
Chemphyschem 5:1794-9. 
105. Hecht, H. J., H. M. Kalisz, J. Hendle, R. D. Schmid, and D. Schomburg. 1993. 
Crystal structure of glucose oxidase from Aspergillus niger refined at 2.3 A 
resolution. J Mol Biol 229:153-72. 
106. Hendrickson, W. A., J. R. Horton, and D. M. LeMaster. 1990. Selenomethionyl 
proteins produced for analysis by multiwavelength anomalous diffraction (MAD): 
a vehicle for direct determination of three-dimensional structure. Embo J 9:1665-
72. 
107. Hillenkamp, F., and M. Karas. 1990. Mass spectrometry of peptides and proteins 
by matrix-assisted ultraviolet laser desorption/ionization. Methods Enzymol 
193:280-95. 
108. Himo, F., T. Lovell, R. Hilgraf, V. V. Rostovtsev, L. Noodleman, K. B. Sharpless, 
and V. V. Fokin. 2005. Copper(I)-catalyzed synthesis of azoles. DFT study 
predicts unprecedented reactivity and intermediates. J Am Chem Soc 127:210-6. 
109. Hochuli, E. 1990. Purification of recombinant proteins with metal chelate 
adsorbent. Genet Eng (N Y) 12:87-98. 
110. Hogg, P. J. 2003. Disulfide bonds as switches for protein function. Trends 
Biochem Sci 28:210-4. 
111. Hollenbeck, J. J., D. L. McClain, and M. G. Oakley. 2002. The role of helix 
stabilizing residues in GCN4 basic region folding and DNA binding. Protein Sci 
11:2740-7. 
112. Hopp, T., K. Prickett, V. Price, R. Libby, C. March, D. Cerretti, D. Urdal, and P. 
Conlon. 1988. A short polypeptide marker sequence useful for recombinant 
protein identification and purification. Bio/Technology 6:1204-1210. 
113. Hopp, T. P., B. Gallis, and K. S. Prickett. 1996. Metal-binding properties of a 
calcium-dependent monoclonal antibody. Mol Immunol 33:601-8. 
  
170
 
114. Hunter, I., T. Schulthess, and J. Engel. 1992. Laminin chain assembly by triple 
and double stranded coiled-coil structures. J Biol Chem 267:6006-11. 
115. Iijima, S. 1991. Helical microtubules of graphitic carbon. Nature 354:56-58. 
116. Ishino, T., G. Pasut, J. Scibek, and I. Chaiken. 2004. Kinetic interaction analysis 
of human interleukin 5 receptor alpha mutants reveals a unique binding topology 
and charge distribution for cytokine recognition. J Biol Chem 279:9547-56. 
117. Ishino, T., U. Pillalamarri, D. Panarello, M. Bhattacharya, C. Urbina, S. Horvat, 
S. Sarkhel, B. Jameson, and I. Chaiken. 2006. Asymmetric usage of antagonist 
charged residues drives interleukin-5 receptor recruitment but is insufficient for 
receptor activation. Biochemistry 45:1106-15. 
118. Ishino, T., N. Robertson, and I. Chaiken. 2005. Cytokine recognition by human 
interleukin 5 receptor. Vitam Horm 71:321-44. 
119. Ito, T., and S. Okazaki. 2000. Pushing the limits of lithography. Nature 406:1027-
31. 
120. Jackson, D., D. King, J. Chmielewski, S. Singh, and P. Schultz. 1991. General 
approach to the synthesis of short alpha-helical peptides. J. Am. Chem. Soc. 
113:9391-9392. 
121. Johnsson, B., S. Lofas, and G. Lindquist. 1991. Immobilization of proteins to a 
carboxymethyldextran-modified gold surface for biospecific interaction analysis 
in surface plasmon resonance sensors. Anal Biochem 198:268-77. 
122. Jones, S. W., R. Christison, K. Bundell, C. J. Voyce, S. M. Brockbank, P. 
Newham, and M. A. Lindsay. 2005. Characterisation of cell-penetrating peptide-
mediated peptide delivery. Br J Pharmacol 145:1093-102. 
123. Jonsson, U., L. Fagerstam, B. Ivarsson, B. Johnsson, R. Karlsson, K. Lundh, S. 
Lofas, B. Persson, H. Roos, I. Ronnberg, and et al. 1991. Real-time biospecific 
interaction analysis using surface plasmon resonance and a sensor chip 
technology. Biotechniques 11:620-7. 
124. Journet, C., W. Maser, P. Bernier, A. Loiseau, M. Lamy de la Chapelle, S. 
Lefrant, P. Deniard, R. Lee, and J. Fischer. 1997. Large-scale production of 
  
171
 
single-walled carbon nanotubes by the electric-arc technique. Nature 388:756-
758. 
125. Kammerer, R. A., T. Schulthess, R. Landwehr, A. Lustig, J. Engel, U. Aebi, and 
M. O. Steinmetz. 1998. An autonomous folding unit mediates the assembly of 
two-stranded coiled coils. Proc Natl Acad Sci U S A 95:13419-24. 
126. Karas, M., D. Bachmann, and F. Hillenkamp. 1985. Influence of the wavelength 
in high-irradiance ultraviolet laser desorption mass spectrometry of organic 
molecules. Anal Chem 57:2935-2939. 
127. Karas, M., and F. Hillenkamp. 1988. Laser desorption ionization of proteins with 
molecular masses exceeding 10,000 daltons. Anal Chem 60:2299-301. 
128. Karyakin, A. A., G. V. Presnova, M. Y. Rubtsova, and A. M. Egorov. 2000. 
Oriented immobilization of antibodies onto the gold surfaces via their native thiol 
groups. Anal Chem 72:3805-11. 
129. Katz, E., and I. Willner. 2004. Biomolecule-functionalized carbon nanotubes: 
applications in nanobioelectronics. Chemphyschem 5:1084-104. 
130. Keefe, A. D., D. S. Wilson, B. Seelig, and J. W. Szostak. 2001. One-step 
purification of recombinant proteins using a nanomolar-affinity streptavidin-
binding peptide, the SBP-Tag. Protein Expr Purif 23:440-6. 
131. Keleman, K., S. Rajagopalan, D. Cleppien, D. Teis, K. Paiha, L. Huber, G. 
Technau, and Dickson BJ. 2002. Comm sorts robo to control axon guidance at the 
Drosophila midline. Cell 110:415-427. 
132. Kellermann, O. K., and T. Ferenci. 1982. Maltose-binding protein from 
Escherichia coli. Methods Enzymol 90 Pt E:459-63. 
133. Kharenko, O. A., and M. Y. Ogawa. 2004. Metal-induced folding of a designed 
metalloprotein. J Inorg Biochem 98:1971-4. 
134. Kiick, K. L., E. Saxon, D. A. Tirrell, and C. R. Bertozzi. 2002. Incorporation of 
azides into recombinant proteins for chemoselective modification by the 
Staudinger ligation. Proc Natl Acad Sci U S A 99:19-24. 
  
172
 
135. Kiick, K. L., R. Weberskirch, and D. A. Tirrell. 2001. Identification of an 
expanded set of translationally active methionine analogues in Escherichia coli. 
FEBS Lett 502:25-30. 
136. Knappik, A., and A. Pluckthun. 1994. An improved affinity tag based on the 
FLAG peptide for the detection and purification of recombinant antibody 
fragments. Biotechniques 17:754-61. 
137. Knight, D. E., and M. C. Scrutton. 1986. Gaining access to the cytosol: the 
technique and some applications of electropermeabilization. Biochem J 234:497-
506. 
138. Kohn, W., and R. Hodges. 1998. De novo design of alpha-helical coiled coils and 
bundles: models for the development of protein-design principles. Trends in 
Biotechnology 16:379-389. 
139. Kolb, H. C., M. G. Finn, and K. B. Sharpless. 2001. Click Chemistry: Diverse 
Chemical Function from a Few Good Reactions. Angew Chem Int Ed Engl 
40:2004-2021. 
140. Krantz, B., and T. Sosnick. 2001. Engineered metal binding sites map the 
heterogeneous folding landscape of a coiled coil. Nature 8:1042-1047. 
141. Kretschmann, E. 1971. Die Bestimmung optischer Konstanten von Metallen 
durch Anregung von Oberflächenplasmaschwingungen. Zeitschrift für Physik A 
Hadrons and Nuclei 241:313. 
142. Kretschmann, E., and H. Raether. 1968. Radiative decay of non-radiative surface 
plasmons excited by light. Z. Naturforsch. A 23a:2135–2136. 
143. Krylov, D., I. Mikhailenko, and C. Vinson. 1994. A thermodynamic scale for 
leucine zipper stability and dimerization specificity: e and g interhelical 
interactions. Embo J 13:2849-61. 
144. Kusnezow, W., and J. D. Hoheisel. 2002. Antibody microarrays: promises and 
problems. Biotechniques Suppl:14-23. 
145. Kwon, S. J., E. Kim, H. Yang, and J. Kwak. 2006. An electrochemical 
immunosensor using ferrocenyl-tethered dendrimer. Analyst 131:402-6. 
  
173
 
146. Lakowicz, J. R. 1999. Pricincples of Fluorescence Spectroscopy. Kluwer 
Academic, New York. 
147. Lamla, T., and V. A. Erdmann. 2004. The Nano-tag, a streptavidin-binding 
peptide for the purification and detection of recombinant proteins. Protein Expr 
Purif 33:39-47. 
148. Layton, B. E., and A. M. Sastry. 2004. A mechanical model for collagen fibril 
load sharing in peripheral nerve of diabetic and non-diabetic rats. ASME Journal 
of Biomechanical Engineering 126:803-814. 
149. Layton, B. E., A. M. Sastry, C. M. Lastoskie, M. A. Philbert, T. J. Miller, K. A. 
Sullivan, E. L. Feldman, and C.-W. Wang. 2004. In situ imaging of mitochondrial 
outer membrane pores using atomic force microscopy. BioTechniques 37:564-
573. 
150. Layton, B. E., S. M. Sullivan, J. J. Palermo, G. J. Buzby, R. Gupta, and R. E. 
Stallcup. 2005. Nanomanipulation and aggregation limitations of self-assembling 
structural proteins. Microelectronics Journal 36:644-649. 
151. Leahy, D. J., W. A. Hendrickson, I. Aukhil, and H. P. Erickson. 1992. Structure 
of a fibronectin type III domain from tenascin phased by MAD analysis of the 
selenomethionyl protein. Science 258:987-991. 
152. Lewin, M., N. Carlesso, C. H. Tung, X. W. Tang, D. Cory, D. T. Scadden, and R. 
Weissleder. 2000. Tat peptide-derivatized magnetic nanoparticles allow in vivo 
tracking and recovery of progenitor cells. Nat Biotechnol 18:410-4. 
153. Li, H., F. Cheng, A. M. Duft, and A. Adronov. 2005. Functionalization of single-
walled carbon nanotubes with well-defined polystyrene by "click" coupling. J Am 
Chem Soc 127:14518-24. 
154. Li, J., C. Papadopoulos, and J. Xu. 1999. Nanoelectronics: Growing Y-junction 
carbon nanotubes. Nature 402:253. 
155. Li, J., C. Papadopoulos, J. Xu, and M. Moskovits. 1999. Highly-ordered carbon 
nanotube arrays for electronic applications. Appl. Phys. Lett. 75:367-369. 
  
174
 
156. Li, W. Z., S. S. Xie, L. X. Qian, B. H. Chang, B. S. Zou, W. Y. Zhou, R. A. Zhao, 
and G. Wang. 1996. Large-Scale Synthesis of Aligned Carbon Nanotubes. 
Science 274:1701-3. 
157. Li, X., K. Suzuki, K. Kanaori, K. Tajima, A. Kashiwada, H. Hiroaki, D. Kohda, 
and T. Tanaka. 2000. Soft metal ions, Cd(II) and Hg(II), induce triple-stranded 
alpha-helical assembly and folding of a de novo designed peptide in their trigonal 
geometries. Protein Sci 9:1327-33. 
158. Link, A. J., M. L. Mock, and D. A. Tirrell. 2003. Non-canonical amino acids in 
protein engineering. Curr Opin Biotechnol 14:603-9. 
159. Link, A. J., M. K. Vink, and D. A. Tirrell. 2004. Presentation and detection of 
azide functionality in bacterial cell surface proteins. J Am Chem Soc 126:10598-
602. 
160. Liu, S., Z. Zhang, and M. Han. 2005. Gram-scale synthesis and 
biofunctionalization of silica-coated silver nanoparticles for fast colorimetric 
DNA detection. Anal Chem 77:2595-600. 
161. Ljungquist, C., A. Breitholtz, H. Brink-Nilsson, T. Moks, M. Uhlen, and B. 
Nilsson. 1989. Immobilization and affinity purification of recombinant proteins 
using histidine peptide fusions. Eur J Biochem 186:563-9. 
162. Loweth, C., W. Caldwell, X. Peng, A. Alivisatos, and P. Schultz. 1999. DNA-
based assembly  of gold nanoparticles. Angew. Chem., Intl. Ed. 38:1808-1812. 
163. Luby-Phelps, K. 1994. Physical properties of cytoplasm. Curr Opin Cell Biol 6:3-
9. 
164. Lupas, A., M. Van Dyke, and J. Stock. 1991. Predicting coiled coils from protein 
sequences. Science 252:1162-4. 
165. Lyu, P. C., M. I. Liff, L. A. Marky, and N. R. Kallenbach. 1990. Side chain 
contributions to the stability of alpha-helical structure in peptides. Science 
250:669-73. 
166. Mann, M., and G. Talbo. 1996. Developments in matrix-assisted laser 
desorption/ionization peptide mass spectrometry. Curr Opin Biotechnol 7:11-9. 
  
175
 
167. Mant, C., and R. Hodges. 1991. High-Performance Liquid Chromatography of 
Peptides and Proteins. Separation, Analysis and Conformation. CRC Press, Boca 
Raton. 
168. Marras, S. A., F. R. Kramer, and S. Tyagi. 2002. Efficiencies of fluorescence 
resonance energy transfer and contact-mediated quenching in oligonucleotide 
probes. Nucleic Acids Res 30:e122. 
169. Martin, B. R., B. N. Giepmans, S. R. Adams, and R. Y. Tsien. 2005. Mammalian 
cell-based optimization of the biarsenical-binding tetracysteine motif for 
improved fluorescence and affinity. Nat Biotechnol 23:1308-14. 
170. Mason, J. M., and K. M. Arndt. 2004. Coiled coil domains: stability, specificity, 
and biological implications. ChemBioChem 5:170-176. 
171. Mason, J. M., M. A. Schmitz, K. M. Muller, and K. M. Arndt. 2006. Semirational 
design of Jun-Fos coiled coils with increased affinity: Universal implications for 
leucine zipper prediction and design. Proc Natl Acad Sci U S A 103:8989-94. 
172. Massodi, I., G. L. Bidwell, 3rd, and D. Raucher. 2005. Evaluation of cell 
penetrating peptides fused to elastin-like polypeptide for drug delivery. J Control 
Release 108:396-408. 
173. Matthews, T., M. Salgo, M. Greenberg, J. Chung, R. DeMasi, and D. Bolognesi. 
2004. Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 
lymphocytes. Nat Rev Drug Discov 3:215-25. 
174. McCourt, P., J. Nickels, T. Ishino, and I. Chaiken. in press, 2007. Protein 
Recognition in Biology. In R. S. Marks, D. C. Cullen, I. Karube, C. R. Lowe, and 
H. H. Weetall (ed.), Handbook of Biosensors and Biochips. John Wiley and Sons. 
175. McLellan, W. 1960. The McLellan micromotor photographed under a 
microscope. 
176. Medintz, I. L., H. T. Uyeda, E. R. Goldman, and H. Mattoussi. 2005. Quantum 
dot bioconjugates for imaging, labelling and sensing. Nature Materials 4:435-446. 
  
176
 
177. Medvedev, D. M., I. Daizadeh, and A. A. Stuchebrukhov. 2000. Electron transfer 
tunneling pathways in bovine heart cytochrome c oxidase. J Am Chem Soc 
122:6571-6582. 
178. Melikov, K., and L. V. Chernomordik. 2005. Arginine-rich cell penetrating 
peptides: from endosomal uptake to nuclear delivery. Cell Mol Life Sci 62:2739-
49. 
179. Meng, G., Y. J. Jung, A. Cao, R. Vajtai, and P. M. Ajayan. 2005. Controlled 
fabrication of hierarchically branched nanopores, nanotubes, and nanowires. Proc 
Natl Acad Sci U S A 102:7074-8. 
180. Menon, V., and C. Martin. 1995. Fabrication and Evaluation of Nanoelectrode 
Ensembles. Analytical Chemistry 67:1920-1928. 
181. Merrifield, R. 1963. Solid Phase Peptide Synthesis. I. The Synthesis of a 
Tetrapeptide. J. Am. Chem. Soc. 85:2149–2154. 
182. Michalet, X., F. F. Pinaud, L. A. Bentolila, J. M. Tsay, S. Doose, J. J. Li, G. 
Sundaresan, A. M. Wu, S. S. Gambhir, and S. Weiss. 2005. Quantum dots for live 
cells, in vivo imaging, and diagnostics. Science 307:538-544. 
183. Michalet, X., F. F. Pinaud, L. A. Bentolila, J. M. Tsay, S. Doose, J. J. Li, G. 
Sundaresan, A. M. Wu, S. S. Gambhir, and S. Weiss. 2005. Quantum dots for live 
cells, in vivo imaging, and diagnostics. Science 307:538-44. 
184. Moitra, J., L. Szilak, D. Krylov, and C. Vinson. 1997. Leucine is the most 
stabilizing aliphatic amino acid in the d position of a dimeric leucine zipper coiled 
coil. Biochemistry 36:12567-73. 
185. Monthioux, M., and K. VL. 2006. Who should be given the credit for the 
discovery of carbon nanotubes? Carbon 44:1621. 
186. Morgan, N. Y., S. English, W. Chen, V. Chernomordik, A. Russo, P. D. Smith, 
and A. Gandjbakhche. 2005. Real time in vivo non-invasive optical imaging using 
near-infrared fluorescent quantum dots. Acad Radiol 12:313-23. 
187. Muto, A., S. Watanabe, A. Miyajima, T. Yokota, and K. Arai. 1995. High affinity 
chimeric human granulocyte-macrophage colony-stimulating factor receptor 
  
177
 
carrying the cytoplasmic domain of the beta subunit but not the alpha subunit 
transduces growth promoting signals in Ba/F3 cells. Biochem Biophys Res 
Commun 208:368-75. 
188. Myszka, D. G., and I. M. Chaiken. 1994. Design and characterization of an 
intramolecular antiparallel coiled coil peptide. Biochemistry 33:2363-2372. 
189. Newman, J. R., and A. E. Keating. 2003. Comprehensive identification of human 
bZIP interactions with coiled-coil arrays. Science 300:2097-101. 
190. Nguyen, C. V., L. Delziet, A. M. Cassell, J. Li, J. Han, and M. Meyyappan. 2002. 
Preparation of nucleic acid functionalized carbon nanotube arrays. Nano Lett 
2:1079-1081. 
191. Nieba, L., S. Nieba-Axmann, A. Persson, M. Hämäläinen, F. Edebratt, A. 
Hansson, J. Lidholm, K. Magnusson, A. Karlsson, and A. Plückthun. 1997. 
BIACORE Analysis of Histidine-Tagged Proteins Using a Chelating NTA Sensor 
Chip. Analytical Biochemistry 252:217-228. 
192. Nielsen, C., P. Hansen, A. Lihme, and P. Heegaard. 1989. Real time monitoring 
of acylations during solid phase peptide synthesis: a method based on 
electrochemical detection. Journal of Biochemical and Biophysical Methods 
20:69-80. 
193. Nilsson, B., and L. Abrahmsen. 1990. Fusions to staphylococcal protein A. 
Methods Enzymol 185:144-61. 
194. Niman, H., R. Houghten, L. Walker, R. Reisfeld, I. Wilson, J. Hogle, and R. 
Lerner. 1983. Generation of protein-reactive antibodies by short peptides is an 
event of high frequency: Implications for the structural basis of immune 
recognition. Proc. Natl. Acad. Sci. 80:4949-4953. 
195. Nisonoff, A., G. Markus, and F. C. Wissler. 1961. Separation of univalent 
fragments of rabbit antibody by reduction of a single, labile disulphide bond. 
Nature 189:293-5. 
196. O'Neil, K. T., and W. F. DeGrado. 1990. A thermodynamic scale for the helix-
forming tendencies of the commonly occurring amino acids. Science 250:646-51. 
  
178
 
197. O'Reilly R, K., M. J. Joralemon, C. J. Hawker, and K. L. Wooley. 2006. 
Fluorogenic 1,3-Dipolar Cycloaddition within the Hydrophobic Core of a Shell 
Cross-Linked Nanoparticle. Chemistry. 
198. O'Shea, E. K., J. D. Klemm, P. S. Kim, and T. Alber. 1991. X-ray structure of the 
GCN4 leucine zipper, a two-stranded, parallel coiled coil. Science 254:539-44. 
199. O'Shea, E. K., K. J. Lumb, and P. S. Kim. 1993. Peptide 'Velcro': design of a 
heterodimeric coiled coil. Curr Biol 3:658-67. 
200. O'Shea, E. K., R. Rutkowski, and P. S. Kim. 1989. Evidence that the leucine 
zipper is a coiled coil. Science 243:538-42. 
201. O'Shea, E. K., R. Rutkowski, and P. S. Kim. 1992. Mechanism of specificity in 
the Fos-Jun oncoprotein heterodimer. Cell 68:699-708. 
202. Oas, T. G., L. P. McIntosh, E. K. O'Shea, F. W. Dahlquist, and P. S. Kim. 1990. 
Secondary structure of a leucine zipper determined by nuclear magnetic resonance 
spectroscopy. Biochemistry 29:2891-4. 
203. Otto, A. 1968. Excitation of nonradiative surface plasma waves in silver by the 
method of frustrated total reflection. Zeitschrift für Physik A Hadrons and Nuclei 
216:398. 
204. Panchuk-Voloshina, N., R. P. Haugland, J. Bishop-Stewart, M. K. Bhalgat, P. J. 
Millard, F. Mao, W. Y. Leung, and R. P. Haugland. 1999. Alexa dyes, a series of 
new fluorescent dyes that yield exceptionally bright, photostable conjugates. J 
Histochem Cytochem 47:1179-88. 
205. Papadopoulos, C., B. Chang, A. Yin, and J. Xu. 2002. Engineered carbon 
nanotubes via  template growth. Int. J. of Nanosci. 1:205-212. 
206. Parsonage, D., H. Miller, R. P. Ross, and A. Claiborne. 1993. Purification and 
analysis of streptococcal NADH peroxidase expressed in Escherichia coli. J Biol 
Chem 268:3161-7. 
207. Patel, R. A., B. Legum, Y. Gogotsi, and B. E. Layton. 2006. Presented at the 8th 
Biennial ASME Conference on Engineering Systems Design and Analysis ESDA, 
Turin, Italy. 
  
179
 
208. Patterson, S. D., and R. H. Aebersold. 2003. Proteomics: the first decade and 
beyond. Nat Genet 33 Suppl:311-23. 
209. Pavletich, N. P., and C. O. Pabo. 1991. Zinc finger-DNA recognition: crystal 
structure of a Zif268-DNA complex at 2.1 A. Science 252:809-817. 
210. Pelet, S., M. Previte, and P. So. in press. Comparing the quantification of Forster 
resonance energy transfer measurement accuracies based on intensity, spectral 
and lifetime imaging. Journal of Biomedical Optics. 
211. Pessi, A., E. Bianchi, A. Crameri, S. Venturini, A. Tramontano, and M. Sollazzo. 
1993. A designed metal-binding protein with a novel fold. Nature 362:293-294. 
212. Pierce, M., C. Raman, and B. Nall. 1999. Isothermal titration calorimetry of 
protein-protein interactions. Methods Enzymol 19:213-221. 
213. Pillarisetti, A., M. Pekarev, A. D. Brooks, and J. P. Desai. 2006. Evaluating the 
Effect of Force Feedback in Cell Injection. IEEE Transactions on Automation 
Science and Engineering available online. 
214. Piner, R. D., J. Zhu, F. Xu, S. Hong, and C. A. Mirkin. 1999. "Dip-Pen" 
nanolithography. Science 283:661-3. 
215. Pinkel, D., J. Landegent, C. Collins, J. Fuscoe, R. Segraves, J. Lucas, and J. Gray. 
1988. Fluorescence in situ hybridization with human chromosome-specific 
libraries: detection of trisomy 21 and translocations of chromosome 4. Proc Natl 
Acad Sci U S A 85:9138-42. 
216. Porath, J. 1992. Immobilized metal ion affinity chromatography. Protein Expr 
Purif 3:263-81. 
217. Porath, J., J. Carlsson, I. Olsson, and G. Belfrage. 1975. Metal chelate affinity 
chromatography, a new approach to protein fractionation. Nature 258:598-9. 
218. Prickett, K. S., D. C. Amberg, and T. P. Hopp. 1989. A calcium-dependent 
antibody for identification and purification of recombinant proteins. 
Biotechniques 7:580-9. 
  
180
 
219. Qu, F., M. Yang, G. Shen, and R. Yu. 2006. Electrochemical biosensing utilizing 
synergic action of carbon nanotubes and platinum nanowires prepared by template 
synthesis. Biosens Bioelectron. 
220. Qureshi, M. H., and S. L. Wong. 2002. Design, production, and characterization 
of a monomeric streptavidin and its application for affinity purification of 
biotinylated proteins. Protein Expr Purif 25:409-15. 
221. Ramachandran, S., N. E. Merrill, R. H. Blick, and D. W. van der Weide. 2005. 
Colloidal quantum dots initiating current bursts in lipid bilayers. Biosens 
Bioelectron 20:2173-6. 
222. Rasmussen, R., D. Benvegnu, E. K. O'Shea, P. S. Kim, and T. Alber. 1991. X-ray 
scattering indicates that the leucine zipper is a coiled coil. Proc Natl Acad Sci U S 
A 88:561-4. 
223. Reginato, M. J., K. R. Mills, E. B. Becker, D. K. Lynch, A. Bonni, S. K. 
Muthuswamy, and J. S. Brugge. 2005. Bim regulation of lumen formation in 
cultured mammary epithelial acini is targeted by oncogenes. Mol Cell Biol 
25:4591-601. 
224. Reineke, U., R. Volkmer-Engert, and J. Schneider-Mergener. 2001. Applications 
of peptide arrays prepared by the SPOT-technology. Curr Opin Biotechnol 12:59-
64. 
225. Rich, R. L., and D. G. Myszka. 2000. Advances in surface plasmon resonanace 
biosensor analysis. Current Opinion in Biotechnology 11:54-61. 
226. Rizzo, M. A., G. H. Springer, B. Granada, and D. W. Piston. 2004. An improved 
cyan fluorescent protein variant useful for FRET. Nat Biotechnol 22:445-9. 
227. Roepstorff, P. 2000. MALDI-TOF mass spectrometry in protein chemistry. Exs 
88:81-97. 
228. Rohrer, L., M. Freeman, T. Kodama, M. Penman, and M. Krieger. 1990. Coiled-
coil fibrous domains mediate ligand binding by macrophage scavenger receptor 
type II. Nature 343:570-2. 
  
181
 
229. Rose, A., and I. Meier. 2004. Scaffolds, levers, rods and springs: diverse cellular 
functions of long coiled-coil proteins. Cellular and Molecular Life Sciences 
61:1996-2009. 
230. Rose, A., S. J. Schraegle, E. A. Stahlberg, and I. Meier. 2005. Coiled-coil protein 
composition of 22 proteomes--differences and common themes in subcellular 
infrastructure and traffic control. BMC Evol Biol 5:66. 
231. Ross, R. P., and A. Claiborne. 1991. Cloning, sequence and overexpression of 
NADH peroxidase from Streptococcus faecalis 10C1. Structural relationship with 
the flavoprotein disulfide reductases. J Mol Biol 221:857-71. 
232. Rostovtsev, V. V., L. G. Green, V. V. Fokin, and K. B. Sharpless. 2002. A 
stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective 
"ligation" of azides and terminal alkynes. Angew Chem Int Ed Engl 41:2596-9. 
233. Sako, Y., S. Minoghchi, and T. Yanagida. 2000. Single-molecule imaging of 
EGFR signalling on the surface of living cells. Nat Cell Biol 2:168-72. 
234. Sarin, V. K., S. B. Kent, J. P. Tam, and R. B. Merrifield. 1981. Quantitative 
monitoring of solid-phase peptide synthesis by the ninhydrin reaction. Anal 
Biochem 117:147-57. 
235. Sawa, M., T. L. Hsu, T. Itoh, M. Sugiyama, S. R. Hanson, P. K. Vogt, and C. H. 
Wong. 2006. Glycoproteomic probes for fluorescent imaging of fucosylated 
glycans in vivo. Proc Natl Acad Sci U S A 103:12371-6. 
236. Sayle, R. A., and E. J. Milner-White. 1995. RASMOL: biomolecular graphics for 
all. Trends Biochem Sci 20:374. 
237. Schmidt, T. G., J. Koepke, R. Frank, and A. Skerra. 1996. Molecular interaction 
between the Strep-tag affinity peptide and its cognate target, streptavidin. J Mol 
Biol 255:753-66. 
238. Schneider, U., H. U. Schwenk, and G. Bornkamm. 1977. Characterization of 
EBV-genome negative "null" and "T" cell lines derived from children with acute 
lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J 
Cancer 19:621-6. 
  
182
 
239. Schuhmann, W., T. J. Ohara, H. Schmidt, and A. Heller. 1991. Electron transfer 
between glucose oxidase and electrodes via redox mediators bound with flexible 
chains to the enzyme surface. J. Am. Chem. Soc. 113:1394-1397. 
240. Schweitzer, B., P. Predki, and M. Snyder. 2003. Microarrays to characterize 
protein interactions on a whole-proteome scale. Proteomics 3:2190-9. 
241. Scibek, J. J., E. Evergren, S. Zahn, G. A. Canziani, D. Van Ryk, and I. M. 
Chaiken. 2002. Biosensor analysis of dynamics of interleukin 5 receptor subunit 
beta(c) interaction with IL5:IL5R(alpha) complexes. Anal Biochem 307:258-65. 
242. Sergi, M., J. Zurawski, S. Cocklin, and I. Chaiken. 2004. Proteins, recognition 
networks and developing interfaces for macromolecular biosensing. J Mol 
Recognit 17:198-208. 
243. Sergi, M., J. Zurawski, S. Cocklin, and I. M. Chaiken. 2004. Proteins, recognition 
networks and developing interfaces for macromolecular biosensing. Journal of 
Molecular Recognition 17:198-208. 
244. Shaner, N. C., R. E. Campbell, P. A. Steinbach, B. N. Giepmans, A. E. Palmer, 
and R. Y. Tsien. 2004. Improved monomeric red, orange and yellow fluorescent 
proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 
22:1567-72. 
245. Shaner, N. C., P. A. Steinbach, and R. Y. Tsien. 2005. A guide to choosing 
fluorescent proteins. Nat Methods 2:905-9. 
246. Shiraishi, T., and P. E. Nielsen. 2006. Photochemically enhanced cellular delivery 
of cell penetrating peptide-PNA conjugates. FEBS Lett 580:1451-6. 
247. Sigmundsson, K., G. Masson, R. Rice, N. Beauchemin, and B. Obrink. 2002. 
Determination of active concentrations and association and dissociation rate 
constants of interacting biomolecules: an analytical solution to the theory for 
kinetic and mass transport limitations in biosensor technology and its 
experimental verification. Biochemistry 41:8263-76. 
248. Siuzdak, G. 1994. The emergence of mass spectrometry in biochemical research. 
Proc Natl Acad Sci U S A 91:11290-7. 
  
183
 
249. Sljukic, B., C. E. Banks, and R. G. Compton. 2006. Iron oxide particles are the 
active sites for hydrogen peroxide sensing at multiwalled carbon nanotube 
modified electrodes. Nano Lett 6:1556-8. 
250. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides 
expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 
67:31-40. 
251. Smith, R. D., J. A. Loo, C. G. Edmonds, C. J. Barinaga, and H. R. Udseth. 1990. 
New developments in biochemical mass spectrometry: electrospray ionization. 
Anal Chem 62:882-99. 
252. Sotiropoulou, S., and N. A. Chaniotakis. 2003. Carbon nanotube array-based 
biosensor. Anal Bioanal Chem 375:103-5. 
253. Steinmetz, M. O., A. Stock, T. Schulthess, R. Landwehr, A. Lustig, J. Faix, G. 
Gerisch, U. Aebi, and R. A. Kammerer. 1998. A distinct 14 residue site triggers 
coiled-coil formation in cortexillin I. Embo J 17:1883-91. 
254. Stephens, D. J., and R. Pepperkok. 2001. The many ways to cross the plasma 
membrane. Proc Natl Acad Sci U S A 98:4295-8. 
255. Stofko-Hahn, R. E., D. W. Carr, and J. D. Scott. 1992. A single step purification 
for recombinant proteins. Characterization of a microtubule associated protein 
(MAP 2) fragment which associates with the type II cAMP-dependent protein 
kinase. FEBS Lett 302:274-8. 
256. Stryer, L. 1978. Fluorescence energy transfer as a spectroscopic ruler. Annu Rev 
Biochem 47:819-46. 
257. Stryer, L., and R. P. Haugland. 1967. Energy transfer: a spectroscopic ruler. Proc 
Natl Acad Sci U S A 58:719-26. 
258. Stults, J. T. 1995. Matrix-assisted laser desorption/ionization mass spectrometry 
(MALDI-MS). Curr Opin Struct Biol 5:691-8. 
259. Summerer, D., S. Chen, N. Wu, A. Deiters, J. W. Chin, and P. G. Schultz. 2006. 
A genetically encoded fluorescent amino acid. Proc Natl Acad Sci U S A 
103:9785-9. 
  
184
 
260. Tan, K., J. Liu, J. Wang, S. Shen, and M. Lu. 1997. Atomic structure of a 
thermostable subdomain of HIV-1 gp41. Proc Natl Acad Sci U S A 94:12303-8. 
261. Tanaka, K., H. Waki, Y. Ido, S. Akita, Y. Yoshida, and T. Yoshida. 1988. Protein 
and Polymer Analyses up to m/z 100 000 by Laser Ionization Time-of flight Mass 
Spectrometry. Rapid Commun Mass Spectrom 2:151-153. 
262. Tekle, E., H. Oubrahim, S. M. Dzekunov, J. F. Kolb, K. H. Schoenbach, and P. B. 
Chock. 2005. Selective field effects on intracellular vacuoles and vesicle 
membranes with nanosecond electric pulses. Biophys J 89:274-84. 
263. Terpe, K. 2003. Overview of tag protein fusions: from molecular and biochemical 
fundamentals to commercial systems. Applied Microbiology and Biotechnology 
60:523-533. 
264. Thess, A., R. Lee, P. Nikolaev, H. Dai, P. Petit, J. Robert, C. Xu, Y. H. Lee, S. G. 
Kim, A. G. Rinzler, D. T. Colbert, G. E. Scuseria, D. Tomanek, J. E. Fischer, and 
R. E. Smalley. 1996. Crystalline Ropes of Metallic Carbon Nanotubes. Science 
273:483-7. 
265. Thorne, R. G., and C. Nicholson. 2006. In vivo diffusion analysis with quantum 
dots and dextrans predicts the width of brain extracellular space. Proc Natl Acad 
Sci U S A 103:5567-72. 
266. Tomlinson, E., N. Palaniyappan, D. Tooth, and R. Layfield. 2007. Methods for 
the purification of ubiquitinated poteins. Proteomics 7:1016-1022. 
267. Tornoe, C. W., C. Christensen, and M. Meldal. 2002. Peptidotriazoles on solid 
phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar 
cycloadditions of terminal alkynes to azides. J Org Chem 67:3057-64. 
268. Trammell, S. A., L. Wang, J. M. Zullo, R. Shashidhar, and N. Lebedev. 2004. 
Orientated binding of photosynthetic reaction centers on gold using Ni-NTA self-
assembled monolayers. Biosens Bioelectron 19:1649-55. 
269. Tripet, B., G. De Crescenzo, S. Grothe, M. O'Connor-McCourt, and R. S. Hodges. 
2002. Kinetic analysis of the interactions between troponin C and the C-terminal 
troponin I regulatory region and validation of a new peptide delivery/capture 
system used for surface plasmon resonance. J Mol Biol 323:345-62. 
  
185
 
270. Tripet, B., and R. S. Hodges. 2002. Helix capping interactions stabilize the N-
terminus of the kinesin neck coiled-coil. J Struct Biol 137:220-35. 
271. Tripet, B., K. Wagschal, P. Lavigne, C. T. Mant, and R. S. Hodges. 2000. Effects 
of side-chain characteristics on stability and oligomerization state of a de novo-
designed model coiled-coil: 20 amino acid substitutions in position "d". Journal of 
Molecular Biology 300:377-402. 
272. Tripet, B., L. Yu, D. L. Bautista, W. Y. Wong, R. T. Irvin, and R. S. Hodges. 
1996. Engineering a de novo-designed coiled-coil heterodimerization domain off 
the rapid detection, purification and characterization of recombinantly expressed 
peptides and proteins. Protein Eng 9:1029-42. 
273. Tropsha, A., J. P. Bowen, F. K. Brown, and J. S. Kizer. 1991. Do interhelical side 
chain-backbone hydrogen bonds participate in formation of leucine zipper coiled 
coils? Proc Natl Acad Sci U S A 88:9488-92. 
274. Tsang, S., Y. Chen, J. Harris, and M. Green. 1994. A simple chemical method of 
opening and filling carbon nanotubes. Nature 372:159-162. 
275. Usui, K., M. Takahashi, K. Nokihara, and H. Mihara. 2004. Peptide arrays with 
designed alpha-helical structures for characterization of proteins from FRET 
fingerprint patterns. Mol Divers 8:209-18. 
276. Velazquez-Campoy, A., S. S. A. Leavitt, and E. E. Freire. 2004. Characterization 
of protein-protein interactions by isothermal titration calorimetry. Methods Mol 
Biol 261:34-54. 
277. Wagner, D. E., C. L. Phillips, W. M. Ali, G. E. Nybakken, E. D. Crawford, A. D. 
Schwab, W. F. Smith, and R. Fairman. 2005. Toward the development of peptide 
nanofilaments and nanoropes as smart materials. Proc Natl Acad Sci U S A 
102:12656-61. 
278. Wagschal, K., B. Tripet, P. Lavigne, C. Mant, and R. S. Hodges. 1999. The role 
of position a in determining the stability and oligomerization state of alpha-helical 
coiled coils: 20 amino acid stability coefficients in the hydrophobic core of 
proteins. Protein Sci 8:2312-29. 
  
186
 
279. Waizenegger, T., T. Stan, W. Neupert, and D. Rapaport. 2003. Signal-anchor 
domains of proteins of the outer membrane of mitochondria: structural and 
functional characteristics. J Biol Chem 278:42064-71. 
280. Wallimann, P., R. J. Kennedy, and D. Kemp. 1999. The analysis of the molar 
ellipticity. Angew. Chem. Int. Ed.Engl. 38:1290–1292. 
281. Wang, J., A. N. Kawde, and M. R. Jan. 2004. Carbon-nanotube-modified 
electrodes for amplified enzyme-based electrical detection of DNA hybridization. 
Biosens Bioelectron 20:995-1000. 
282. Wang, S., E. Humphreys, S. Chung, D. Delduco, S. R. Lustig, H. Wang, K. 
Parker, N. Rizzo, S. Subramoney, Y. Chiang, and A. Jagota. 2003. Peptides with 
selective affinity for carbon nanotubes. Nature Materials 2:196-200. 
283. Wang, Y., D. Maspoch, S. Zou, G. C. Schatz, R. E. Smalley, and C. A. Mirkin. 
2006. Controlling the shape, orientation, and linkage of carbon nanotube features 
with nano affinity templates. Proc Natl Acad Sci U S A 103:2026-31. 
284. Watson, B. S., T. L. Hazlett, J. F. Eccleston, C. Davis, D. M. Jameson, and A. E. 
Johnson. 1995. Macromolecular arrangement in the aminoacyl-tRNA.elongation 
factor Tu.GTP ternary complex. A fluorescence energy transfer study. 
Biochemistry 34:7904-12. 
285. Weast, R. 1975. Handbook of Chemistry and Physics, 59 ed. CRC Press, 
Cleveland. 
286. Wei, D., Y. Liu, L. Cao, L. Fu, X. Li, Y. Wang, G. Yu, and D. Zhu. 2006. A new 
method to synthesize complicated multi-branched carbon nanotubes with 
controlled architecture and composition. Nano Lett 6:186-92. 
287. Whitley, P., I. Nilsson, and G. von Heijne. 1994. De novo design of integral 
membrane proteins. Nat Struct Biol 1:858-62. 
288. Willner, B., E. Katz, and I. Willner. 2006. Electrical contacting of redox proteins 
by nanotechnological means. Curr Opin Biotechnol 17:589-96. 
289. Willner, I., B. Willner, and E. Katz. 2007. Biomolecule-nanoparticle hybrid 
systems for bioelectronic applications. Bioelectrochemistry 70:2-11. 
  
187
 
290. Withey, G. D., J. H. Kim, and J. M. Xu. 2007. Wiring efficiency of a metallizable 
DNA linker for site-addressable nanobioelectronic assembly. Nanotechnology 
42:424025 (9pp). 
291. Withey, G. D., A. D. Lazareck, M. B. Tzolov, A. Yin, P. Aich, J. I. Yeh, and J. M. 
Xu. 2006. Ultra-high redox enzyme signal transduction using highly ordered 
carbon nanotube array electrodes. Biosens Bioelectron 21:1560-5. 
292. Wood, W. B. 1966. Host specificity of DNA produced by Escherichia coli: 
bacterial mutations affecting the restriction and modification of DNA. J Mol Biol 
16:118-33. 
293. Woolfson, D. N., and T. Alber. 1995. Predicting oligomerization states of coiled 
coils. Protein Sci 4:1596-607. 
294. Wu, P., and L. Brand. 1994. Resonance energy transfer: methods and 
applications. Anal Biochem 218:1-13. 
295. Xiao, Y., F. Patolsky, E. Katz, J. F. Hainfeld, and I. Willner. 2003. "Plugging into 
Enzymes": nanowiring of redox enzymes by a gold nanoparticle. Science 
299:1877-81. 
296. Xie, X. S., J. Yu, and W. Y. Yang. 2006. Living cells as test tubes. Science 
312:228-30. 
297. Yao, T., and G. A. Rechnitz. 1987. Amperometric enzyme-immunosensor based 
on ferrocene-mediated amplification. Biosensors 3:307-12. 
298. Yeh, J. I., A. Claiborne, and W. G. Hol. 1996. Structure of the native cysteine-
sulfenic acid redox center of enterococcal NADH peroxidase refined at 2.8 A 
resolution. Biochemistry 35:9951-7. 
299. Yeh, J. I., M. B. Zimmt, and A. L. Zimmerman. 2005. Nanowiring of a redox 
enzyme by metallized peptides. Biosens Bioelectron 21:973-8. 
300. Yu, Y. B. 2002. Coiled-coils: stability specificity and drug delivery potential. 
Advanced Drug Delivery Reviews 54:1113-1129. 
  
188
 
301. Yuan, Z., H. Huang, L. Liu, and S. Fan. 2001. Controlled growth of carbon 
nanotubes in diameter and shape using template-synthesis method. Chemical 
Physics Letters 345:39-43. 
302. Zaks-Zilberman, M., A. Harrington, T. Ishino, and I. Chaiken. 2007. Presented at 
the 14th Annual Meeting of the ASBMB  Washington, DC, April 29, 2007. 
303. Zhang, K., M. R. Diehl, and D. A. Tirrell. 2005. Artificial polypeptide scaffold 
for protein immobilization. J Am Chem Soc 127:10136-7. 
304. Zhang, S. 2002. Emerging biological materials through molecular self-assembly. 
Biotechnol Adv 20:321-39. 
305. Zhao, X., and S. Zhang. 2004. Fabrication of molecular materials using peptide 
construction motifs. Trends Biotechnol 22:470-6. 
306. Zhu, B. Y., N. E. Zhou, C. M. Kay, and R. S. Hodges. 1993. Packing and 
hydrophobicity effects on protein folding and stability: effects of beta-branched 
amino acids, valine and isoleucine, on the formation and stability of two-stranded 
alpha-helical coiled coils/leucine zippers. Protein Sci 2:383-94. 
307. Zimmerman, S. B., and S. O. Trach. 1991. Estimation of macromolecule 
concentrations and excluded volume effects for the cytoplasm of Escherichia coli. 
J Mol Biol 222:599-620. 
 
  
189
 
APPENDIX 1: LIST OF ABBREVIATIONS  
 
 
 
 
AAO  Anodized aluminum oxide 
ACN  Acetonitrile 
APS   Ammonium persulfate 
BME  β-mercaptoethanol 
Boc  t-butyloxycarbonyl 
BSP  Bis(p-sulfonatophenyl) phenylphosphine dihydrate dipotassium salt  
bZIP  Basic leucine zipper  
CNT  Carbon nanotube 
CV  Column volumes or Cyclic voltammetry 
CVD  Chemical vapor deposition 
DCM  Dichloromethane  
DIEA  Diisopropylethylamine  
DMF  Dimethyl formamide  
DMSO  Dimethyl sulfoxide  
DNA   Deoxyribonucleic acid 
DPN  Dip pen nanolithography 
DTT  Dithiothreitol 
EC  Extinction coefficient 
EDC   1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride 
EDTA   Ethylene diamine tetraacetic acid 
EGTA  Ethylene glycol tetraacetic acid 
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ESI  Electrospray ionization 
FDA  Federal Drug Administration 
Fmoc  9-fluorenylmethoxycarbonyl 
FPLC  Fast protein liquid chromatography 
FRET  Förster resonance energy transfer 
GCN4  Eukaryotic transcriptional activator 
GOx  Glucose oxidase 
gp41  41 kDa glycoprotein on HIV fusion spike 
HBS-P  HEPES buffered saline with P-20 
HF  Hydrofluoric acid 
HIV  Human immunodeficiency virus 
HOBt H2O  1-Hydroxybenzotriazole monohydrate hexafluorophosphate 
IgG  Antibody subclass 
IL5  Interleukin 5 
IMAC  Immobilized metal affinity chromatography 
IPTG  Isopropyl β-D-1-thiogalactopyranoside 
ITC  Isothermal titration calorimetry 
LB  Luria-Bertani 
LOC  Lab on a chip 
MALDI-TOF Matrix assisted laser desorption ionization time of flight  
MCH  Mercaptohexanol 
MRE   Mean residue ellipticity 
mRNA  Messenger RNA 
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MS  Mass spectrometry 
NADH  Nicotinamide adenine dinucleotide 
NEE  Nanoelectrode ensembles 
NHS   N-hydroxy-succinimide 
NMP  N-methyl-2-pyrrolidinone  
NMR  Nuclear magnetic resonance 
Npx  NADH peroxidase 
NTA  Nitrilotriacetic acid 
OD  Optical Density 
PCR  Polymerase chain reaction 
PDEA  2-(2-pyridinyldithio)-ethaneamine hydrochloride 
PSA  Prostate serum antigen 
RNA   Ribonucleic acid 
RP-HPLC Reverse phase high performance liquid chromatography  
SAM  Self assembled monolayers 
SDS  Sodium Dodecyl Sulfate 
SPPS  Solid phase peptide synthesis 
SPR  Surface plasmon resonance 
TCEP  Tris[2-carboxyethyl] phosphine 
TEMED N,N,N',N'-tetramethylethylenediamine  
TFA  Trifluoroacetic acid  
TGS  TRIS/Glycine/SDS 
tRNA  Transfer RNA 
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TTS  TRIS/Tricine/SDS 
UV/Vis Ultraviolet/Visible  
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APPENDIX 2: CELL PROBES GRANT 
 
 
 
 
SPECIFIC AIMS  
 Progress in molecular biology and biochemistry, particularly in genomics and 
proteomics, is leading to the complete identification of the proteins that drive virtually all 
biological processes.  From these starting points, the networks of interactions between 
proteins that control cell function in health and disease are beginning to be revealed. Yet, 
methodologies currently available to track proteins and their interactions at the surface of 
and within cells are often too insensitive to reveal the dynamics of protein expression, 
movement and interaction that lead to regulation and function at the cellular level.   
 The research in the laboratories of our unique consortium opens up the 
opportunity to develop a self-assembling cell probe delivery technology that can achieve 
the high sensitivity needed to visualize and measure the occurrence of a wide range of 
proteins and other biological molecules in cells.  This work combines the delivery of 
fluorophore probe modules into a cell and their complexation with complementary 
genetically encoded polypeptide target modules expressed in the cell.  Self-assembly of 
probe and cellular targets will be driven by complementary coiled-coil peptide tags on 
probe and target components.  The proposed project will enable all major objectives of 
RFA-07-234 to be evaluated with our self-assembling modular cell probe delivery 
system:  [1] non-disruptive delivery of fluorescent probes into cells, [2] specific targeting 
of sub-cellular targets, (172) lack of interference with targeting and normal cell 
physiology and [4] single molecule sensitivity.  
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 This project will develop and evaluate the performance of a cell probe delivery 
system for targeting and imaging proteins in cells.   
Aim 1. Cell Entry of Coiled-Coil Peptide Fluorophore Probes. Establish methodology for 
delivery of coiled peptide probe modules with fluorophore tags into cells by processes 
that maintain cellular viability. Evaluate the feasibility of electroporation and endocytosis 
processes to achieve delivery. Compare with delivery using microinjection.  Demonstrate 
the range of applicability with multiple cell types. 
Aim 2. Intracellular Imaging of Coiled Peptide Targets.  Validate the ability of coiled 
peptide cell probes to localize within cells and dynamically image specific intracellular 
target sites.  Establish ability to image protein sites on the inner side of the cell outer 
membrane and on intracellular compartments such as mitochondria.   
Aim 3. Enhanced Specificity and Brightness in Cellular Imaging.  Test the coiled-coil 
probe-target system to image with increasing specificity and sensitivity.  Demonstrate 
specific intracellular FRET signals between coiled peptide probe and target proteins.  
Evaluate the capacity to deliver ultra-bright particle-fused peptide probes into cells and, 
using these, to detect intracellular targets with minimal photobleaching using standard 
fluorescence microscopy tools. 
Long term, the cell probe delivery technology developed in this project has the potential 
to lead to incorporation of recognition domains into genetically encoded targets in order 
to detect multi-molecular complexes in cells. Additionally, the cell probe delivery 
technology can provide molecular and cellular tools to spatially and temporally resolve 
dynamic signaling processes within cells.  
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BACKGROUND AND SIGNIFICANCE 
 Future efforts to understand human health and combat disease will confront the 
necessity to learn more about molecular mechanisms of proteins on and in cells by 
tracking their expression, localization and interactions. Here, we offer a fundamentally 
novel and “minimally invasive” method for gaining access to this information. 
 
B.1. Molecular Organization in Cells  
 An overarching goal of modern cell biology is to determine the spatial and 
temporal organization of the molecular building blocks that drive cellular processes. 
Proteins comprise the working machinery of a cell.  Their functions are implicated in 
every facet of cell survival, as well as both self-induced and externally-imposed 
pathogenic processes that lead to cell death.  Identification of all proteins is being driven 
by genomic and proteomic technologies, and structural mechanisms are being elucidated 
for an increasing subset of these biological macromolecules through structural and 
molecular biology approaches.  It is increasingly clear that a fundamental mechanism of 
protein function in the cell is non-covalent recognition, which often results in complex 
protein machines. While non-covalent interaction distances are short (a few Angstroms), 
protein components in multimolecular complexes may be separated by 10’s of nm.  The 
abundance of cellular protein components is dynamically modulated over wide and often-
transient time scales (15). The range of concentrations at which specific proteins interact 
functionally can vary widely, by roughly six orders of magnitude in yeast cells (100), and 
  
196
 
more than ten orders outside cells (208).  Overall, the goals of tracking proteins on and 
within cells, and attempting to reveal the underlying cellular processes in which they 
participate, require technologies that can provide temporal resolution down to sub-second 
time scales, spatial resolution down to nanometer or smaller distances and levels of 
perhaps only a few molecules per cell.  
 Technologies that track proteins and protein interactions in cells must overcome 
more than the spatial, temporal and abundance limitations of these systems.  Cells 
achieve functional concentrations for diverse proteins and organize their multimolecular 
assemblies and pathways of biological processes by imposing a highly ordered 
physicochemical environment that is not at all reflected in the behavior of proteins in the 
dilute aqueous solutions in which proteins often are studied experimentally.  Intracellular 
space, although close to the viscosity of water (163), is 20-30% occupied by 
macromolecules, leading to extremely high overall concentrations, for example 300-400 
mg/ml in E. coli (307).  As a result, macromolecules become densely packed in the cell, 
favoring states with the smallest occupied volume and limiting the unperturbed diffusion 
of similar size macromolecules (75).  Closely-packed, membrane-bound and membrane-
enclosed structures work in conjunction with cytoskeleton to package and deliver new 
biomolecules, to sequester materials in order to form functional, energy-rich 
concentration gradients, and to degrade and recycle cellular components (16).  
Elucidating the interactions and transformations of crowded macromolecular machines 
and dynamics in the highly organized compartments of cells represent important goals of 
future cell sciences.  Molecular crowding and compartmentation also are important 
barriers to tracking protein localization and assembly in the cell. 
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B.2. Fluorescence-based Probes of Cells  
 Fluorescence microscopy has proven invaluable to image molecules in cells (90, 
296). The advent of fluorescent protein tags (green fluorescence protein and its 
chromovariants) has provided the opportunity to genetically encode fluorescent 
macromolecules in cells and to observe their localization and interactions (233).  In 
addition, real-time expression dynamics of specific proteins has been observed in a 
prokaryotic cell using a protein fusion with a red-fluorescent genetically encodable tag 
(245). The recently reported genetic coding of proteins with fluorescent amino acids 
further increases the diversity of fluorescent proteins expressed in cells (259).  
Nonetheless, these genetically encodable fluorescent tag systems have limited brightness 
and finite photobleaching rates that diminish their application to routine single molecule 
investigations.  Ultrastable nanoparticles offer fluorescence brightness and stability 
characteristics that can overcome these limitations.  
 Over the last few years, the Geddes laboratory at the University of Maryland 
Biotechnology Institute (UMBI) has developed a new near-field concept, Metal-
Enhanced Fluorescence (MEF), which has the potential to help improve high-sensitivity 
cellular imaging.  Many surfaces and solution-based particles (probes) have been 
developed for metal-enhanced fluorescence.  These surfaces have led to enhanced 
fluorescence and luminescence signatures, ranging from a few-fold, to several thousand-
fold (8, 84-86). Metal-enhanced fluorescence particles (MEF particles) offer significant 
advantages over conventional fluorophores or even GFP. These include the following: 
fluorescence enhancement factors ranging from 10-100 fold; 10-20 fold reduced 
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lifetimes; 100-2000–fold increase in signal / noise due to reduced lifetime and increased 
system quantum yield (an important criterion in cellular imaging); improved 
photostability when in close proximity to the silver nanostructures; compatibility with the 
sol-gel coatings, enabling many wavelengths from the visible to near-IR to be used and 
use of simple glass or other coating chemistries to attach biomolecules (11); use of 
lanthanide probes with long time constants to off-gate cellular auto-fluorescence; and 
similar size to antibody targeted quantum dots that are used in high-sensitivity cellular 
imaging (4, 7, 186, 221, 265). 
 
B.3. Vision for Self-Assembling Cell Probe Delivery, Intracellular Targeting and 
Protein Imaging 
 Many of the existing limitations of single molecule investigations of cells can be 
overcome using newly developing classes of ultrabright fluorescent probes, such as MEF 
particles, if such probes can be introduced and homed in cells. To incorporate such 
probes requires probe delivery and targeting in cells.  Here, we propose a cell probe 
delivery and targeting methodology that is adaptable to diverse fluorophores and hence 
will ultimately enable intracellular protein imaging using increasingly-bright fluorophore 
tags. 
 Our goal in this proposal is to develop a modular molecular probe technology for 
cell microscopy to detect intracellular proteins and protein complexes through homing of 
extracellular probes, fused to fluorophores, to intracellular genetically-encoded targets in 
the cell.  The fundamental approach of the technology is shown schematically in Figure 
1.  
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Figure 1.  Scheme of cell imaging using self-
assembling coiled-coil probe and target 
modules, and the four objectives of RFA-06-
288 that we will be able to address in this 
technology research and development study. 
In the self-assembling probe target system, the 
probe fluorophore is introduced from outside 
the cell and contains a coiled peptide tagged with a fluorescent tag to provide the 
enhanced signal. The probe module ultimately will be able to incorporate metal-
enhanced fluorophores that are several orders of magnitude brighter than existing 
fluorescent protein fusions and more resistant to photobleaching.  The target is a 
genetically expressed protein in the cell that contains a coiled peptide sequence 
complementary with the probe coiled peptide.  The target can be encoded to contain a 
fluorophore domain of its own that forms a FRET pair with the probe fluorophore, 
enabling detection of the target by a specific FRET signal. This technology will form the 
basis to image diverse target sequences as they occur within the protein networks of the 
cell.  Long term, molecules that form non-covalent assemblies with the target can also be 
imaged, and factors that control these assemblies can be identified.   
 Coiled-coil designs, recombinant protein constructions and cell systems to test the 
fluorescent probe cell delivery, targeting and imaging technology of Figure 1 have been 
developed in the Chaiken group at Drexel University College of Medicine (48, 96, 242).  
The coiled-coil delivery system will be tested with a range of fluorophores, including 
ultra-bright metal-enhance nanoparticles (8) through the expertise of the Geddes 
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laboratory at the University of Maryland Biotechnology Institute.  Delivery investigations 
will be facilitated by the Cell and Protein Mechanics Lab at Drexel, led by the Layton 
group, which has established expertise in cell microinjection (213), microfluidics (148), 
nanomanipulation (150), single mitochondria imaging (149) and nanoprobe assembly 
(207).  The opportunity for synergy between the Chaiken, Geddes and Layton groups to 
develop and test enhanced molecular imaging in cells through coiled-coil probe-target 
assemblies leads us to this proposal. 
 The self-assembling cell probe delivery system envisioned in Figure 1 will utilize 
complementary coiled peptide sequences on synthetic cell probe and intracellular 
genetically encoded target that will enable formation of high affinity coiled-coil 
assemblies for cellular imaging of the targets.  The coiled-coil motif is a well-
characterized conformational scaffold in proteins, involving two or more supercoiled 
alpha-helices. As shown by the prototype in Figure 2, synthetic coiled-coil peptide 
dimers can be formed using heptad repeat sequences denoted as (a b c d e f g)n. Positions 
a and d in each helix are hydrophobic amino acid residues and form the majority of the 
coiled-coil interface.  Residues at positions e and g are charged and serve to increase the 
strength of the coiled-coil association. Our coiled-coil is designed such that heterodimers 
will be stabilized by interaction between basic residues bounding the hydrophobic face of 
one helix and acidic residues in similar positions on the other. The remaining residues (b, 
c and f) are exposed to solvent in the dimeric coiled-coil structure and therefore variable.  
We and others previously have designed and validated heterodimeric coiled-coil 
structures from synthetic peptides (48, 60, 96, 171, 242).  Such dimeric structures have 
been used, for example, as stable, oriented and renewable biosensor capture elements, 
  
201
 
and function in crude lysates (35, 36, 60, 69, 243, 275).  The use of genetically-encoded 
or externally applied coiled-coils on and in cells has yet 
to be explored. 
Figure 2. Helical wheel diagram of the generic R and E 
coiled-coil peptides used in this study. Each peptide 
design includes 5 heptad repeats for high affinity 
interaction.  
 
B.4. Addressing the Objectives of RFA-07-234 and Challenges in the Technology 
Development 
 The technology research and development study proposed here provides an 
experimental framework that will enable us to address all four objectives of RFA-07-234. 
[1] Non-disruptive delivery into cells: We will investigate and develop methods to 
deliver coiled peptide probes into cells, by such methodologies as electroporation, 
endocytosis and microinjection, and will compare the viability of cells in response to 
these methods of delivery. 
[2] Specific targeting of sub-cellular targets: We will localize genetically encoded 
coiled peptide-labeled targets in cells and detect their movement in response to cellular 
stimuli such as cytokine activation. 
(172) Lack of interference with targeting and normal cell physiology: We will 
investigate the viability of cells containing coiled peptide probes and targets both for 
general survival, ability to bind cell surface receptors and activation of intracellular 
phosphorylation. 
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 [4] Single molecule sensitivity: We will develop chemistries to produce increasingly 
ultra-bright coiled peptide probes and test their detection limits for specific cellular 
targets.  With metal-enhanced fluorophores, we will look for increased detectability of 
between 100-400 fold.  
 While technologies we have already developed provide a strong starting point to 
meet the objectives of this RFA, there are nonetheless important technological challenges 
that we will have to address and overcome experimentally.  Perhaps most apparent is 
non-disruptive delivery of coiled peptide probes into cells.  We believe we have a viable 
path to accomplish this important objective based on the charged characteristics of coiled 
peptides, one of which has multiple negatively charged side chains arrayed along the 
length of the heptad repeat sequence and the other of which has multiple positively 
charged side chains.  Electroporation of negatively charged DNA (137) forms a precedent 
for applying this method to probes containing the negatively charged coiled peptide 
component.  On the other hand, the precedent to deliver Arg-rich sequences into cells by 
receptor-mediated endocytosis (122) forms a precedent to investigate endocytosis for 
delivery of probes containing the positively charged coiled peptide component.  In this 
project, we will utilize microinjection of cell probes to compare and assess the more 
generally-accessible electroporation and endocytosis methods.   A second major 
challenge is achieving intracellular detection with single molecule sensitivity and 
specificity.  We believe that prior work on metal-enhanced fluorophores in the Geddes 
group makes the achievement of single molecule sensitivity feasible using the coiled-coil 
probe delivery system once developed.  The brightness of the fluorophores and the 
potential for intracellular FRET provide useful experimental starting points to reduce 
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background glow in the cell and achieve adequate specificity in target detection.  An 
additional challenge for specificity is the possibility that coiled peptide cell probes may 
associate with normally occurring coiled peptide-containing proteins in cells.  The ability 
to design coiled peptide sequences to control their association affinities (170, 171) 
provides a starting point to reducing non-specificity caused by inadvertent coiled peptide 
association.   
 
B.5. Comparison with Related Alternative Technologies  
 Several technologies for cellular imaging of protein targets have been reported 
and must be compared with the current proposal for strengths and weaknesses.  
1. Oligonucleotides have been used to carry fluorescent probes into cells and to pair 
with intracellular DNA (215) using complementary “Velcro” binding.  This widespread 
technique, fluorescence in situ hybridization, is similar in concept to what we envision 
with coiled-coil peptides.  However, typically this method does not enable imaging of 
protein targets.  A probe-target strategy similar to our current proposal has been reported 
in which the probe is a biarsenite-fluorescent analogue delivered into cells to associate 
with protein targets genetically encoded with tetracysteine sequences (98, 169).  
However, the potential exists for oxidation of the Cys SH groups in tetraCys sequences, 
and also for high non-specific backgrounds due to other Cys-containing proteins in the 
cell. The peptide system proposed here provides the opportunity to fuse specific, high-
affinity targeting components to proteins while adding minimal size onto the fluorophore.  
Antibody delivery of fluorophore probes for protein targeting can be envisioned.  
However, probe size of ~150kDa necessitates cell permeabilization for 
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immunofluorescence imaging and limits diffusion within cells.  Furthermore, this 
approach requires a different antibody-fluorophore fusion with potentially variable 
affinities for each target.   Avidin-biotin targeting pairs are also in the realm of 50kDa, 
limiting diffusion, and can suffer from high endogenous biotin levels in vivo.   
2. Fluorescent proteins isolated from jellyfish and later coral have been developed to 
genetically encode intracellular proteins with fluorescent labels (245).  Advances with 
these fluorescent fusions have led to brighter and more stable chromovariants for FRET 
pairs to monitor molecular interactions (226, 245).  The resulting technology of 
genetically encoded fluorescent protein fusions has had a massive impact on modern 
cellular imaging and its use to investigate biological mechanisms.  Recently, a fluorescent 
amino acid analogue was genetically encoded into proteins at distinct locations 
throughout the protein sequence (259).  These technologies all have limitations of 
fluorescence yield and photobleaching that preclude single molecule detection and FRET 
distances beyond ≈ 6 nm.  In stark contrast, nanoparticles such as metal enhanced 
fluorophores offer advantages in spectral characteristics such as high photon flux and low 
(or no) photobleaching.  These MEF particles require packaging and delivery to label 
intracellular targets.  We will test delivery of ultra-bright fluorophores as an application 
of the coiled peptide fluorophore probe delivery and imaging technology to be developed 
in this proposed project.  
 
EXPERIMENTAL PLAN 
This technology research and development project has 3 specific aims that will 
directly address the 4 objectives of RFA-07-234.  Long term, this project will 
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provide core probe delivery capabilities for imaging protein complexes and spatially 
and temporally resolved events in cells. 
 
D.1. Specific Aim 1 - Cell Entry of Coiled-Coil Peptide Fluorophore Probes. 
 Establish methodology for delivery of coiled peptide probe modules with 
fluorophore tags into cells by processes that maintain cellular viability. Evaluate the 
feasibility of electroporation and endocytosis processes to achieve delivery. Compare 
with delivery using microinjection.  Demonstrate the range of applicability with multiple 
cell types. 
 
D.1.a.  Synthesis and Assembly Validation In Solution and On Cells 
 Probe modules will contain coiled peptide sequences that will ultimately form 
high affinity coiled-coil assemblies for cellular imaging of genetically encoded coiled 
peptide targets.  Based on prior successful dimer designs (48, 96, 242), we will produce 
probe-target module coiled peptide sequences starting with one peptide comprised of five 
Arg-rich heptads (positively charged in e and g positions) and the complementary peptide 
comprised of five Glu-rich heptads (negatively charged in e and g positions).  Both 
positively and negatively charged components will be synthesized using conventional 
solid phase peptide synthesis (Applied Biosystems 433A/Protein Technologies 
Symphony) with Fmoc chemistry, purified via reverse phase HPLC (Agilent 1100) and 
validated by mass spectrometry (Wistar Proteomics Facility, Philadelphia, PA).  A 
number of coupling chemistries will be used as needed in order to covalently attach 
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fluorophores to coiled peptides, as shown in Figure 3.  Importantly, the coiled peptide 
probes will be adaptable to diverse fluorophores.  
Fig. 3. Chemistries for covalent formation 
of coiled peptides fluorophores through 
reactions at amino, sulfhydryl or alkyne 
groups incorporated into the peptides.  Initial fluorophores to be tested will include Alexa 
and tetramethylrhodamine.  N-hydoxysuccinimide and maleimide derivatives of these  are 
suitable for coupling to amino and sulhydryl groups on peptides and are available from 
Invitrogen.  The N-hydroxysuccinimide can be reacted with azido amino acids such as 
azido-alanine to form an azidofluorophore; this can be reacted with peptide alkynes 
(139)  for additional specific routes to coiled peptide fluorophore probes. 
 We will test the viability of coiled peptide fluorescent probes to form high affinity 
complexes with gene-encoded coiled peptide targets (Figure 4), initially producing these 
targets as soluble recombinant proteins and utilizing surface plasmon resonance (SPR, 
with sensor surface-immobilized soluble partners) and isothermal titration calorimetry 
(ITC) to characterize formation of complexes outside the cell context.  Cassette DNA 
constructs with C-terminal coiled peptide will initially be made; N-terminal or internal 
coiled peptide locations can also be constructed to assure access for coiled peptide probe 
binding.  Quantitative analyses of coiled-coil formation with recombinant targets will 
enable us to compare the kinetics (by SPR) and affinity (SPR and ITC) of recombinant 
vs. synthetic coiled-coil formation, thus serving as a predictor of specificity for each 
target-probe interaction in the cellular context. Furthermore, ITC will verify the 
stoichiometry of probe:target complexes. 
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 We will test the ability to use FRET to detect binding of probe and target modules 
both in solution and in cell surface imaging.  This will provide a basis to use FRET in 
AIM 3 to improve specificity of intracellular imaging (see D.3.c) with wide-field inverted 
(Olympus IX70) and confocal (Leica TCS SP2) fluorescence microscopy.  For solution 
FRET, we will prepare recombinant target proteins and probe peptides fused to suitable 
FRET partners, including tetramethylrhodamine (TMR) or Alexa 546 on the probe and 
monomeric fluorophore mCherry on coiled peptide target (Fig. 4).  Vectors for 
generating coiled peptide targets will be developed for use in bacteria, insect and 
mammalian cell lines.  Solution studies will use over-expressed recombinant protein from 
bacteria or insect cells containing coiled peptide fused to mCherry, or to mCherry fused 
to a model protein such as IL5 receptor α soluble domain, sIL5Rα (116). FRET efficiency 
will be measured from mCherry emission upon donor excitation, using a 
spectrophotometer (Varian).  For initial cell surface imaging tests, Phoenix cells (see 
D.1.b) will be transiently transfected with full length IL5Rα expressed on the surface (51) 
and will contain N-terminal coiled peptide complementary to coiled peptide probe. The 
ability of the probe to bind to the target on the cell surface will be tested by localization 
of probe fluorescence emission and also by FRET using Phoenix cells displaying an N-
terminally tagged coiled peptide-mCherry-IL5Rα construct. Stable cell lines will be 
derived in such cases to provide continuous cell resources with tagged intracellular 
targets.  
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Figure 4. Strategy for cloning and 
recombinant expression of target 
proteins with E42C acidic coiled 
peptide tag.  Genes encoding 
proteins of interest can be inserted 
as cassettes into multiple cloning 
sites (MCS) in bacterial, insect and 
mammalian plasmids, to be 
translated as fusions with the target peptide. Purified targets, including fluorescent 
fusions, will first be tested for association with fluorescent probe peptide conjugates in 
solution. Subsequently, formation of target-probe complexes will be analyzed on live cells 
using FRET. These constructs will consist of E42C and a FRET partner fused to the N-
terminus of transmembrane glycoprotein IL5Rα. Lastly, the E42C coil can be directed to 
various intracellular locations using membrane anchor sequences or by fusion with 
proteins that translocate in response to cellular signals, e.g. transcription factor STAT.  
 
D.1.b. Cells for intracellular delivery  
 The overall goal of this project is to develop a cell probe technology that will be 
useful for imaging proteins in diverse cell types to enable investigation of a range of 
biological processes.  To demonstrate feasibility for introducing fluorescent probes into 
cells, we will focus on delivering probes into recombinant cells, as these are the cells we 
will use to investigate targeting and imaging in AIMS 2 and 3.  As an initial model 
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system for delivery, targeting and imaging, we will use adherent Phoenix cells.  We have 
experience culturing and transfecting these cells and imaging them using fluorescence 
microscopy (302).  We will test for the ability to deliver fluorescently-labeled coiled 
peptide probe fluorophores into these cells, as delineated in D.1.c.  These cells will 
enable us to compare probe delivery by transfection and electroporation with delivery by 
microinjection. In addition to naïve cells, we will prepare Phoenix cells containing IL5-
binding receptor subunits α and βc on their cell surface, with or without signaling 
proteins such as JAK expressed intracellularly.  These will enable assessment of cell 
viability through specific binding and intracellular effects of IL5 in addition to general 
cell viability using Alamar Blue.  
 We also will evaluate probe delivery into non-adherent cells.  Our initial focus 
will be BaF3 cells, a cytokine-dependent early mouse pre-B cell line. Since BaF3 cells 
are human IL5-independent but endogenously express the necessary components for IL5 
cytoplasmic signaling as well as the signaling receptor c, this cell line has been used for 
transfection of the IL5Rα gene (117).  With BaF3, cell viability will be assessed 
quantitatively by IL5 stimulation of JAK/STAT phosphorylation (Western blotting) and 
cell proliferation.  
 To evaluate range of probe delivery technology in later stages of this project, we 
will investigate additional recombinant cells, including HEK293, Jurkat and COS cell 
lines.  293 and COS can be transfected with cytokine receptors as well as intracellular 
proteins and therefore can be used with coiled peptide targets to investigate localization 
and imaging at different cell locations.  Jurkat cells also have been used for peptide and 
protein transfection (238).  Each of these cell lines is expected to offer unique delivery 
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and trafficking challenges and hence provides a means of assessing variations in probe 
delivery behavior in different cell types.  
 We also will investigate probe delivery into a range of other cells that are readily 
available from cell biology re-search programs in the Drexel Biochemistry Dept. (see 
Clifford letter), including breast cancer model cell lines (223) and primary cells such as 
hepatocytes (22).  These latter cells could ultimately be useful to image protein 
movement and interactions during the cell cycle and apoptosis. 
 
D.1.c. Endocytosis and Electroporation of coiled peptide fluorescent probes  
 Delivery of coiled peptide probe modules to intracellular loci is an important 
challenge of this project.  Three means for probe entry will be investigated initially.  We 
will examine probe-treated cells using confocal microscopy and FACS analysis to 
quantify the extent of entry. Toxicity of probes will be monitored via an appropriate cell 
viability assay using Alamar Blue (Biosource, CA). Of the available techniques (254), we 
will focus significantly on batch scale techniques, namely endocytosis and 
electroporation, that are commonly available to biological researchers.  
 Endocytosis. An important precedent for our studies is that endocytosis has been 
observed to occur with arginine-rich cell penetrating peptides, such as HIV-Tat and 
penetratin, which can deliver cargo (PNA, nanoparticles) inside cells (152, 172, 246).   
The R39C coiled peptide has a large percentage of positively charged residues (> 40%) 
and hence, like Tat, may interact electrostatically with negatively charged 
glycosaminoglycan conjugates on cell surface receptors and trigger receptor-mediated 
endocytosis (93, 122, 178). We will investigate the extent to which positively charged 
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coiled peptides can act as membrane penetrants.  We will investigate the effects of 
temperature, time, concentration and pH on internalization of coil peptide probes.  We 
will image fluorescence by wide field (for live cells) and confocal (for fixed and live 
cells) microscopy. We will evaluate mechanisms of entry using known pathway-selective 
and other inhibitors of function.  These will include chlorpromazine for clathrin-
dependent pathways, nystatin for caveolae-dependent pathways, methyl-β-cyclodextrin 
for membrane cholesterol depletion and cytochalasin D for disruption of f-actin 
polymerization.    Controls will be carried out with scrambled coiled peptide sequences to 
examine linear sequence and secondary structure effects on entry. HIV-Tat labeled 
fluorophores will also serve as controls.  We will examine the benefits of treatments to 
release probe modules from vesicles (18, 246) to increase the extent of endocytosis-
mediated probe delivery into the cytosol  and subcellular locations of the cell. 
 Electroporation: We also will investigate electroporation as a means to deliver 
coiled peptide probe modules into cells based on the pervasive use of this methodology to 
deliver DNA and nanoparticles into cells (137, 182).  Electroporation utilizes an 
externally applied electric field to create nanopores in cellular membranes through which 
our probe module may pass.  We will initially investigate probe module conjugated to 
negatively charged coiled peptides in view of the success of electroporation to deliver 
negatively charged DNA into cells. Based on experience with DNA, we will transfect 
coiled peptide into BaF3 cells initially using 960 µF and 260 V (Gene Pulser II, BioRad).  
We will optimize electroporation settings and assess efficiency by imaging cells by 
fluorescence microscopy. 
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D.1.d. Microinjection of Coiled Peptide Probes into Cells 
 As an alternative to endocytosis and electroporation, we will use microinjection to 
deliver probes of varying sizes directly into cells. Microinjection has been found to 
successfully deliver monodisperse quantum dots into cells (63).  This method provides an 
experimental basis to evaluate the extent of fluorophore probe delivery achievable by 
endocytosis and electroporation, and also provides an alternative means to deliver 
fluorophores probes into cells for evaluating the intracellular targeting capabilities of the 
coiled-coil delivery and targeting system (see Sections D.2.b, D.3.b). The Layton 
laboratory has mentoring experience and instrumentation for microinjection into both 
adherent and suspension cells (213), as demonstrated in Figure 5.  We will use glass 
micropipettes with a 500 nm inner diameter and a 700 nm outer diameter (Eppendorf) to 
perform injections on adherent cells. Non-adherent cells will be held in place with a 
second, larger micropipette under suction. Fluorescence excitation and emission will be 
isolated via appropriate filter sets (Olympus) and captured using a side-port mounted 
CCD camera (Spot). Probe delivery will be augmented by nanomanipulation and 
potentially nanoscale injection techniques being developed in the Layton laboratory (26, 
28, 30).  
 
Figure 5. A test microinjection of a Phoenix cell 
performed on the Olympus IX81 inverted 
microscope outfitted with epi-fluorescence and 
Eppendorf NK-2 micromanipulation system.  
 
5μm
Cell Micro-
pipette 
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D.1.e.  Potential problems and alternative approaches 
 Nonspecific probe module binding to outer membrane.  We are mindful that 
non-specific interactions could occur between probe modules and cell membrane 
components.  The surface of the membrane is negatively charged, and peptide-
fluorophore conjugates, especially when these are the positively charged component, 
could remain bound to the cell surface.  Removal may be necessary to minimize 
background signal.  Because the engineered coiled-coil peptide pairs have subnanomolar 
affinity, we will consider adding excess complementary coiled peptide to remove non-
internalized probes via competition.  Another alternative is to remove heparan sulfate, 
which also may electrostatically retain the R-coil peptide on the cell surface, by 
heparinase. We also will investigate enzymatic digestion to remove the extracellular 
domains of cell proteins.  
 Targeting cytoplasmic and organelle specific locations. A significant problem 
that we could encounter is the sequestering of probe module within endosomes and 
lysosomes, a noted concern with endocytosis-mediated entry. If this is observed, we 
propose two means to release probe modules into cytosol: photochemical internalization 
with aluminum phthalocyanine (Frontier Scientific), or electroporation with nanosecond 
pulse fields. Both of these techniques have been shown to disrupt internal membranes in 
cells (18, 246, 254, 262). On the other hand, delivery of quantum dot fluorophores via 
electroporation has led to aggregation of much larger structures (~500 nm) inside cells 
(182).  If our peptide probes undergo such intracellular accumulation, we will investigate 
functionalization with varied peptide-targeting densities that may overcome this potential 
limitation. We believe this is feasible due to the electrostatic and steric repulsion afforded 
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by the charged peptides. If inadequate probe delivery into cells persists, we will employ 
commercially available molecular internalization enhancers, such as jetPEI (Qbiogene) 
and Chariot (Active Motif). 
 
D.2. Specific Aim 2 - Intracellular Imaging of Coiled Peptide Targets.   
 Validate the ability of coiled peptide cell probes to localize within cells and 
dynamically image specific intracellular target sites.  Establish ability to image sites on 
the inner side of the cell outer membrane and on intracellular compartments such as 
mitochondria.   
 
D.2.a.  Expression and localization dynamics of coiled peptide components in cells 
 For developing intracellular targeting with coiled peptide modules, we will 
initially investigate the recombinant co-expression of coiled peptide targets and probe 
simulants in Phoenix and BaF3 cells.  This line of work will establish that protein 
modules containing complementary coiled peptide sequences can be expressed together 
in cells without disrupting normal cell function and that they will bind to each other 
stably in the intracellular environment.  As noted in Section D.1.b, both Phoenix and 
BaF3 cells have already been demonstrated to be tolerant of transfection with diverse 
recombinant proteins (43, 187).  We will express complementary coiled peptides each 
fused to one of two fluorescent proteins of a FRET pair, for example R42-mCherry and 
E42-GFP.  We will determine expression levels by western blot analysis and cell viability 
using an Alamar Blue assay, assessing each component expressed alone, as well as when 
both are co-expressed.  We will use confocal microscopy to compare fluorescence of 
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cells that are singly and dual-transfected and measure the extent of complex-produced 
FRET in the cells using confocal microscopy with 2-color detection. In addition, we will 
use a stable line of BaF3 cells that contains the interleukin 5 receptor system and can be 
activated by IL5 (116).  IL5 activation induces assembly of the receptor subunits α and 
βc, and also leads to downstream phosphorylation and migration of intracellular signaling 
proteins (118, 174).  IL5 receptors and signaling proteins will be used as additional 
intracellular tools to evaluate targeting and imaging properties of coiled peptide probe 
and target modules. As noted in D.1.b, studies will extend to other cell lines and primary 
cells to evaluate range of technology. 
 
D.2.b.  Membrane and intracellular imaging of genetically-encoded coiled peptide 
targets with probe modules  
 We will examine the ability to image gene-encoded coiled peptide targets at 
specific intracellular locations using fluorescent probes.  Eukaryotes use a variety of 
polypeptide sequences to direct newly-synthesized proteins to appropriate locations in the 
cell. These “molecular zip codes” are short sequences that are usually removed by signal 
peptidases upon docking with receptors on the surfaces of target organelles.   Among 
sequences of this type are those for signal anchors, which serve for both targeting and 
retention of proteins on the outer membranes of cellular organelles such as the 
mitochondrion (279) and the endoplasmic reticulum (287) (both hydrophobic 
transmembrane helices).  We will insert nucleotide sequences encoding these signal 
peptides adjacent to the target peptide and express these fusions recombinantly in 
Phoenix, BaF3 and other cells, resulting in the target E42C being localized on the 
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cytosolic face of the organelles (Figure 4).  After delivering peptide-fluorophore probe 
into these transfected cells, we will track specific accumulation of fluorophore at 
appropriate intracellular sites corresponding to the target localization sequences 
incorporated.  As a test for localized imaging on the cytosolic surface of the cell 
membrane, we will express a cell surface receptor such as full length IL5Rα with coiled 
peptide fused on the intracellular C-terminus.  We will look for localization of probe 
molecules containing a coiled peptide complementary to the peptide fused to the C-
terminus of IL5Rα.  We also will test for the ability to image proteins that change their 
cellular locations in response to external stimuli, such as JAK’s, which are recruited to 
the intracellular face of IL5R subunits upon cell stimulation with IL5.  In addition, since 
STAT is known to be phosphorylated at the cell outer membrane (by JAK) and as 
phospho-STAT is a nuclear transcription factor, we will attempt to observe transient 
recruitment of coiled peptide-STAT to the intracellular face of IL5Rα followed by 
movement to the nucleus.  All of the above intracellular gene targets can be expressed 
fused with mCherry.  These latter fluorescent targets will provide tools to visualize the 
localization of the targets themselves in cells. 
 
D.2.c.  Potential problems and alternative approaches 
 Low affinity of coiled peptide R and E peptides when inserted in probe and 
target sequences.  The protein or fluorophore contexts of coiled peptides could affect 
their affinities.  We will optimize coiled-coil formation as needed by adding more heptad 
repeat sequences and/or linker sequences, altering the positions of the coiled peptide 
sequence with respect to other sequence domains and alter the specific sequences in 
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hydrophobic and charged interface regions of the coiled peptide components.  Coiled 
peptide sequence variations will be achieved by peptide synthesis for probes, and by 
recombinant cloning for intracellular targets. 
 Reduced fluorescence signal. Should there be insufficient fluorescence signal 
from the fluorescent probes after coil formation inside the cell, we will increase 
fluorophore loading by multisite attachment enabled by functional groups introduced into 
the probe peptides.  Loading at coiled-coil interfaces will be avoided. 
 
D.3. Specific Aim 3.  Enhanced Specificity and Brightness in Cellular Imaging  
 Test the coiled-coil probe-target system to image with increasing specificity and 
sensitivity.  Demonstrate specific intracellular FRET signals between coiled peptide 
probe and target proteins.  Evaluate the capacity to deliver ultra-bright particle-fused 
peptide probes into cells and, using these, to detect intracellular targets with minimal 
photobleaching using standard fluorescence microscopy tools. 
 Our experimental plan aims to establish that modular, self-assembling coiled-coil 
complexes can form between probe and target sequences, persist within the cell and lead 
to an intracellular imaging technology. In AIM 3, we will seek to improve signal to noise 
and specificity in intracellular imaging, through investigations with ultra-bright 
fluorophore particles and intracellular FRET between probe and target. 
 
D.3.a. Evaluation of MEF particles with ultra-bright fluorescence characteristics  
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 We will test applicability of coiled peptide probe delivery and targeting for ultra-
bright sensing using MEF fluorophores.  We will prepare silica coated silver colloids 
(Ag@SiO2) containing immobilized MEF fluorophores (Figure 6) for direct imaging, or 
for use as either a FRET donor or accepter. Silver colloids will be produced, then coated 
with SiO2.  Fluorophore and coiled peptide will be immobilized independently. Varying 
concentration ratios of reagents and blocking agents such as hydrophilic alkoxy silanes 
will be used to fine tune fluorophore and peptide loading.  Silver colloids average 20-50 
nm and have tunable diameter (160). Metal-enhanced fluorescence studies to date (8, 84-
86) indicate that a silica shell thickness between 2-5 nm gives the greatest enhancements 
in signals of coating-immobilized fluorophores (10).   
Figure 6. Synthesis of the MEF-
probes with surface chemistries for 
both fluorophore and peptide 
attachment. Ag@SiO2 particles will 
be reacted with mixtures of 3-
aminopropyl triethoxylsilane (APS) 
and 3-azidopropyl trimethoxysilane (AzPTS). Amino and azido sites introduced on the 
silica surface will be used for fluorophore and coiled peptide covalent attachment, the 
latter through copper-catalysed cycloaddition to form triazoles (139, 197).  Sulfhydryl 
groups (via 3-mercaptopropyl triethoxysilane) and carboxyl groups through iodoacetic 
acid conversion of sulfhydryl groups are among other functionalizations that can be 
introduced.   
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 A wide range of fluorophores and luminophores are available for attachment to 
sol-gel amine groups. This diversity will enable incorporation of bright fluorophores and 
FRET partners for target-incorporated fluorescent protein fusions. Early experiments will 
incorporate tetramethyl rhodamine (TMR) and Alexa Fluor 532 given their 
photostability, high quantum efficiencies, and favorable FRET pairing possibilities with 
fluorescent protein fusions such as mCherry (244) on coiled peptide targets.  MEF probes 
containing coiled peptide will be separated by centrifugation. Differently-sized MEF 
probes will be developed by changing the silver core (20 to 50 nm) and thickness of the 
silica shell (2 to 35 nm) (12).  MEF-nanoparticles will be characterized for physical 
dimensions and uniformity using transmission electron microscope (TEM) (Jeol Jem 
1200 Ex II Microscope) and Atomic Force Microscope (TMX 2100 Explorer SPM, 
Veeco).   
 With standard fluorescence quantification instrumentation, quantum yields of 
synthesized particles will be evaluated in bulk solutions and compared to quantum dots, 
fluorescent proteins and high quantum yield dyes.  Also, since decreased lifetimes and 
hence increased fluorophore photostabilities are expected in the presence of metal, 
photostabilities (integrated intensity at a given wavelength over time) of the synthetic 
particles will be measured to fully characterize the’ improved fluorescence 
characteristics. Photostability measurements will be recorded by immobilizing 
fluorescent particles on glass or quartz substrates and exposing them to excitation 
intensities (irradiances) comparable to those intended for intracellular measurements. 
 
D.3.b. Evaluate the viability of delivery of MEF-type probes 
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 Many recent reports detail the use of quantum dots for single molecule 
intracellular imaging (52, 176, 183).  Several strategies have been devised to minimize 
the cytotoxic effect of quantum dots; many involve surface chemistries that can be 
adapted to the MEF particles.  Initially, we use microinjections to evaluate the cytoxicity 
of different sized MEF particles (20-50 nm) without any surface modifications and 
compare with levels of toxicity observed for quantum dots (64).  Though we are mindful 
that microinjection places stress on a cell, success provides precedence for our proposal 
(63). 
 Using electroporation and endosomic delivery methods, we will investigate the 
delivery of coiled peptides conjugated to MEF particles.  We also will investigate the 
impact, on effectiveness of delivery, of variables such as linkage chemistry, linkage site 
in peptide sequence and peptide loading on the MEF nanoparticles.  We will assess 
targeting to intracellular targets. Delivery of probes labeled with gold particles, and 
imaging by scanning EM and plasmon scattering (9, 10), will provide a means to further 
assess nanoparticle delivery capabilities of coiled peptide probes.  
 
D.3.c. Enhanced specificity of cellular imaging offered using FRET between probe 
and fluorophore-containing coiled peptide target modules. 
 Previously published work has detailed the high affinity of coiled-coil modules.  
Our experimental plan aims to establish that this powerful and specific interaction can 
form between probe and target sequences and persist within the cell. Going forward, we 
will seek to improve signal to noise in intracellular imaging.  As one part of this work, we 
will incorporate FRET pairs using the fluorophore probe and coiled-coil peptide target 
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and observe appropriate FRET, as distinguished from probe fluorescence alone in vitro 
and in vivo. Initial intracellular FRET studies will be performed using the microinjection 
technique outlined in section D.1.d.  For example, the MEF probe containing TMR or 
Alexa 546 will be microinjected into the cells and the coiled peptide target with fused 
mCherry will be recombinantly expressed in the cell.  
 
D.3.d. Potential problems and alternative approaches. 
 Low FRET efficiency and spectral bleed-through.  Donor-acceptor spectral 
overlap may generate contamination of the FRET and, more importantly, the acceptor 
emission signal.  We will evaluate a number algorithms and techniques (40, 210) to 
remove this spectral bleed-through.  
 Aggregation of peptide-linked MEF probes.  Aggregation of the MEF probes, 
especially larger sizes, could occur, resulting in decrease in efficiency of coiled-coil 
formation. Should this occur, we will vary the number of peptides linked to the MEF 
probes by changing available surface groups on/within the MEF probes, and/or vary the 
site of linkage of peptide to MEF probe. 
 Inadequate fluorescence signal with MEF probes for single-molecule imaging.  
Should there be insufficient fluorescence signal from the MEF probes after coil formation 
inside the cell, we will increase fluorophore loading in the MEF probe, increase the 
diameter of the silver particle or use lanthanide probes (146) to off-gate biological auto-
fluorescence (nanosecond time scale) due to their long lifetimes (micro-seconds).  
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D.4. Milestones and Long-Term Plans 
     Quantitative milestones to monitor progress in this research and development 
project are as follows: attain nM Kd between coiled peptide fluorophore probes and 
coiled peptide targets in solution for both organic dye and nanoparticles; demonstrate 
internalization of coiled peptide probes in adherent and non-adherent cell lines and 
primary cells; establish cassette recombinant expression vectors for coiled peptide targets 
in recombinant cells and demonstrate intracellular expression; demonstrate formation of 
probe-target complexes in cells with retention of cell viability; quantify the extent of 
single particle detection of MEF probes and their coiled-coil complexes in solution, on 
cell surface and inside at least one recombinant cell line. 
 Long term, the modular, self-assembling coiled-coil probe-target platform 
technology adapted to ultrabright fluorophores can be used as a springboard to map 
intracellular complexes between coiled peptide targets and target-binding proteins using 
FRET between probe, target, and target-associating proteins. Delivery and targeting of 
ultrabright cell probe fluorophores also will provide new opportunities to investigate the 
use of image correlation spectroscopy (ICS or RICS) and fluorescence correlation 
spectroscopy (FCS) to resolve complex dynamic signaling processes in living cells.  
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APPENDIX 3:  SOLID PHASE PEPTIDE SYNTHESIS PROTOCOL 
 
 
 
 
1. Weigh amino acids in cartridges (for 0.25 mmole scale -> weigh 1 mmoles of aa, 4x; 
for 0.1mmole scale -> weigh 0.5 mmoles of aa, 5x) 
2. Seal cartridges with a 13 mm cap and flatten the top of the seal on a flat surface. 
Unflattened caps may jam during the eject cartridge sequence. If there is an aluminum 
tab on the cap, remove tab. 
3. Check level and fill, if necessary, external bottles with peptide synthesis grade NMP 
(N-methyl-2-pyrrolidinone) and DCM (dichloromethane, CH2Cl2) 
4. Fill bottle 1 with piperidine 
5. Fill bottle 5 with 0.45M HBTU/HOBt solution (2-(1H-Benzotriazole-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate/N-Hydroxybenzotriazole · H2O; weigh 13.5 
g  of HOBt, put in 250 ml cylinder , add DMF (dimethyl formamide) until 200 ml 
level; stir solution until all solid is dissolved; in a 500 ml flask or beaker put 37.9 g of 
HBTU, add the HOBt solution and stir until HBTU is completely dissolved; filter on 
funnel with paper filter).  This solution is stable up to two weeks; for long peptides 
use fresh reagents.  
6. Fill bottle 6 with methanol 
7. Fill bottle 7 with DIEA (N,N-Diisopropylethylamine) 2 M in NMP (34.8 ml of DIEA 
+ 65.2 ml of NMP). This solution is stable up to 3 months 
8. Change 4 on-line filters 
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9. Open nitrogen gas tank valve (around 65 psi), turn the synthesizer on and open 2 vent 
valves (to “up” position; pressure around 10 psi) 
10. On computer, open Synthassist software, go to SYNTHESIZER → CONNECT →  
select COMUNICATION ENABLED (phone icon should be highlighted) →  OK 
11. FILE → OPEN →  “Flow test 1-18_10 sec” 
12. SYNTHESIZER → SEND →  OK 
13. On the instrument, selecting “test modules”, select test B (4x, NMP), D (4x, HBTU), 
H (2x, DIEA), a (2x, piperidine), g (1x, DIEA) Record values, if values are outside 
tolerances, clean lines or adjust program as described in the manual. 
14. FILE →  OPEN →  “Flow test 19-23_10 sec” 
15. SYNTHESIZER →  SEND →  OK 
16. FILE →  NEW →  RUN →  click “sequence” and put “none”, click “calculation” and 
put “cycles”, click on “modules” and type “b” →  Enter 
17. FILE →  SAVE AS →  OK 
18. SYNTHESIZER →  SEND →  OK 
19. Click on monitor (to open it); on the instrument, select module “b” and start 
20. FILE → NEW → SEQUENCE → type your sequence → SAVE AS 
21. FILE → OPEN → “Fast moc 0.25(or 0.10) Ω Mon Prev Pk”; SYNTHESIZER → 
SEND → OK 
22. FILE → NEW → RUN → click on “amide resin”, select “Rink amide” 
23. Click on “Subst.(mmol/g)”, type substitution value listed on resin,  Enter 
24. check mg of resin to weight (on “weight” column) 
25. FILE → SAVE AS → OK 
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26. SYNTHESIZER → SEND → OK 
27. Weigh the resin on a weighing paper and put it in the appropriate reaction vessel (for 
0.1 or 0.25 mmoles scale), with filters on top and bottom 
28. Put reaction vessel on the instrument in place of measuring cylinder 
29. Put amino acid cartridges from step 1 on the instrument (from N to C terminus); 
remember to put an extra cartridge (empty) as first cartridge 
30. To start the synthesis, on the instrument, go to main menu → monitor → continue → 
…no → begin 
31. When the synthesis is complete (“Synthesis complete” on the instrument display), 
turn off the machine, close vent valves (put them down) and nitrogen tank valve; 
remove the reaction vessel and replace it with the measuring cylinder 
32. Remove used cartridges, remove the caps, wash them with H2O and acetone and let 
them dry.  Empty waste tank into chemical waste container  
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APPENDIX 4: DETERMINATION OF BIOMOLECULE CONCENTRATION 
 
 
 
 
 In many applications involving biological materials it is critical to identify 
fractions that contain samples or determine the concentration of the purified sample.  
Nucleic acids and amino acids containing aromatic side chains (tyrosine, phenylalanine 
and tryptophan) possess the characteristic alternating single-double-single carbon 
bonding pattern that absorbs photons in the ultraviolet region.  Consequently, these 
biomolecules absorb UV light proportional to their aromatic content and total 
concentration.  
 The basis for spectrophotometric determination of concentration is as follows: 
The ratio of radiant power transmitted (P) to the radiant power incident (P0) on the 
sample is defined as the transmittance (T): 
 T = P / P0 
Absorbance (A) is defined as the logarithm base 10 of the reciprocal of transmittance: 
 A = log (1/T) = - log T 
In a spectrophotometer, monochromatic light is incident at right angles to the plane-
surface of the sample and the absorbance follows Beer’s Law: 
 A = ε c L 
where ε is defined as the molar absorption coefficient in cm-1 M-1, c is the concentration 
in M and L is the path length in cm which the monochromatic light passes through. 
Beer’s law states that the molar absorption coefficient is constant and the absorbance is 
proportional to concentration for a given substance dissolved in a given solute for a given 
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wavelength. Standard spectrophotometers often have cuvettes with path lengths of 1 cm 
and the concentration is simplified to: 
 c = A / ε 
 Upon determining the molar extinction coefficient, concentration can be 
calculated from its absorbance.  For tryptophan, absorption is maximum at 280 nm and 
the extinction coefficient is 3400 M-1 cm-1 whereas, for tyrosine, absorption is maximum 
at 276 nm and the extinction coefficient is a less-intense 1400 M-1 cm-1. Phenylalanine 
absorbs light less strongly and at shorter wavelengths. The absorption of light at 280 nm 
can be used to estimate the concentration of a protein in solution if the number of 
tryptophan and tyrosine residues in the peptide or protein is known. 
 The concentration measurement is not accurate for complex solutions such as cell 
lysates, because many protein and nucleic acid components contribute to the absorbance 
in the UV range.  Typically the absorbance of pure solutions proteins and peptides are 
measured at 280nm, using 320nm as a reference. For nucleic acids, a solution containing 
50 µg/ml of double stranded DNA has an absorbance value of 1.0 at λ = 260 nm, thus the 
concentration in µg/ml or ng/µl of DNA can be calculated as follows: 
 DNA [µg/ml] = 50 x A260       
For single stranded DNA and RNA use 40, and for oligonucleotides use 20 in lieu of 50. 
Pure DNA has A260/A280 ratio between 1.8 and 2.0. If the ratio is somewhat smaller, it 
indicates a contamination and it may be necessary to purify the DNA again. It is 
important to note that sample cuvettes should be made of quartz when using ultraviolet 
wavelengths because materials such as plastic absorb light in this region. 
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